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Summary
Alcoholism is a psychiatric disorder whose main symptom is an uncontrollable desire to
consume alcoholic beverages and which is often associated with a disturbed impulse con-
trol. The aim of this thesis was to improve the understanding of the molecular foundations
of alcohol addiction and impulsive behaviour through four gene expression studies.
The ﬁrst sub-project analysed if there is an interaction between alcohol addiction and
the body's `endogenous clock'. DNA microarrays were used to measure genome-wide tran-
scription rates in the nucleus accumbens of alcohol-drinking rats and control animals at
diﬀerent times of the day. The experiment did not provide evidence that such a systematic
interaction is taking place in the investigated brain region. Based on the vast number of
genes that were found to be diurnally oscillating, the study could nonetheless show how
important it is to consider the time of measurement as an important variable in gene
expression experiments.
The second sub-project aimed at registering genome-wide transcription curves over a
period of 24 hours in the blood of healthy human volunteers. Using also DNA microarrays,
the main focus was again on genes with circadian oscillating expression levels. The obtained
rhythmic expression proﬁles were mostly from immune genes and can now be used as a
baseline for a follow-up study which will assess the impact of alcohol addiction on diurnal
gene expression proﬁles in human blood.
In the third study we analysed genome-wide transcription levels in the infralimbic cortex
and the nucleus accumbens of rats which had been selectively bred for extremes of high and
low impulsivity. This microarray study discovered several genes which were closely linked
to the degree of impulsive behaviour in the rats. Some of the most diﬀerentially expressed
genes were P2ry12, Frzb and Gprc5b.
In the fourth sub-project we analysed the expression of four candidate genes, AUTS2,
GRIN3A, RASGRF2 and TACR1 in brain tissue taken from deceased alcoholics and non-
alcoholic control persons. The expression of AUTS2 was linked to a single-nucleotide poly-
morphism (SNP) which was situated in an intronic region of the gene and which had been
previously associated with increased alcohol consumption. No such link could be establis-
hed for RASGRF2 concerning a similarly situated SNP. The expression of GRIN3A was
elevated in the prefrontal cortex and the expression of TACR1 diminished in the anterior
cingulate cortex of alcohol addicted subjects.
v

Zusammenfassung auf Deutsch
Alkoholismus ist ein Krankheitsbild der Psychiatrie, das durch einen unkontrollierbaren
Drang zum Konsum alkoholhaltiger Getränke gekennzeichnet ist und häuﬁg mit einer ge-
störten Impulskontrolle einhergeht. Ziel dieser Arbeit war es die molekularbiologischen
Grundlagen der Alkoholsucht und der Impulsivität anhand von vier Genexpressionsstudi-
en besser zu verstehen.
Die erste Teilstudie ging dabei der Frage nach, ob es eine Wechselwirkung zwischen
Alkoholismus und eine Störung der körpereigenen inneren Uhr gibt. Dazu wurde mit-
tels DNA-Microarrays die genomweite Transkription im Nucleus accumbens von Alkohol-
trinkenden Ratten sowie Kontrolltieren zu verschiedenen Tageszeitpunkten gemessen. Das
Experiment hat keinen Hinweis auf eine derartige, systematische Wechselwirkung in der un-
tersuchten Hirnregion geliefert. Aufgrund der Vielzahl an detektierten tageszeitabhängigen
Genexpressionskurven konnte die Studie aber zeigen wie wichtig es ist bei Genexpressions-
experimenten den genauen Messzeitpunkt zu wählen und in allen Gruppen konstant zu
halten.
Die zweite Teilstudie hatte zum Ziel über einen Zeitraum von 24 Stunden die genomwei-
te Transkription mittels DNA-Microarray Technologie im Blut von gesunden Probanden
zu messen. Der Fokus lag hier wiederum auf Genen mit tageszeitabhängig oszillierender
Expression. Die detektierten rhythmischen Expressionskurven stammten zum größten Teil
von Immungenen und können nun als Ausgangsbasis für eine Fortsetzungsstudie zur Stö-
rung der zirkadianen Genexpression im Blut von alkoholabhängigen Patienten dienen.
In der dritten Teilstudie wurde die Genexpression im infralimbischen Kortex und im
Nucleus accumbens von Ratten untersucht, die bidirektional auf eine möglichst geringe
oder eine möglichst hohe Neigung zu impulsivem Verhalten hin gezüchtet worden waren.
Eine Reihe von Genen konnte ermittelt werden, die im Zusammenhang mit dem Hang zur
Impulsivität standen, darunter P2ry12, Frzb und Gprc5b.
In der vierten Studie wurde die Expression von vier Kandidatengenen, AUTS2, GRIN3A,
RASGRF2 und TACR1 im Hirngewebe von verstorbenen Alkoholikern und Kontrollper-
sonen untersucht. Während die Expression von AUTS2 im Zusammenhang mit einem
Einzelnukleotid-Polymorphismus (SNP) stand, der in einem Intron des Gens liegt und mit
einem verstärkten Hang zum Alkoholkonsum assoziiert worden war, konnte für RASGRF2
kein derartiger Zusammenhang bezüglich eines ähnlich gelegenen SNPs festgestellt werden.
Im Gehirn von Alkoholkranken war die Expression von GRIN3A im präfrontalen Kortex
verringert und die von TACR1 im anterioren Teil des Gyrus cinguli erhöht.
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1. General Introduction
The ancient Greeks, having become masters in the art of wine making, soon realised the
ambivalent nature of their liquid product. While they enjoyed its exhilarating and relaxing
eﬀects, they became wary of its inebriating and addictive properties and urged for mod-
eration in consumption. In fact, wine was mostly served diluted with water. Nonetheless,
drunkenness was commonplace and the Greek philosophers started speculating how wine
could exert its magic eﬀects on men. Among the most popular theories was the belief that
there was a daemon, or spirit, of wine who would enter the human body with the ingestion
of the fermented grape juice and take control over the drinkers thoughts and emotions
causing madness (Thompson, 2010).
More than 2,500 years have passed since the Greeks made their ﬁrst experience with
alcohol but the problems caused by it are as prevailing today as they were then. Although
the perception of what is the main problem with alcohol has shifted. Sure, drunkenness is
still a problem, as accidents and emergency departments as well as law enforcement oﬃ-
cers witness on a daily basis. But the biggest danger of alcohol does not lie in occasional
surges of insobriety, as dangerous as they might be. It lies in the fact that alcohol is both
addictive and, when applied in higher doses or over longer times, severely organotoxic. So
the neutral daemon of wine of the Greek mythology turned out to be a demon, an evil
spirit pushing men to loose control over their drinking habits and ruining their body and
mind.
The majority of people consume alcohol occasionally and in moderate manner which is
regarded safe from a medical point of view. But the toll of those whose consumption does
not stay moderate is high. The federal government of Germany estimates that out of its
current population of 82 million, 9.5 million (12%) consume alcoholic beverages so exces-
sively that their health is at risk. An estimated 1.3 million of them (1.6% of the population)
have a full-blown addiction to alcohol (Die Drogenbeauftragte der Bundesregierung, 2012).
The deﬁnition of alcohol addiction is thereby based on the classiﬁcation set out in the
Diagnostic and Statistical Manual of Mental Disorders (Version IV) of the American Psy-
chiatric Association (2000). It describes alcohol dependence as a psychiatric condition
which is characterised by a `maladaptive pattern of alcohol use, leading to clinically sig-
niﬁcant impairment or distress' which has to meet at least three of the following criteria
within a period of twelve month:
 An abnormal tolerance towards the intoxicating eﬀects of alcohol.
 Withdrawal symptoms when alcohol is not available.
 Alcohol is consumed in larger amounts or over a longer period than was intended.
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 Unsuccessful attempts to reduce alcohol consumption despite having the desire to
stop drinking.
 Obtaining, drinking and recovering from alcohol absorb a great deal of time.
 Neglect of other social and occupational activities for the sake of obtaining and
drinking alcohol.
 Continued consumption of alcohol despite experiencing persistent or recurring phys-
ical or psychological negative consequences due to the consumption.
While the American Psychiatric Association used the term alcohol dependence in their
manual, it has been proposed that this word should be reserved to describe the purely
physiological dependence (Spanagel, 2009). Alcoholism as a whole, with its interwoven
relationship of physiological as well as psychological and social aspects, should then be
referred to as alcohol addiction as it will be done in this thesis.
Biological research on addiction tries to bridge the gap between these diﬀerent aspects,
especially when the focus of research is on the psychological phenomenon of craving, which
describes the intense urge of an addicted person to re-administer the drug. Biomedical
research tries to discover the modiﬁcations of cell receptor densities, gene expression rates
and neuronal circuits which can be related to this phenomenon. Another example is the
analysis of epigenetic modiﬁcation, such as DNA methylation, which arise as a consequence
of diﬃcult childhood and which might modify gene expression and thereby brain respon-
siveness to stress and drugs throughout the whole life (McGowan and Szyf, 2010).
The ﬁrst challenge in biological addiction research was to discover the targets of alco-
hol in the human body. Today we know that alcohol interacts primarily with ﬁve neu-
ronal cell surface receptors and two ion channels (see table 1.1 for an overview). Alcohol
slows down brain activity by increasing the signalling of the inhibitory neurotransmitter
γ-aminobutyric acid (GABA) via its activation of GABAA receptors and decreasing the
signalling of the excitatory neurotransmitter glutamate via its inhibition of N-methyl-D-
aspartate (NMDA)-sensitive glutamatergic receptors.
Alcohol also interacts with the glycine receptors but here the eﬀect is more complex. It
seems to act on at least two distinct locations of the receptor, one in the transmembrane
domain and the other in the extracellular part, with opposing eﬀects (Crawford et al., 2007).
Further molecular interactions of alcohol are an activation of serotonergic and nicotine-
responsive acetylcholine receptors. And alcohol also inﬂuences two ion channels without
endogenous ligands as it inhibits the long-lasting voltage-dependent calcium channels and
activates the G protein-coupled inwardly rectifying potassium channels (Spanagel, 2009).
In addition, there is evidence that the positive feelings triggered by alcohol are also
mediated by receptors of the opioid and the endocannabinoid systems (Olive et al., 2001;
Hungund and Basavarajappa, 2004), although alcohol seems to have no direct eﬀect on the
receptors of these neuromodulatory systems. Another important secondary eﬀect is the
increased release of dopamine in the nucleus accumbens shell by neurons that project from
the ventral tegmental area (see below for anatomic details) (Spanagel and Weiss, 1999).
The identiﬁcation of these alcohol-responsive neurotransmitter receptors has helped to
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Table 1.1.: Receptors and channels targeted by alcohol
Receptor
Description Type
Eﬀect of
or Channel alcohol
GABAA-R γ -aminobutyric acid receptor type A inhibitory activation
NMDA-R NMDA∗-responsive glutamate receptor excitatory inhibition
GlyR glycine receptor inhibitory both
5-HT3-R serotonin (5-hydroxytryptamine-3) receptor excitatory activation
nAChR nicotine-responsive acetylcholine receptor excitatory activation
L-type Ca2+ long-lasting voltage-dependent calcium channel - inhibition
GIRK G protein-coupled inwardly rectifying - activation
potassium channel
∗ NMDA = N-methyl-D-aspartate
identify neuronal networks that play a crucial role in the development of alcohol addiction.
The most salient ﬁnding is the mesolimbic pathway which consists of dopaminergic neurons
of the medial forebrain bundle whose cell bodies are situated in a neuron cluster of the
midbrain called the ventral tegmental area (VTA) and whose axons run to the nucleus
accumbens, the amygdala and the hippocampus (Oades and Halliday, 1987) (ﬁgure 1.1).
The nucleus accumbens is a part of the ventral striatum which belongs to the basal ganglia
system. The latter structure is associated with the emotion processing limbic system, which
includes the amygdala and the hippocampus among other structures. Another important
neuronal connection is the mesocortical pathway which consists of dopaminergic neurons
which lead from the ventral tegmental area (VTA) to the frontal lobe as well as other
parts of the cerebral cortex. These connections have been labelled the reward system of
the brain, as the experience of pleasure is associated with a surge in dopamine signalling in
those neurons (Wise and Bozarth, 1984) although some authors use this term exclusively
for the neuronal connections running from the VTA to the nucleus accumbens.
Diﬀerent theories have been proposed to explain how mesolimbic dopamine exerts its role
in reward. An increase in dopamine secretion might attribute a feeling of pleasure or 'lik-
ing' to rewarding stimuli or it might convey a prediction of future reward based on passed
experience ('learning') or it might cause an incentive salience or 'wanting' of rewarding
stimuli (Berridge, 2007). It was proposed that addiction follows a chronic repetition of
a binge drinking intoxication phase, a withdrawal phase dominated by negative emotions
and an anticipation phase dominated by craving for the drug. The reward system would be
especially important during the binge drinking phase while the extended amygdala would
dominate the withdrawal phase and the prefrontal cortex and the hippocampus would be
pivotal for the anticipation phase (Koob and Volkow, 2010). The role of the prefrontal cor-
tex in the latter phase would be based on its importance in decision making and top-down
control of impulsive drives (Dalley et al., 2011).
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Figure 1.1.: Reward system of the human brain. The medial forebrain bundle, containing
the axons of dopaminergic neurons, transmits signals from the ventral tegmental area to
the nucleus accumbens and amygdala (mesolimbic pathway) and to the prefrontal cortex
(mesocortical pathway). Image modiﬁed from Gray (1918) (book in public domain).
Based on the acquired information on the biological substrates of addiction, a number
of drugs have been proposed for the treatment of alcohol addiction. On the one hand,
there are drugs which are used to bring the patients safely through the phase of alcohol
withdrawal which is the ﬁrst step of nearly all treatment programs. Pharmacological
management of withdrawal symptoms, which can range from mild agitation to seizures
or full-blown delirium tremens, is based on benzodiazepines, anticonvulsants, betablockers
and antihypertensives (Manasco et al., 2012). On the other hand are drugs speciﬁcally
developed for relapse prevention in sober alcoholics. Table 1.2 gives an overview of the
major drugs in use or in testing for this purpose and their putative biological targets.
The oldest of these drugs is disulﬁram which interferes with the metabolism of alcohol.
Under normal conditions, alcohol is converted to acetaldehyde by the enzyme alcohol
dehydrogenase and then further processed to acetic acid by acetaldehyde dehydrogenase
with the bulk of this metabolism happening in the liver. Disulﬁram inhibits acetaldehyde
dehydrogenase causing increased levels of acetaldehyde after alcohol consumption. High
levels of acetaldehyde cause feelings of nausea and headache which are often associated
with 'hangover' and which should deter the patient to drink further alcohol.
Another anti-craving drug used for relapse-prevention of sober alcoholics is acamprosate.
Although it showed some eﬃcacy in clinical trials (Mason et al., 2006) the drug's exact
mechanism of action is still not completely understood. It has been proposed that acam-
prosate antagonises glutamatergic NMDA receptors, which are over-expressed in chronic
alcoholics as a cellular reaction to alcohol's inhibiting eﬀect on these receptors. This eﬀect
might be dose-dependent and lower concentrations of the drug could act stimulating on
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Table 1.2.: Major drugs currently in use or in testing for the post-withdrawal treatment of
alcohol addiction
Drug Class Status
Disulﬁram (Antabuse) acetaldehyde dehydrogenase inhibitor FDA1 approved
Acamprosate putative NMDA receptor modulator FDA1 approved
Naltrexone opioid receptor antagonist FDA1 approved
Nalmefene opioid receptor antagonist in testing
Baclofen GABAB receptor agonist in testing
Topiramate GABAA receptor agonist / AMPA2- in testing
and Kainate3 receptor antagonist
1) FDA = Food and Drug Administration of the United States Department of Health and Human Services;
2) AMPA = 2-amino-3-hydroxy-5-methylisoxazol-4-propanoic acid, an agonist for a subtype of ionotropic
glutamate receptor; 3) Kainate = agonist for another subtype of ionotropic glutamate receptor
this receptor. Acamprosate would therefore act towards a normalisation of glutamater-
gic signalling. But there is also evidence that the drug has a subtly activating eﬀect on
GABAA receptors (Daoust et al., 1992; Zeise et al., 1994; Littleton, 1995; Mann et al.,
2008).
There are also anti-craving drugs available that act on the opioid system. Naltrexone is a
competitive antagonist of the µ- and κ-opioid and to a lesser degree of the σ-opioid receptors
and probably exerts its action via the neuronal network of the mesolimbic pathway by
interfering with the attribution of rewarding feelings to alcohol consumption (Herz, 1997).
It is hypothesised that a polymorphism in the OPRM1 gene for the µ-opioid receptor has
a signiﬁcant eﬀect on treatment eﬃcacy with carriers of the minor G allele showing higher
naltrexone responsiveness (Anton et al., 2008). This constitutes an important example how
genotyping of speciﬁc DNA locations could lead to alcohol addiction pharmacotherapy.
The second opioid antagonist, Nalmefene, has a similar mechanism of action as naltrexone
but has a longer pharmacokinetic half-life, is less liver toxic and acts as a partial agonist
on the κ-opioid receptor (Swift, 2013). It has been proposed recently to give nalmefene
to actively drinking alcoholics in an attempt to reduce their consumption levels without
the goal of complete abstinence (Mann et al., 2012). Sinclair (2001) proposed a similar
approach, consisting of giving naltrexone to non-abstinent alcoholics trying to provoke a
pharmacological extinction of the association of rewarding eﬀects with the consumption of
alcohol.
Another drug proposed for the treatment of post-withdrawal alcoholisc is baclofen which
was originally designed as a muscle relaxant for the treatment of spasticity. It acts as an
agonist at the GABAB receptor. Ameisen (2005) suggested that a high-dose, long-term
application of baclofen reduces alcohol craving.
Topiramate is a drug which was originally developed for the treatment of epilepsy. As in
the case of acamprosate, its exact mechanism of action is unknown. Most likely it acts as
an antagonist on the 2-amino-3-hydroxy-5-methylisoxazol-4-propanoic acid- (AMPA) and
kainate-susceptible ionotropic glutamate receptors and as an agonist on the GABAA re-
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ceptor. Additional mechanisms of action might include an inhibition of voltage-dependent
sodium channels as well as an inhibition of carbonic anhydrase enzymes (Johnson, 2008).
Topiramate signiﬁcantly reduced alcohol consumption in both a rodent study (Zalewska-
Kaszubska et al., 2013) and human trials (Johnson et al., 2007).
While these drugs might all work to a certain degree, none of them could claim a deﬁnite
success in the treatment of alcohol addiction and relapse stays a prevailing problem for
alcohol addicted patients. Based on a meta-analysis of studies from the United States,
Miller et al. (2001) estimated that the percentage of patients who relapse after alcohol
rehabilitation treatment is up to 75%. Kiefer et al. (2003) obtained relapse rates of ap-
proximately 43% during the ﬁrst 12 weeks of anticraving therapy with either acamprosate
or naltrexone. A meta-analysis of double-blind randomised controlled trials concluded
that acamprosate reduced the risk of drinking after detoxiﬁcation to 86% of the risk under
placebo treatment and one out of nine patients would beneﬁt from acamprosate treatment
(Rösner et al., 2010).
This dissertation aims to further the current understanding of the molecular underpin-
nings of psychiatric disorders. It will focus on a small subset of the cellular machinery,
namely the rate at which genes are expressed in the central nervous system in the context
of mental disorders. Four studies were conducted to investigate the correlation between
gene transcription and mental problems:
In the ﬁrst study, the focus is on alcohol addiction. Based on a rat model of chronic
ethanol consumption, we analysed how gene expression patterns in the brain changed from
non-alcohol exposed animals to rats with a history of short- and long-term drinking. As it
has been proposed that alcoholism might impair the body's endogenous circadian rhythm
which is responsible for our daily sleep-wake cycle, we investigated if this eﬀect can be
observed on the level of gene transcription as well.
The focus of the second study was also on circadian rhythmicity. The study aimed to
discover genes with circadian oscillating expression levels in the blood of healthy human
volunteers. As not only alcoholism but also other psychiatric conditions such as major
depression seem to interact with endogenous circadian rhythms, the established expression
proﬁles can be used as a baseline for future studies assessing the impact of these conditions
on circadian gene expression in human blood.
The third study focused on impulsivity as a behavioural trait implicated in a variety
of psychiatric disorders such as drug addiction, attention deﬁcit hyperactivity disorder
(ADHD), bipolar and borderline disorder. In a rat model of high and low impulsivity we
screened for gene expression diﬀerences associated with this trait which has also been put
forward as a factor of vulnerability for drug addiction.
And in the fourth part of this dissertation the focus was on the expression levels of
selected candidate genes in post-mortem tissue of deceased mentally ill subjects as well
as of control person who died of non-psychiatry related causes. The aim was to translate
ﬁndings from animal models to the human situation.
6
Due to the molecular biological focus of these studies, they can only provide a partial
view on the ﬁeld of addictive disorders. There would be a lot to say about the social con-
text of alcohol addicted persons and the way they grew up as adverse childhood conditions,
including sexual abuse, as well as traumatising life events surely play a great role on the
road to alcohol abuse and addiction. So, while focusing on the molecular aspects of addic-
tion, the present thesis is not meant to curtail the role of psychotherapeutic interventions
such as group therapies and individual behaviour therapies as well as the role of welfare
workers who help alcohol addicted patients to regain control over their professional and
private life.
7

2. Inﬂuence of alcohol exposure and
circadian rhythmicity on gene
expression in the rat brain
2.1. Introduction to study
Previous studies have suggested that drug addiction is often accompanied by a disruption
of the sleep-wake cycle and perturbations of daily oscillating physiological parameters such
as body temperature and blood pressure (Devaney et al., 2003; Kawano et al., 2002). This
part of the thesis investigates the molecular mechanisms which form the underpinning of
this interaction.
2.1.1. Circadian rhythms
An endogenous clock to adapt to the day-night rhythm of the earth
Life on earth is subject to the presence of natural rhythms such as the seasonal changes in
weather and daylight or the alternation between day and night due to the earth rotation
around its own axis. It is essential for living creatures to adapt to these periodic changes
in order to compete successfully in the struggle of natural selection.
Most living beings do not rely solely on external cues such as oscillations in daylight
intensity or temperature to adapt to the 24-hour light-dark cycle of the earth. Instead they
possess an internal - `endogenous' - clock which sets an approximately diurnal rhythm. In
mammals this function is fulﬁlled by the suprachiasmatic nucleus (SCN), a network of
about 10 000 neurons which is part of the anterior hypothalamus and is situated just
superior to the optic chiasm (hence the name supra-chiasmatic) (Hastings, 1997).
The SCN regulates numerous physiological functions such as the activity of the diﬀerent
parts of the endocrine system. For example, the SCN regulates the secretion of melatonin
by the pineal gland whose plasma concentration peaks during the night and is almost not
detectable during the day (Lincoln et al., 1985). The production of cortisol by the adrenal
glands is also inﬂuenced by the SCN. It reaches a peak at the beginning of the active
phase of an animal which would be in the early morning in - at least originally - diurnal
humans and in the evening in nocturnal rodents such as most rat species (Bujis et al.,
2003; Fries et al., 2009). As cortisol production is also part of the body's stress response
this rhythm can be blurred by external events. Figure 2.1a and ﬁgure 2.1b depict the
theoretical rhythms of the melatonin and the cortisol concentration in the blood as they
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would occur in a 24 hour period with alternation of 12 hours light and 12 hours darkness.
The time in a thus deﬁned light-dark cycle is called zeitgeber time.
0 4 2412 16 208
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100
light dark
human
rat
Zeitgeber time (hours)
hormone
concentration
in blood
(% of peak)
(a) Melatonin
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Figure 2.1.: Schematic curves of the circadian oscillating concentrations of melatonin (a) and
cortisol (b) in the blood of humans and rats. Melatonin always peaks in the night phase while
cortisol peaks at the beginning of the active phase (human: day, rat: night). Time is presented
as theoretical zeitgeber time with 12 h light followed by 12 h darkness. Data sources: see text.
The SCN is also implicated in the circadian regulation of blood pressure and body
temperature, two physiological parameters which reach a minimum level during the inactive
phase only to rise again before the beginning of the active phase (Janssen et al., 1994;
Biaggioni, 2008; Scheer et al., 2005).
The diurnal rhythm of the SCN, with its quality of being entrainable by external cues,
is called circadian, a compound of the Latin words for `approximately' (circa) and `day'
(dies). But the rhythm of the SCN is only approximately diurnal and slightly deviates
from the 24 hour scheme if an organism is kept under invariable light conditions without
any external time cues (Czeisler et al., 1999). Under normal conditions, ganglion cells
in the retina sense the external light intensity and communicate their daytime dependent
excitation level to the suprachiasmatic nucleus, thus entraining its endogenous rhythm.
Other factors, such as eating times and social activities also have an entraining inﬂuence
(Klermann et al., 1998). These external cues, which are referred to as zeitgebers (German
for `time givers'), are thus responsible for adjusting the body's inner clock to the actual
day-night pattern of the environment. They prompt, for instance, the re-adjustment of the
body's wake-sleep cycle after a long-distance ﬂight over several time zones.
The molecular machinery sustaining the circadian rhythms
Over the last decades, research has made substantial progress in deciphering the molecular
mechanisms which are at the basis of circadian rhythms. Its foundation is a complex net-
work of cross-talking regulatory transcriptional and post-transcriptional feedback loops of
several proteins coded by the so-called clock genes (Ko and Takahashi, 2006; Lowrey and
Takahashi, 2011).
A central role is played by the circadian clock genes period 1, 2 and 3 (Per1, Per2, Per3 )
as well as cryptochrome 1 and 2 (Cry1, Cry2 ). All these genes contain speciﬁc sequences
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in their promoter region called enhancer boxes (E-boxes). These regulatory sequences are
the target of a heterodimer made of two further proteins, the aryl hydrocarbon receptor
nuclear translocator-like (Arntl - sometimes also referred to as Bmal1 ) and the circadian
locomotor output cycles kaput (Clock). As a feedback mechanism, the Per and Cry pro-
teins also form heterodimers which get activated by phosphorylation by casein kinase 1
epsilon (Csnk1e) or a related protein. The PER-CRY dimers then enter the nucleus and
inhibit the activity of the ARNTL-CLOCK dimer (ﬁgure 2.2) (Ko and Takahashi, 2006).
E-box clock controlled genesE-box clock controlled genes
E-box
AAAAAAA
E-box Per2
AAAAAAA
E-box Cry1
AAAAAAA
E-box
AAAAAAA
PER2
CRY1
RORE
AAAAAAA
Arntl
E-box clock controlled genes
AAAAAAA
AAAAAAA
Clock
ARNTL CLOCK
PER2 CRY1
nucleus
cytoplasm
ARNTL
CLOCK
Rev-Erbα
Rorα
REV-ERBα
RORα
clock
controlled
proteins
Figure 2.2.: Simpliﬁed scheme of the network of the feedback loops of the mammalian cir-
cadian clock. E-box and RORE are regulatory sequences in the promoter regions of the
succeeding genes. Based on the network scheme proposed by Ko and Takahashi (2006).
In another regulatory loop, the ARNTL-CLOCK dimer also binds to the E-box elements
of retinoic acid related orphan receptor alpha (Rorα) and member 1 of group D of nuclear
receptor subfamily 1 (Nr1d1 also known as Rev-ErbA α) and increases the transcription of
these genes. RORα and REV-ERBA α both bind to a regulatory sequence called retinoic
acid-related orphan receptor response element (RORE) which is found in the promoter of
Arntl. RORα increases and REV-ERBA α decreases Arntl expression. The proteins thus
ﬁne-tune the molecular clock (see also ﬁgure 2.2) (Ko and Takahashi, 2006).
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Figure 2.3.: Theoretical expression pattern of Per2 and Arntl in the suprachiasmatic nucleus
in rats. Based on data from Oishi et al. (1998).
E-box elements are not only found in the promoter regions of the core clock genes but
also in a variety of other genes. It is via those genes that the rhythm of the molecular
clock gets propagated to other parts of the cellular machinery. These additional E-box
containing genes are often referred to as clock controlled genes (Zhang et al., 2004).
Concentration measurements of clock gene mRNAs in the suprachiasmatic nucleus have
shown a distinctly circadian rhythm in the transcription rate of Arntl and Per2 while the
gene expression of Clock did not show signs of circadian oscillation (ﬁgure 2.3) (Oishi et al.,
1998).
Lesion and transplantation studies have proven the role of the suprachiasmatic nucleus
as the primary circadian rhythm pacemaker in mammals (Weaver, 1998). Nonetheless,
molecular clock components are expressed in all transcriptionally active cells throughout
the body and peripheral cells display signs of various periodic activities. Some of these
activities, like the rhythmic contraction of the heart myocytes, have a comparatively short
period, but numerous other cellular processes appear to have a circadian rhythm such as
the expression of genes involved in metabolism and glucose homeostasis (Mohawk et al.,
2012). Some of these oscillatory rhythms were shown to be self-sustaining in cell culture
experiments and it was suggested that the SCN works as a master clock synchronising
these peripheral or secondary oscillators (Kowalska and Brown, 2007).
2.1.2. Alcohol addiction and circadian rhythmicity
Clinical evidence
As mentioned in the beginning of the introduction, there is reasons to believe that alcohol
addiction interferes with the proper functioning of the endogenous circadian clock. As an
example, alcohol addicted patients often report disruptions in their sleep-wake cycle and
insomnia is a common problem after withdrawal (Asheychik et al., 1989; Egbert, 1993;
Jones et al., 2003). From the physiological point of view, alcohol is known to disturb the
normal circadian cycle of body temperature (Wasielewski and Holloway, 2001; Devaney
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et al., 2003) and blood pressure (Kawano et al., 2002). An analysis of emergency depart-
ment records showed a signiﬁcant daily pattern of drug-related admissions with a peak in
the early evening. While a large portion of these admissions are due to opiate and cocaine
consumption, alcohol intoxicated patients also tend to arrive in phases (Raymond et al.,
1992). The variation in the number of hospital admissions depending on the time of day
could of course also be caused by environmental factors such as shop and pub opening
hours.
Evidence from animal studies
Animal studies have provided further evidence for a disturbance of the endogenous circa-
dian clock by alcohol consumption. Similar to the situation in humans, Rosenwasser et al.
(2005) have shown that alcohol consumption signiﬁcantly alters the daytime-dependent
occurrence of activity phases in rats. This ﬁnding was reproduced in two mice strains
(Rosenwasser and Fixaris, 2013). Another study in rats reported that chronic alcohol con-
sumption impairs the circadian rhythm of the transcription of the mRNA of Per2 and
Per3 in the suprachiasmatic nucleus (Chen et al., 2004).
In addition, it was shown that a deletion mutation within the sequence of Per2 signiﬁ-
cantly increased alcohol drinking in mice (Spanagel et al., 2005; Zheng et al., 1999) showing
thus that there is also an eﬀect of the circadian clock machinery on alcohol consumption.
Evidence from transcriptional regulation
There is also evidence from molecular biology that genes involved in alcohol addiction and
core clock genes interfere with each other. It was suggested that the heterodimer of ARNTL
and CLOCK does not only play a role as a transcription factor in the molecular clock
machinery but might also inﬂuence the expression of addiction-related genes. Manev and
Uz (2006) have mentioned a number of such addiction-related genes that contain E-boxes
in their promoter regions and which could therefore be targets of ARNTL/CLOCK. Their
list contained among others:
 Th: tyrosine hydroxylase
 Drd1: dopamine receptor D1
 Slc6a3: dopamine transporter (solute carrier family 6 member 3)
 Oprd1: opioid receptor delta 1
 Slc6a2: norepinephrine transporter (solute carrier family 6 member 2)
 Slc1a3: glial glutamate transporter (solute carrier family 1 member 3)
 Grm4: metabotropic glutamate receptor 4
Often the E-boxes are in the proximity of other regulatory sequences such as cAMP re-
sponse elements (CRE) which are the target of the cAMP response element-binding protein
(CREB) and TPA responsive elements (TRE) that are bound by the activator protein 1
(AP-1 ) transcription factor which is a heterodimer of Fos and Jun. Alcohol might inﬂuence
the eﬃciency with which the ARNTL/CLOCK dimer binds to the E-boxes of addiction-
related genes by modulating CREB and AP-1 binding which alternates the availability of
the surrounding promoter region (Manev and Uz, 2006).
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2.1.3. Transition to alcohol dependence and its molecular correlates
A fully developed alcohol addiction is the result of a long history of high alcohol consump-
tion in the course of which a transition takes place from controlled recreational alcohol
drinking to compulsive consumption. In a rodent model of cocaine addiction, Kasanetz
et al. (2010) showed how synaptic plasticity, measured by the ability of neurons to induce
long-term depression at their synapsis, is permanently impaired in animals which undergo
a transition to addiction but not in rats which showed no signs of compulsive consump-
tion. It is conceivable that changes in gene expression underlie this observation and that
a similar mechanism takes place during the development of alcohol addiction. Epigenetic
modiﬁcations of the promoter regions of implicated genes could be a possible mechanism
behind this diﬀerential regulation of gene expression (Spanagel, 2009).
Spanagel and Heilig (2005) proposed that transition to alcohol addiction might be corre-
lated to a 'molecular switch' which could involve an up-regulation of Delta FosB, a trun-
cated form of FosB, in the mesolimbic dopamine pathway. But while the up-regulation of
FosB after drug consumption lasts only a few weeks another gene with a longer-lasting up-
regulation has been brought forward: Per2. This suggests an involvement of the circadian
clock - addiction interaction in the transition to addiction.
Another mechanism which might act as a `molecular switch' to addiction is an imbalance
in the concentration ratio between synaptic and non-synaptic glutamate in the prefrontal
cortex which might cause an impairment in top-down behavioural control on drug con-
sumption (Kalivas, 2009; Meinhardt et al., 2013).
2.1.4. Research goals
The present study is based on the hypothesis that alcohol addiction and circadian rhythm
systems interact with each other on the transcriptional level. The aim of the study was
therefore to identify genes in the brain's reward system which show diurnally oscillating
expression levels and whose transcription rhythmicity would be altered by a history of
chronic alcohol consumption.
We therefore simulated alcohol addiction in a rat model of voluntary self-administration
with repeated withdrawal phases. Rats were divided in a short-term and long-term alcohol-
exposed group which should make it possible to assess gene expression before and after
the transition to addiction. By sacriﬁcing the animals at diﬀerent time points throughout
the day we were able to identify diurnally oscillating genes and the modulation of their
expression patterns by the short-term and long-term alcohol exposure.
We isolated the RNA of the nucleus accumbens of the animals and measured the gene
expression using microarrays. The focus was thereby on a brain region which plays a
pivotal role in drug addiction and was large enough for the extraction of microarray-grade
RNA.
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The drinking paradigm of this study was implemented by my co-workers Stephanie Perreau-
Lenz and Valentina Vengeliene. I assisted in sacriﬁcing the animals and continued with
the RNA preparation and the microarray experiment.
2.2.1. Alcohol exposure of rats
In order to study the molecular mechanisms of the interaction between circadian rhythmic-
ity and alcohol dependence, we used a well-established animal model of addictive behaviour
to alcohol (Spanagel and Hölter, 1999). The model is based on rats and consists of the
voluntary self-administration of alcohol which is interrupted by repeated alcohol depriva-
tion phases. In brief, rats were kept solitary with free access to standard rat food and
water as well as three solutions of diﬀerent ethanol concentration: 5%, 10%, and 20%. The
continuous presence of the water bottle guaranteed that the consumption of the ethanol
solutions was always voluntary and never driven by thirst. The access to ethanol was
interrupted by deprivation phases where the three ethanol solutions were removed. This
paradigm with its alteration between access and deprivation reliably causes an escalating,
uncontrolled and dependent-like alcohol consumption in rats (Spanagel and Hölter, 1999).
In our study we used a total of 96 male Wistar rats which were divided into four equally
large experimental groups:
 short-term ethanol exposed animals
 short-term control animals
 long-term ethanol exposed animals
 long-term control animals
All animals were eight weeks old at the beginning of the experiment. The short-term
ethanol exposed animals had six weeks of access to the ethanol concentrations followed by
a deprivation period of two and a half weeks after which they were sacriﬁced (ﬁgure 2.4a).
The long-term ethanol exposed animals underwent the same six week access, two week
deprivation scheme but this was followed by another four units of four weeks access to
alcohol which were alternated by two and a half weeks deprivation phases (ﬁgure 2.4b).
After the last four weeks of ethanol access animals underwent a three week deprivation
phase before they were sacriﬁced. The prolongation of the last deprivation phase is nec-
essary to produce a high level of craving in the animals as the rats tend to get used to
the fact that alcohol becomes available again after two and a half weeks. The rats of the
short-term and long-term control group underwent exactly the same time schedule as the
respective alcohol exposed animals, except that they always only had access to the water.
2.2.2. Light-dark cycle
To obtain an environment with controlled time cues, rats were kept in a windowless room
with alternating periods of 12 hours light and 12 hours darkness. Time was reported
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Figure 2.4.: Schedule of alcohol access and deprivation phases for the ethanol exposed rats
according to a standardised notation, the so-called zeitgeber time where ZT00 is the begin-
ning of the light phase and ZT12 the beginning of the dark phase (see for example Gerstner
and Yin, 2010).
2.2.3. Killing of rats
Animals were killed at four diﬀerent time points throughout the day to obtain time-
dependent gene expression proﬁles: ZT05, ZT11, ZT17, and ZT23 (see also ﬁgure 2.5).
These time points were selected to present the mid of the light phase, the end of the
light phase, the mid of the dark phase, and the end of the dark phase. All time points
were one hour before the actual mid time points (ZT06, ZT12, ZT18, and ZT24) to allow
for the consecutive killing of six animals before the start of the next quarter of the day.
Killing at time points ZT17 and ZT23 were performed under red light to maintain the
circadian rhythm. Always six animals of each experimental condition were killed at one
time point with the exception of long-term control rats at killing time point ZT23, where
only ﬁve animals were sacriﬁced due to a premature death in this group. Animals were
brieﬂy anaesthetised with CO2 and beheaded with a hand-held guillotine. Brains were
immediately taken out from the sculls, shock-frozen in −50 ◦C cold isopentane and stored
at −80 ◦C until further processing.
2.2.4. Brain dissection
The frozen rat brains were cut into 120 µm thick coronal slices at an ambient temperature
of −20 ◦C in a Leica CM 3000 Cryostat (Leica, Wetzlar, Germany). The nucleus accumbens
was identiﬁed according to images from a rat brain atlas ((Paxinos and Watson, 1998) and
extracted with 0.75 to 1.5 mm diameter tissue punches (Stoelting, Wood Dale, IL, USA).
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Figure 2.5.: Time-points of sacriﬁce of the rats throughout the circadian rhythm in zeitgeber
notation with lights on from 00 hours till 12 hours and lights out from 12 hours till 24 hours.
The grey shaded areas correspond to the four time slots for sacriﬁcing the animals starting at
05, 11, 17 and 23 hours.
2.2.5. RNA isolation and puriﬁcation
RNA was isolated by phenol-chloroform extraction (Chomczynski and Sacchi, 1987). 1 ml
of TRIzol® Reagent (Life Technologies, Darmstadt, Germany), a monophasic solution of
phenol and the chaotropic agent guanidinium thiocyanate, was added to the punched tissue
samples and the suspensions were homogenised by multiple passages through a 22 gauge
needle. Samples were ﬁlled up with 200 µl of chloroform, mixed and centrifuged to obtain a
separation of the aqueous upper and the organic lower phase. The RNA containing upper
phases were carefully collected and puriﬁed with an RNeasy MinElute Cleanup Kit (Qiagen,
Hilden, Germany) according to the manufacturer's instructions. The concentration and
purity of the RNAs were analysed with a Nanodrop 1000 Spectrophotometer (Peqlab,
Erlangen, Germany). All samples had a ratio of absorption at 260 nm versus 280 nm in
the range of 1.8 to 2.2, signifying low contamination with leftover proteins. RNA integrity
was further analysed with an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA). All samples had RNA integrity number (RIN) values above eight.
2.2.6. Illumina RatRef-12 Expression BeadChips
RNA samples were prepared for microarray analysis at the Genomics and Proteomics Core
Facility of the German Cancer Research Center (DKFZ) using the Illumina TotalPrep RNA
Ampliﬁcation Kit (Life Technologies, Darmstadt, Germany) following the manufacturer's
protocol. In brief, 500 ng RNA were reverse transcribed to ﬁrst strand complementary DNA
(cDNA) using Array Script reverse transcriptase with oligo-thymidine primers connected
to the promoter region of the T7 bacteriophage. The cDNA was puriﬁed and processed
using RNAse H to clean the ﬁrst strand DNA from remaining RNA. DNA polymerase was
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used for second strand synthesis after which the DNA was puriﬁed once again. T7 RNA
polymerase was used for in vitro transcription. As a part of the required uridine triphos-
phate (UTP) was tagged with biotin this process yielded biotinylated complementary RNA
(cRNA). The cRNA was puriﬁed, quantiﬁed with the Nanodrop 1000 Spectrophotometer
and quality checked with the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA, USA). All cRNA samples had an acceptable RNA size distribution.
The cRNA was hybridised on the microarrays using the RatRef-12 Expression BeadChip
Kit (Illumina, San Diego, CA, USA) following the manufacturer's protocol. In brief, 750
ng cRNA per sample were hybridised on RatRef-12 Expression BeadChips and incubated
for 14 hours on a rocker mixer. BeadChips were subjected to two washing steps according
to manufacturer's protocol to remove unbound cRNA. BeadChips were then stained with
Cyanine 3 coupled to streptavidin which binds to the biotinylated UTPs of the cRNA.
This was followed by another washing step.
BeadChips were scanned on an Illumina BeadArray Reader using Bead Scan Software
(Illumina) and read out as text ﬁles.
2.2.7. Microarray data pre-processing
The acquired ﬂuorescence values from the hybridised microarrays were pre-processed in
the DKFZ Core Facility's R pipeline. The pre-processing in the pipeline included the
removal of outliers, quality assessment, between array normalisation, and averaging of the
bead-level data. As a last step I updated the array annotation as described below.
Removal of outliers
The ﬁrst step was to exclude all beads with ﬂuorescence values below 20, as lower values
can no longer be distinguished from the array's background signal. Outliers were deﬁned
as having a median deviation of more than 2.5 times greater than a consistent estimation
of the standard deviation:
If X was the set of the ﬂuorescent values x1, x2, ..., xi from the multiple replicates of one
probe on the array and k = 1.4826 the scaling factor for a consistent, robust estimation of
the standard deviation assuming a normal distribution of X (Sachs and Hedderich, 2006)
then the outliers were calculated according to the following equations:
Median absolute deviation: MAD = median(|xi −median(X)|)
Estimator of standard deviation: σ∗ = 1.4826 ·MAD
Deﬁnition of outliers: |xi −median(X)| > 2.5 · σ∗
Quality control
Microarray data were quality assessed using the quality control features present on the
Illumina arrays. These consisted of the following items and their complementary probes:
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 Hybridisation control: Detection of six diﬀerent Cy3-labelled oligonucleotides which
were spiked in the hybridisation buﬀer.
 Negative control: Detection of the system background noise with random sequence
probes which are not complementary to any known rat RNA.
 Hybridisation stringency control: Detection of the Cy3-labelled oligonucleotides form
the hybridisation control with complementary probes that contain two mismatches.
 Gene intensity control: Detection of selected housekeeping genes.
 Biotin control: Detection of two heavily biotin-tagged oligonucleotides which were
spiked in the hybridisation buﬀer.
 High stringency control: Detection of a spiked-in oligonucleotide with a very high
GC content that would hybridise and yield a signal even if hybridisation stringency
was too high.
All samples but one passed the quality control. The failed sample belonged to one of the
long-term control animals and was excluded from subsequent steps. Given the one incident
of premature death which also aﬀected this group, the long-term control group had only
four array data available. All other groups had six array data sets.
Normalisation and averaging of bead level values
All bead values were log2 transformed to reduce the inﬂuence of absolute intensity magni-
tude on variation and to approximate the bead intensity values to a Gaussian distribution.
Arrays were normalised over all samples and beads using the quantile normalisation algo-
rithm (Bolstad et al., 2003) of Bioconductor's aﬀy package (Gautier et al., 2004). Intensity
values of one bead type were averaged using arithmetic mean.
Annotation
The most up-to-date Illumina annotation for the RatRef-12 Bead Array was `RatRef-12
V1 0 R5 11222119 A'. Excluding the quality control probes, each BeadChip contained
22 517 probes. But only 6 366 (28,3%) of those probes had a biologically interpretable
annotation, while the remaining probes consisted of locus identities, predicted proteins, or
non-speciﬁed rat genome database and mammalian gene collection entries.
We therefore made use of the Re-annotation and Mapping for Oligonucleotide Array
Technologies (ReMOAT) project, which provides re-computed probe annotations for Il-
lumina BeadArrays (Barbosa-Morais et al., 2010). We compared ReMoat's `Rat-RS-V1
rn4 V1.0.0 Aug09 ' annotation to Illumina's `RatRef-12 V1 0 R5 11222119 A' and kept all
congruent probes (3 433). Probes which had only a locus identity, mammalian genome cor-
poration or rat genome database number were eliminated. To this we added the remaining
probes which had a ReMoat annotation labelled "good" or "perfect" (893) despite having a
purely numerical Illumina probe annotation. And ﬁnally we added those probes that were
well-annotated in the Illumina version (no locus ID, etc.) despite having a bad ReMoat
annotation. This led to a ﬁnal number of 7 656 probes per array.
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2.2.8. Statistical analysis
All statistical analyses were performed using LibreOﬃce 3 and R statistical programming
language version 2.15.0.
Principal component analysis
Principal component analysis was performed on the quantile normalised data using the
prcomp-function of the stats-package of R. For graphical presentation, the data points rep-
resenting the microarray data sets from the individual rats were plotted against the ﬁrst two
principal components. The legend was added and the plot was coloured in inkscape 0.48.
Detection of daily oscillating genes
For each treatment group, the four time points were concatenated and then z-score trans-
formed so that every gene had a mean expression of zero and a standard deviation of one
(Cheadle et al., 2003) according to the following formula:
x′ =
x− µ
σ
In the formula, x corresponded to a given log2-transformed expression value of a gene, µ
and σ to the arithmetic mean and standard deviation of all expression values of this gene
and x' to the z-score transformed value.
Genes with circadian oscillating expression levels were then identiﬁed using the fdr-
fourier -function of the cycle-package of R (Futschik and Herzel, 2008) based on a period
of 24 h. The function calculated a Fourier score for each gene which became larger if a
gene was closer to a cosine curve of the given period length of 24 hours:
Fourier score =
√√√√( n∑
i=1
cos(2pi · ti
T
) · x′i
)2
+
( n∑
i=1
sin(2pi · ti
T
) · x′i
)2
In the formula, n corresponded to the number of measurement points (16 for the long-
term control group, 24 for all other groups), T to the period length (24 hours) and x′i to the
z-score transformed expression value at the time ti. The fdrfourier -function also computed
an empirical false discovery rate (FDR) (see Futschik and Herzel (2008) for details) which
was calculated on the basis of 100 permutations within the rows in our case.
The thus calculated oscillation scores and false discovery rates were used as a basis for
the analysis of the daily expression proﬁles of the core clock genes, the E-box containing
genes and the hypothesis-free screening of the microarray data. In the latter - exploratory -
analysis, we considered all genes with a FDR < 5% as oscillating while all genes with a
FDR > 50% were considered non-oscillating.
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Sorting of the genes according to their expression proﬁles and display in heatmaps
Pairwise Pearson correlation distances were computed between the expression patterns of
the oscillating genes using the cor.dist-function of the bioDist-package of R. The hclust-
function of the stats-package was then used to hierarchically cluster the genes based on
these pairwise distances using complete linkage as agglomeration method.
For graphical presentation, heatmaps with the results were drawn using the heatmap.2 -
function of the gplots R package. The heatmaps of the short-term and long-term rats were
each arranged into a composite plot using inkscape 0.48 and ﬁtted with labels and a legend.
T-tests and fold change calculations
Genes that were diﬀerentially regulated under the inﬂuence of alcohol exposure were de-
tected based on Student's t-tests using the Welch adaptation for possibly unequal variances.
The tests were performed on the log2-transformed but not Z-score transformed data. In
addition, the fold change, corresponding to the ratio of the average alcohol-exposed mRNA
concentration versus the average control mRNA concentration, was calculated for each gene
and time point and each treatment-duration group according to the following formula:
fold change =
1
n
∑n
i=1 xalcohol,i
1
m
∑m
i=1 xcontrol,i
In the formula, the variables xcontrol and xalcohol corresponded to the non-logarithmic, non-
Z-score transformed expression values, n to the number of replicates in the alcohol-exposed
groups (always six) and m to the number of replicates in the control groups (six, except
for ZT17 of long-term rats were it was four).
Genes were considered signiﬁcantly diﬀerentially expressed if the t-test p-value was below
0.05 and the absolute fold change (= |fold change|) above 1.2.
Volcano plots were created in R based on the calculated p-values and fold changes. For
purpose of presentation, the values of the x-axis were transformed to log2(fold change)
and the values of the y-axis were converted to log10(p values). The graphs were arranged
into a composite plot using inkscape 0.48.
21
2. Inﬂuence of alcohol exposure and circadian rhythmicity on gene expression in the rat
brain
2.3. Results
Messenger RNA extracted from the nucleus accumbens of short-term and long-term alcohol
drinking rats and from age-matched control animals was quantiﬁed by DNA microarray
technology. After quality control and exclusion of probes missing a proper gene annotation
we obtained a data set consisting of expression values of 7 656 genes in 94 samples, each
sample corresponding to one rat. Based on the time of day when the rats where sacriﬁced,
the access to alcohol or only water and the duration of the experiment, the samples could
be divided into 16 groups (see table 2.1).
Table 2.1.: Overview of the 16 diﬀerent treatment groups and their number of samples.
ZT 5 and 11 lay in the light phase while ZT 17 and 23 lay in the dark phase.
zeitgeber time short-term long-term
(in hours) control alcohol control alcohol
05:00 6 6 6 6
11:00 6 6 6 6
17:00 6 6 4 6
23:00 6 6 6 6
2.3.1. Principal component analysis
To get an impression of the main sources of variability in our data set we conducted a
sample-focused principal component analysis on the quantile normalised and log-trans-
formed values of all arrays combined. The ﬁrst two principal components were responsible
for 44.7% and 7.2%, respectively, of the variability in the data. The samples were plotted
on a coordinate system whose axis corresponded to the ﬁrst two principal components and
labelled according to the rat's treatment (ﬁgure 2.6a) or the time when the animal was
sacriﬁced (ﬁgure 2.6b). Animals did neither cluster according to their access to alcohol
or only water nor did they group according to the length of the experiment. The time
point of sacriﬁce, on the other hand, led to a visible diﬀerentiation with zeitgeber time 17,
corresponding to the midst of the rodents' active dark phase, clearly apart from all other
time points. No further subdivision for zeitgeber times 05, 11 or 23 was visible.
2.3.2. Detection of daily oscillating genes by Fourier transformation
We then proceeded to identify genes which showed a daily oscillating expression pattern
using a fast Fourier transform algorithm which calculated Fourier scores as a measurement
of how far a gene expression proﬁle consistently resembled a 24-hour cosine curve. In
addition, the algorithm calculated a false discovery rates for each gene until which it would
be considered daily oscillating. As the rats had been kept under a cycle of 12 hours light
followed by 12 hours darkness (LD 12:12) the Fourier transform algorithm detected daily
oscillating genes regardless whether the oscillation of their gene expression was driven by
underlying molecular circadian rhythms or by external factors.
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(b) Time of day
Figure 2.6.: Scatter plot of the nucleus accumbens RNA samples projected on the ﬁrst two
axis of variation as calculated by principal component analysis (PCA). Samples were labelled
according to treatment group (a) and time of day (b).
Table 2.2 shows the numbers of genes which were detected as daily oscillating in the
four subgroups according to a false discovery rate of 10%. Up to 50% of the genes were
identiﬁed as showing regular daily oscillations in their mRNA levels. The relatively low
number of such genes in the long-term control rats was probably due to the fact that this
group contained only four replicates which could be concatenated while all other groups
had six.
Table 2.2.: Number of daily oscillating genes in the four treatment groups (out of 7 656 genes
in total).
control alcohol
short-term 4 096 3 748
long-term 2 308 3 830
2.3.3. Analysis of the core clock genes
Having identiﬁed the oscillating genes, we ﬁrst concentrated our attention on the core clock
genes which had been presented in ﬁgure 2.2 of the introduction.
Table 2.3 presents an overview of the Fourier scores and associated false discovery rates
(FDR) of these genes. Rora and Csnk1e were not present in the quality ﬁltered microarray
data set but Csnk1a1, which is closely related to Csnk1e, was present in the data. While
Arntl, Cry1 and Csnk1a1 displayed an oscillating proﬁle in all four treatment groups
according to a FDR < 10%, Cry2 was oscillating in all groups but the long-term control
rats. Nr1d1, Per1, Per2 and Per3 gene expression oscillated each in only one treatment
group.
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Table 2.3.: Fourier scores and false discovery rates of core clock genes. Scores with an
associated FDR < 10% in bold.
short-term long-term
control alcohol control alcohol
Gene score FDR score FDR score FDR score FDR
Arntl 9.29 0.046 9.41 0.043 8.75 0.029 11.19 0.008
Clock 5.74 0.349 2.67 0.815 2.71 0.751 4.31 0.568
Cry1 13.39 0.001 11.70 0.004 7.29 0.084 11.27 0.008
Cry2 9.43 0.041 11.14 0.009 6.09 0.194 9.79 0.032
Nr1d1 11.95 0.004 6.12 0.306 5.66 0.248 6.52 0.260
Per1 6.19 0.291 8.46 0.088 2.24 0.825 7.30 0.176
Per2 3.33 0.716 6.59 0.249 7.27 0.085 7.47 0.161
Per3 7.72 0.134 10.62 0.014 6.99 0.105 7.90 0.127
Csnk1a1 13.30 0.001 11.76 0.004 8.39 0.036 12.35 0.002
Next, we wanted to know if the expression proﬁles of Arntl, Cry1 and Csnk1a1 which had
shown oscillating mRNA levels in all treatment groups had always the same appearance.
The other option would be that either alcohol consumption or treatment duration or both
factors combined alter the expression proﬁle while maintaining its oscillating appearance.
We plotted the expression proﬁles in the four treatment groups (ﬁgure 2.7) and visually
compared the daily curves. Besides of slight variations in the proﬁle of Arntl at ZT05,
ZT17 and ZT23, the three genes showed roughly the same expression proﬁles in all four
conditions.
We also plotted the expression proﬁles of Per1 and Per2 because of these genes' pivotal
role in both circadian rhythm generation and transition to addiction (ﬁgure 2.8). Per1
showed a phase reversal with a peak of mRNA concentration during the light phase in short-
term rats and during the dark phase in the long-term animals. There was no consistent
eﬀect of alcohol in the short-term and long-term treatment group and the low mRNA level
amplitudes combined with the big error bars explain why the algorithm did not consider
these proﬁles circadian oscillating with the exception of the one of the short-term alcohol
drinking rats.
In the case of Per2, all treatment groups showed the highest mRNA concentration at
zeitgeber time 11, corresponding to the end of the light phase with the peak approximately
twice as big in the rats of the long-term paradigm. This diﬀerence in peak height was not
signiﬁcant according to a t-test comparing the Z-score transformed expression values at 11
hours of all short-term to the corresponding values of all long-term rats (p-value: 0.16).
The long-term control animals had their lowest Per2 expression at zeitgeber time 23 and
showed a bigger amplitude than all other groups which explains why this group proﬁle
was rated as oscillating by the Fourier algorithm. The short-term control animals had the
lowest amplitude and the short- and long-term alcohol groups were in between.
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Figure 2.7.: Daily expression proﬁles of Arntl, Cry1 and Csnk1a1 in the four treatment
groups. Shown are mean values ± standard error of the mean.
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Figure 2.8.: Daily expression proﬁles of Per1 and Per2 in the four treatment groups. Shown
are mean values ± standard error of the mean.
Legend: = short-term control, = short-term alcohol
= long-term control, = long-term alcohol
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2.3.4. Analysis of selected E-box genes
In the next step, we wanted to assess the degree of diurnal oscillation in the expression
of E-box genes. We concentrated the analysis on the expression proﬁles of the addiction-
related E-box containing genes listed in the introduction (see section 2.1.2).
Table 2.4 presents the Fourier scores and false discovery rates of these genes. Oprd1
and Slc6a2 showed signiﬁcant oscillation in their expression pattern in all four treatment
groups based on a false discovery rate < 10%. Th and Grm4 showed oscillating expression
levels in two or only one group, respectively. Drd1 was not present in the quality ﬁltered
microarray data.
Table 2.4.: Fourier scores and false discovery rates of selected E-box genes. Scores with an
associated FDR < 10% in bold.
short-term long-term
control alcohol control alcohol
Gene score FDR score FDR score FDR score FDR
Grm4 7.74 0.133 9.44 0.042 5.90 0.217 4.14 0.553
Oprd1 11.07 0.009 12.19 0.003 7.72 0.061 11.79 0.004
Slc1a3 3.63 0.669 8.04 0.114 2.54 0.782 4.72 0.506
Slc6a2 9.93 0.027 12.33 0.002 8.17 0.043 10.88 0.011
Slc6a3 2.08 0.881 2.02 0.892 0.72 0.981 4.43 0.551
Th 9.19 0.050 4.55 0.532 4.14 0.495 13.21 0.001
As in the case of the core clock genes, we plotted the expression proﬁles of the oscillating
genes to assess if their appearance was diﬀerent between the treatment groups. Grm4 had
about the same proﬁle in all four treatment groups with the biggest diﬀerence in the short-
term alcohol-exposed rats. Oprd1 and Slc6a2 had each approximately identical expression
proﬁles in all groups. Th showed the biggest deviations in the proﬁles of short-term alcohol-
drinking and long-term control rats. The expression diﬀerence appeared most pronounced
at ZT17 but did not reach statistical signiﬁcance with an uncorrected p-value of a Student's
t-test of 0.247 (see ﬁgure 2.9).
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Figure 2.9.: Daily expression patterns of E-box containing genes: Metabotropic glutamate
receptor 4 (Grm4 ), opioid receptor δ1 (Oprd1 ), norepinephrine transporter (Slc6a2 ) and
tyrosine hydroxylase (Th) in the four rat groups. Shown are mean values ± standard error of
the mean.
Legend: = short-term control, = short-term alcohol
= long-term control, = long-term alcohol
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2.3.5. Screening for oscillating genes that change under the inﬂuence of
alcohol
Having analysed the expression proﬁles of core clock genes and selected E-box containing
genes, we wanted to screen our data set for genes whose circadian expression rhythm was
disturbed by the rats' alcohol consumption. In this exploratory approach, we deﬁned genes
showing daily oscillating mRNA levels according to a false discovery rate below 5% in the
Fourier analysis as truly oscillating and genes that oscillated with a false discovery rate
above 50% as not oscillating. Table 2.5 shows the number of genes which were identiﬁed
according to these conditions.
Table 2.5.: Number of oscillating genes according to diﬀerent false discovery conditions
(out of a total of 7 656 genes).
FDR < 05% FDR > 50%
short-term
control 2 864 1 099
alcohol 2 613 1 203
long-term
control 874 1 677
alcohol 2 691 1 211
We then started with the short-term paradigm rats and determined the overlap between
the truly oscillating genes of the control and alcohol samples. In addition, we identiﬁed
those genes which oscillated in the control but not in the alcohol-drinking rats and those
genes which did not oscillate in the control but showed rhythmicity in the alcohol-exposed
rats.
In order to get a visual expression of the oscillation pattern we sorted the genes according
to a hierarchical clustering based on a Pearson correlation of the control samples and
displayed the results in form of a heatmap (ﬁgure 2.10). The topmost heatmap contains
the genes which were oscillating in both control and alcohol-exposed rats. It visually
depicts that the vast majority of genes maintained the same oscillation pattern in both
conditions. The mid-level heatmap shows the genes which oscillated in control but not in
alcohol-exposed rats. It becomes evident that the expression pattern in the alcohol group
resembled a pale copy of the pattern in the control group indicating that the genes in the
former group had a similar oscillation tendency but a lower amplitude. The bottommost
heatmap depicts the genes which oscillate in alcohol-exposed rats but not in controls. As
in the mid-level heatmap, the non-oscillating genes seem to mirror the expression pattern
of their oscillating counterparts albeit with a smaller amplitude.
We then performed the same analysis in the long-term paradigm animals and obtained
roughly the same result (ﬁgure 2.11). Overall, the long-term animals showed less overlap
between the diﬀerent oscillation condition of control and alcohol rat genes which was
probably due to the fact that the long-term control group contained only four replicates
while all other groups had six.
Regarding those genes which had a signiﬁcantly oscillating expression proﬁle in both
control and alcohol-exposed animals, there was an overlap of 576 genes between the short-
term (n=1 995 genes) and long-term (n=704 genes) treatment group. There was not a
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Figure 2.10.: Heatmaps of genes with oscillating mRNA levels in rats of the short-term
paradigm. The uppermost heatmap shows genes which oscillated in both control and alcohol
rats, the map in the middle depicts those genes which oscillated only in control rats and the
heatmap at the bottom shows the genes which oscillated only in alcohol-drinking rats. The
height of the uppermost heatmap is half the proportion of the other two maps for purpose of
presentation.
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Figure 2.11.: Heatmaps of genes with oscillating mRNA levels in rats of the long-term
paradigm. The uppermost heatmap shows genes which oscillated in both control and alcohol
rats, the map in the middle depicts those genes which oscillated only in control rats and the
heatmap at the bottom shows the genes which oscillated only in alcohol-drinking rats.
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single common ﬁnding between the two treatment-length cohorts in the lists of those genes
which had oscillating expression proﬁles in control but not in alcohol-exposed rats. And
there was one gene in common between the two treatment-length cohorts in the lists of
those genes which had oscillating expression proﬁles in alcohol-exposed but not in control
animals: neuropeptide B (Npb).
In the long-term exposed rats, there were much more genes (n=215) which showed a
diurnally oscillating pattern only in the alcohol-exposed animals than genes (n=31) which
showed such an expression pattern only in the control animals. This is in contrast to
the short-term animals where there had been more gene oscillating only in control rats
(n=112) than genes oscillating only in alcohol rats (n=65).
Besides the visual analysis of oscillation pattern with the heatmaps we also calculated
the Pearson correlation coeﬃcients (Pearson's ρ) of the averaged gene expression proﬁles
of control and alcohol rats. Table 2.6 contains the genes with the lowest coeﬃcients. There
was no overlap between those genes in short-term and long-term animals and the lowest
Pearson correlation coeﬃcients were still above 0.4 in both paradigms.
Table 2.6.: Top ﬁndings of oscillating genes that change under the inﬂuence of alcohol:
Genes with a FDR < 0.05 in both control and alcohol-exposed rats.
short-term long-term
gene Pearson's ρ proﬁle gene Pearson's ρ proﬁle
Ddx47 0.425 Rps3 0.412
Ugt2b17 0.488 Tas2r114 0.476
Prpf4b 0.601 Pomgnt1 0.583
Jph2 0.632 Plunc 0.612
Lmcd1 0.693 Prkab2 0.628
Proﬁle: = control, = alcohol exposed
Ddx47 = DEAD (Asp-Glu-Ala-Asp) box polypeptide 47
Ugt2b17 = UDP glucuronosyltransferase 2 family, polypeptide B17
Prpf4b = PRP4 pre-mRNA processing factor 4 homolog B (yeast) (serine/threonine kinase)
Jph2 = junctophilin 2 (component of junctional complexes in excitatory cells)
Lmcd1 = LIM and cysteine-rich domains 1 (putative transcription factor)
Rps3 = ribosomal protein S3
Tas2r114 = taste receptor, type 2, member 114
Pomgnt1 = protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)
Plunc = BPI fold containing family A, member 1 (Bpifa1) (injury response in nasal epithelium)
Prkab2 = protein kinase, AMP-activated, beta 2 non-catalytic subunit
(gene information taken from: www.ncbi.nlm.nih.gov/gene/)
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We also extracted the most prominent cases of genes which showed oscillating mRNA
levels in either the control or the alcohol paradigm but not the other. Table 2.7 shows their
Fourier scores and false discovery rates in the control and alcohol groups for the short-term
exposed rats and table 2.8 lists the corresponding values for the long-term consuming rats.
The genes were selected from the two heatmaps at the bottom of the heatmap chart for
the short-term and long-term animals, respectively. For each scenario, we selected the ten
genes with the lowest false discovery rate in one drinking-condition and a false discovery
rate above 50% in other drinking-condition. There were no common ﬁndings among the
top ten genes of any of these conditions.
Table 2.7.: Top 10 genes which showed rhythmic expression in one treatment condition but
not the other. Table for the short-term exposed animals.
control but not alcohol alcohol but not control
control alcohol control alcohol
gene score FDR score FDR gene score FDR score FDR
Angptl4 13.87 0.0003 3.88 0.64 Csmd1 3.13 0.74 11.17 0.008
Arl3 12.40 0.0023 4.25 0.58 Esr2 3.92 0.62 11.62 0.005
Cxcl13 12.36 0.0024 4.25 0.58 Ggnbp1 3.26 0.73 11.90 0.003
Dcir2 11.84 0.0042 2.99 0.77 Gimap6 4.65 0.51 11.29 0.007
Enth 12.36 0.0024 4.74 0.50 Mafk 2.80 0.79 11.33 0.007
Esm1 12.95 0.0013 3.07 0.76 Psbpc1 4.09 0.60 12.35 0.002
Itgbl1 13.70 0.0003 4.65 0.52 Rasl11a 2.73 0.80 10.86 0.011
Mboat5 12.13 0.0032 2.88 0.79 S100a3 1.66 0.92 12.50 0.002
Tpp2 12.95 0.0012 4.57 0.53 Trat1 2.93 0.77 10.80 0.012
V1rc20 11.94 0.0038 4.03 0.61 Ugt1a1 3.93 0.62 11.43 0.006
Table 2.8.: Top 10 genes which showed rhythmic expression in one treatment condition but
not the other. Table for the long-term exposed animals.
control but not alcohol alcohol but not control
control alcohol control alcohol
gene score FDR score FDR gene score FDR score FDR
Accn1 8.80 0.029 4.12 0.600 Arpc5 3.73 0.57 12.27 0.0025
Dmrt1 9.08 0.027 4.32 0.567 Casp3 4.03 0.52 12.60 0.0017
F2rl1 8.73 0.029 4.36 0.561 Crisp2 3.98 0.52 12.87 0.0013
Galnt3 8.79 0.029 1.90 0.899 Cryge 3.76 0.56 12.99 0.0010
Orai1 8.86 0.027 4.58 0.528 Limk1 1.87 0.87 12.74 0.0016
Prkx 8.99 0.026 3.84 0.641 March7 3.14 0.68 12.25 0.0026
Psgb1 8.82 0.028 2.97 0.770 Mtfmt 2.87 0.72 14.00 0.0003
Ptpn21 8.70 0.029 2.68 0.808 Pcsk9 3.87 0.54 12.40 0.0022
Taar5 9.70 0.012 4.06 0.608 Pgk1 3.67 0.58 13.00 0.0010
Taz 9.31 0.024 4.35 0.563 St3gal1 2.14 0.84 12.38 0.0022
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2.3.6. Inﬂuence of exposure time: transition to addiction
Finally, we used the created microarray data set to screen for genes with signiﬁcantly
diﬀerential expression levels in alcohol-exposed compared to control rats. To get a ﬁrst
impression of the amount of gene expression diﬀerences in the nucleus accumbens of the
alcohol versus the control rats at each time point and in both age groups, we plotted our
data in the form of Volcano plots (ﬁgure 2.12). These plots are a special case of scatter
plots in which each data point corresponds to one gene, its x-value indicating the logarithm
of the ratio of average alcohol versus average control mRNA concentration and its y-value
corresponding to the negative logarithm of the p-value of a t-test between the alcohol and
control group. Genes with a signiﬁcant p-value (in our case deﬁned as below 0.05) and a
big diﬀerence in the average expression levels (in our case: absolute fold change > 1.2) are
of particular interest. They can be found in the upper right and left corners of our plots
and were marked by asterisks. Our plots showed that the impact of alcohol on overall gene
expression was approximately the same at all time points. There was also no clear trend
for bigger gene expression diﬀerences in the long-term paradigm rats although there were
more signiﬁcantly diﬀerentially regulated genes in the long-term rats at zeitgeber time 17.
Table 2.9 lists the genes in the short-term paradigm animals which we considered signif-
icantly diﬀerentially expressed according to the above mentioned critera and which were
marked by asterisks in the plot. Table 2.10 does the same for the long-term rats. Only
two genes appeared in more than one condition (marked in bold in the tables). The Cell
division cycle-associated protein 7 (Cdca7 ) was up-regulated in short-term alcohol drink-
ing rats at ﬁve and eleven hours zeitgeber time. Cytoglobin (Cygb) was down-regulated in
short-term alcohol-drinking rats at time point ﬁve and up-regulated at time point eleven
in long-term alcohol-drinking rats.
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Figure 2.12.: Volcano plots of the comparison of alcohol versus control rats. Data points
correspond to individual genes. The horizontal black lines correspond to a p-value level of
0.05 and signiﬁcantly diﬀerentially regulated genes (based on a t-test p-value < 0.05 and an
absolute fold change > 1.2) are represented by asterisks.
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Table 2.9.: Top ﬁndings of diﬀerentially regulated genes∗ in alcohol exposed versus control
rats of the short-term paradigm. Genes that appeared in several groups in this or the next
table were marked in bold. Genes with a known relation to addiction or circadian rhythmicity
were underlined and their role was addressed in the discussion section.
Light phase
ZT05 ZT11
gene t-test ratio gene t-test ratio
p-value alcohol/control p-value alcohol/control
B4galt6 0.022 1.37 Cdca7 0.003 1.28
Cdca7 0.020 1.37 Ctgf 0.024 1.29
Cygb 0.022 0.82 Nr4a3 0.019 1.31
Fxc1 0.018 0.83 Sla 0.028 1.28
Nxf 0.026 1.25 Slc16a3 0.050 0.78
Pacsin2 0.043 0.83
Rnf138 0.033 1.38
Trappc1 0.008 0.83
Dark phase
ZT17 ZT23
gene t-test ratio gene t-test ratio
p-value alcohol/control p-value alcohol/control
Arg1 0.011 1.24 Dlgap1 0.038 1.29
Fip1l1 0.043 0.83 Glg1 0.044 1.23
Hba-a1 0.041 0.78 Grip2 0.042 0.79
Nefh 0.048 0.81 Hapln2 0.006 0.82
Pde1b 0.033 0.83 Hpcal4 0.047 1.33
Pscd3 0.014 0.81 RT1-A2 0.045 1.22
Rarres2 0.017 0.82 Sirt2 0.002 0.80
Slc17a6 0.016 1.24 Tnfsf12 0.050 1.20
Znf672 0.001 1.22 Tuba1 0.014 1.22
*) selected on the basis of a t-test p-value < 0.05 and an absolute ratio > 1.2
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Table 2.10.: Top ﬁndings of diﬀerentially regulated genes∗ in alcohol exposed versus control
rats of the long-term paradigm. Genes that appeared in several groups in this or the previous
table were marked in bold. Genes with a known relation to addiction or circadian rhythmicity
were underlined and their role was addressed in the discussion section.
Light phase
ZT05 ZT11
gene t-test ratio gene t-test ratio
p-value alcohol/control p-value alcohol/control
Bdnf 0.035 0.82 Cygb 0.013 1.22
Prph1 0.046 0.80 Slc6a9 0.006 1.21
Reln 0.017 0.82 Znrd1 0.005 1.20
Unc5a 0.038 0.82
Dark phase
ZT17 ZT23
gene t-test ratio gene t-test ratio
p-value alcohol/control p-value alcohol/control
Amz2 0.005 1.25 Col1a2 0.031 0.78
Angptl4 0.013 0.82 Igf2 0.011 0.83
Cap1 0.013 0.83 Tpbg 0.013 0.82
Cfdp1 0.045 0.81
Chn2 0.042 0.82
Cugbp1 0.022 0.83
Dhrs4 0.044 0.82
Gabbr1 0.009 0.75
Gria4 0.001 1.21
Heph 0.004 1.21
Hspa8 0.009 1.30
Lpl 0.001 0.83
Mtrf1l 0.023 1.24
Nudt3 0.010 0.83
Phactr1 0.028 0.83
Pmch 0.001 1.28
Ppp3r1 0.048 0.78
Rbm34 0.005 0.83
Tnfrsf11b 0.049 1.23
*) selected on the basis of a t-test p-value < 0.05 and an absolute ratio > 1.2
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2.4. Discussion of study
In the present study we wanted to analyse the inﬂuence of alcohol consumption on the
transcription proﬁles of diurnally oscillating genes. Using microarrays, we had measured
mRNA concentrations in the nucleus accumbens of voluntary alcohol-consuming and con-
trol rats because of the prominent role of this brain region in addiction.
Principal component analysis
In order to get a ﬁrst impression of the main sources of variance on global gene expression in
the nucleus accumbens we had performed a principal component analysis on our data. The
fact that alcohol consumption had no visible eﬀect on overall gene expression is probably
due to moderate transcription alterations caused by the drug and to the limited number
of genes which are aﬀected. This is in line with a previous study by Matthäus et al. (2009)
which had also reported that alcohol induced gene expression diﬀerences had little impact
on the overall variability in gene expression data.
Nonetheless, we did not expect such a low inﬂuence of the duration of alcohol con-
sumption on overall gene expression. Of course, the diﬀerence in the drinking history
wasn't likely to play a major role given alcohol's limited eﬀect on gene expression. But
the long-term drinking rats were 185 days older than their short-term counterparts which
is a substantial time span for a laboratory rat with its average life expectancy of three
years. McCutcheon and Marinelli (2009) have argued in a systematic review of neuro-
science articles that the age of an experimental animal can have a profound inﬂuence on
the experimental outcome. We attribute the lack of this eﬀect on the fact that our animals
were 115 and 300 days of age at time of death, both ages being far beyond puberty. Neu-
ronal maturation had been completed long before in both age cohorts and no substantial
brain development happened during this period (Sengupta, 2011).
The big inﬂuence of the daytime on overall gene expression was almost exclusively due
to zeitgeber time 17 which corresponded to the middle of the active night phase of the
rats. Given the setup of our study we could not distinguish gene expression changes due
to an endogenous circadian rhythm from changes due to diﬀerences in the animals activity
levels. We suspect a greater inﬂuence of the latter as only zeitgeber time 17 stands apart
while the other time points had formed a non-divisible cluster. We are not aware of any
study speciﬁcally assessing the eﬀect of behavioural activity levels on gene expression in
the mammalian brain but it is conceivable that the working brain of an awake animal has a
higher protein turnover and subsequently higher gene expression. Two studies, conducted
in rat ﬁbroblasts (Duﬃeld et al., 2002) and rat pineal gland (Fukuhara and Tosini, 2008)
also reported that gene expression showed the biggest alterations during the active night
phase.
Detection of daily oscillating genes
It seems probable that the ability of the Fourier algorithm to discern genes with truly daily
oscillating mRNA levels from those with aleatory ﬂuctuations was diminished by the fact
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that we had only four time points of measurement per day.
As shown in the heatmaps, the gene expression proﬁles were almost completely domi-
nated by the amplitude at zeitgeber time 17 - the middle of the rats active phase. As a
consequence, approximately 50% of the genes were detected as oscillating at a false dis-
covery rate of 10%. We had nonetheless kept this FDR for the analysis of the core clock
and the E-box genes as we considered sensitivity to be more important than speciﬁcity in
the analyses.
Inﬂuence of alcohol consumption on core clock genes
Based on our hypothesis of an interplay between core clock and addiction-related genes,
we had hoped to ﬁnd core clock genes whose mRNA levels showed oscillation in control
but no such oscillation or an altered rhythmicity in alcohol-drinking rats. In the best case
such a loss or modiﬁcation of oscillation should have been visible in both the short-term
and the long-term treated animals.
While none of the core clock genes in our rats had fulﬁlled the best case criteria, two
genes, Rev-ErbA α (Nr1d1 ) and period 2 (Per2 ), had lost their diurnal expression rhythm
in either the short-term or the long-term alcohol-drinking rats. Those genes, which had
shown daily oscillations in all treatment conditions (Arntl, Cry1 and Csnk1a1 ), had not
displayed any noteworthy diﬀerences in their rhythmic proﬁles.
The importance of the Per2 ﬁnding was reduced by the fact that the expression proﬁle
of this gene had reached almost signiﬁcant oscillation in the long-term alcohol-drinking
rats as well. Nr1d1 had therefore been the only gene which unambiguously lost its rhythm
under the inﬂuence of alcohol. This is particularly interesting as this gene was reported
to have a strong impact on post-transcriptional mechanisms such as the expression of the
thyroid hormone receptor (Hastings et al., 2000). Nr1d1 had previously turned up as a
ﬁnding in a gene expression study on ethanol vapour-exposed mice (Melendez et al., 2012)
but an association study on methamphetamine dependent patients had failed to ﬁnd a link
between this nuclear receptor and addiction (Kishi et al., 2011).
Previous studies reported inconsistent results regarding the expression proﬁles of Per1
and Per2 (Masubuchi et al., 2000; Iijima et al., 2002; Uz et al., 2003; Li et al., 2009, 2010).
The peak of Per1 gene expression was reported either at the beginning, in the middle or at
the end of the light phase or at the beginning of the dark phase. The expression maximum
of Per2 was reported either at the beginning or the end of the the dark phase or in the
middle of the light phase (Iijima et al., 2002; Li et al., 2009, 2010). In our experiment, the
expression maxima of Per2 had been at the end of the light phase in all treatment groups.
The lowest expression level of Per2 had been at the end of the dark phase in the long-term
paradigm rats. In the short-term rats, the lowest expression point had been in the middle
of the dark phase for the control animals but had shifted to the end of this phase for the
alcohol-exposed animals. Only the Per2 expression proﬁle of the long-term control group
had been considered oscillating according to the Fourier analysis. Overall the expression
oscillation in Per2 but also Per1 of the rats of the long-term treatment group had been
more pronounced. As the diﬀerent duration of the short- and long-term treatment also
implied an age diﬀerence of several month between the animals, we suggest that the age
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of an experimental animal might have a substantial inﬂuence on the circadian expression
of Per1 and Per2 in the nucleus accumbens.
Previous studies have also reported that the expression proﬁles of the period genes can
be markedly diﬀerent in the nucleus accumbens core and shell region with Per2 even
showing opposing rhythms in these subregions (Li et al., 2009, 2010). This could explain
why we failed to detect a signiﬁcant circadian oscillation in these genes as we might have
obliterated their region speciﬁc rhythms by extracting the mRNA of the nucleus accumbens
as a whole.
Taken together, the analysis of the core clock genes did not substantiate the hypothesis
that alcohol-drinking substantially modiﬁes the circadian expression proﬁles of the core
clock genes in the nucleus accumbens. A possible interpretation of our results is that
the centre of integration between circadian rhythms and addiction does not lie in the
nucleus accumbens. Several studies had reported alterations of the diurnal core clock
gene expression in the hypothalamus of rats after chronic alcohol consumption or in the
hypothalamus, suprachiasmatic nucleus and cerebellum of rats after prenatal exposure
to alcohol (Chen et al., 2004, 2006; Farnell et al., 2008). Alterations of core clock gene
oscillation had also been reported in the case of other drugs of abuse: in the mouse striatum
after methamphetamine consumption (Iijima et al., 2002) and in the nucleus accumbens of
rats following opiate withdrawal (Li et al., 2009, 2010). In a study on human post-mortem
brain tissue, Li et al. (2013) had shown that major depressive disorder leads to signiﬁcant
phase interruptions of core clock gene expression in several brain regions. Interestingly, the
greatest impact was in the dorsolateral prefrontal cortex while the expression proﬁles in the
nucleus accumbens were more conserved between depressive patients and control subjects.
Their ﬁndings suggest that the prefrontal cortex might therefore play a greater role than the
nucleus accumbens in the connection between psychiatric disorder and circadian rhythm
disturbance.
While we did not ﬁnd changes in the expression rhythm of the core clock genes, there
was still a chance that alcohol increased or decreased the expression of these genes at all
time points. This eventuality was discussed below in the discussion of the t-test results.
Inﬂuence of alcohol consumption on selected E-box containing genes
Given the presumed role of E-box regulatory DNA sequences in the interference between
alcohol addiction and the circadian rhythm machinery, we had also analysed a selection of
addiction related genes which contained such E-box elements in their promoter region. As
in the case of the core clock genes, we had speculated to ﬁnd a neutralisation or marked
alteration of diurnal oscillating gene expression under the inﬂuence of alcohol.
In the case of the metabotropic glutamate receptor 4 (Grm4 ) we had found instead a gain
in rhythmicity in short-term alcohol rats although the importance of this result is lessened
by the fact that the gene was almost rhythmic in the corresponding control group as well.
While Grm4 had been linked to schizophrenia and epilepsy (Shibata et al., 2009; Muhle
et al., 2010), there are no reports of a direct relation between this gene and addiction.
The delta opioid receptor 1 (Oprd1 ) has been linked both to addiction in general as well
as speciﬁcally to chronic alcohol abuse (Zhang et al., 2008; Hansell et al., 2009) but its
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strong rhythmic proﬁle had not been altered by alcohol-drinking in the present experiment.
Slc6a2, coding for the norepinephrine transporter which empties the synaptic clefts of
norepinephrine and dopamine, had also shown strong but basically unaltered circadian
rhythmicity in all groups. Its function is related to the action of the tyrosine hydroxy-
lase (Th) which converts tyrosine to L-dopa thus paving the way for the synthesis of the
catecholamine neurotransmitters dopamine and norepinephrine (Nagatsu, 1995). Th had
been the only E-box containing gene which lost its diurnal mRNA oscillation in alcohol-
drinking rats, albeit this happened only in the short-term treated rats. Lemmer et al.
(2003) reported circadian expression oscillations of both Slc6a2 and Th in the adrenal
glands of rats. While their Th result was consistent with our ﬁndings their Slc6a2 proﬁle
in the peripheral tissue was phase-reversed compared to our data from the central nervous
system.
Taken together, our analysis of this small sample of E-box containing genes did not
provide substantial evidence for an alteration of rhythmic expression proﬁles of these genes.
The substantial diurnal oscillation of Oprd1 and Slc6a2 expression in the central nervous
system has not been reported previously to the best of our knowledge and constitutes
therefore an interesting accessory ﬁnding.
General screening for oscillating genes that change under the inﬂuence of alcohol
We had also screened our data in a more general approach for genes whose diurnally
oscillating expression was markedly altered by alcohol, hoping to ﬁnd clusters of genes
which showed a characteristic circadian-oscillating expression pattern in control rats which
would get disturbed in alcohol drinking rats. The visual comparison of gene expression
proﬁles in the heatmaps had not provided any noteworthy examples of such clusters in
short-term or long-term treated rats. The Pearson correlation coeﬃcients of the genes
with the least congruent expression proﬁles between control and alcohol-drinking rats had
still been above 0.4 and would therefore conventionally be considered to indicate a modest
to moderate correlation (Taylor, 1990). In addition, the least congruent genes were DEAD
box polypeptide 47 (Ddx47 ), ribosomal protein S3 (Rbs3 ), polypeptide B17 of family 2 of
glucuronosyltransferases (Ugt2b17 ) and member 114 of type 2 taste receptor (Tas2r114 ).
We assume that these ﬁndings are due to statistical noise as none of these genes had
a reasonable connection to alcohol consumption or circadian rhythm and the ﬁndings of
short-term and long-term animals did not overlap.
As in the previous steps, this part of the analysis did not provide substantial evidence
for an alteration of circadian gene expression proﬁles by alcohol consumption.
Comparison of mRNA levels in control and alcohol drinking rats of the short- and
long-term paradigm
In the last part of our analysis we had compared the gene expression levels in control versus
alcohol drinking rats at all the diﬀerent time points and for both treatment duration groups.
This analysis, based on very moderate cutoﬀ citeria of an uncorrected t-tests below 0.05
and an absolute fold change above 1.2, had produced surprisingly small lists of genes.
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The limited number of signiﬁcantly diﬀerentially expressed genes had made any reasonable
analysis for enriched pathways or gene ontology terms impossible. The lack of substantial
overlap between the diﬀerent time points and the short- and long-term treatment groups
again suggested a large number of biologically insigniﬁcant chance ﬁndings. Cell division
cycle-associated protein 7 (Cdca7 ) and cytoglobin (Cygb) had been the only genes that
were signiﬁcantly diﬀerentially regulated in more than one subgroup. To the best of our
knowledge, none of the two proteins had been previously related to alcohol addiction or
circadian rhythm.
Overall, the lists of diﬀerentially expressed genes contained many transcripts with no
plausible connection to addiction or even neuronal activity. But there was also a number
of genes whose predicted function could play a role in alcohol addiction:
In the short-term paradigm, the mRNA level of neuron-derived orphan receptor 3
(Nr4a3 ) had been increased in alcohol drinking rats at zeitgeber time 11. In line with our
result this gene had also been up-regulated in the striatum of rats following nicotine and
methamphetamine consumption in a study by Saint-Preux et al. (2013) while it was shown
to be down-regulated in the infralimbic cortex of alcohol-vapour exposed rats (Meinhardt
et al., 2013).
The phosphodiesterase 1B (Pde1b) had been down-regulated in alcohol-drinking rats
at ZT17. This gene has a high expression level in the striatum and has been associated
with dopamine turnover (Siuciak et al., 2007) as well as DARPP32-dependent signalling
in striatal medium spiny neurons (Ehrman et al., 2006; Spanagel, 2009).
Another gene of interest was the excitatory amino-acid transporter (Slc17a6 ), also known
as vesicular glutamate transporter 2 (Vglut2 ), which had been down-regulated in the
alcohol-exposed animals at ZT11. The gene codes for a glutamate transporter which trans-
fers glutamate into the synaptic vesicles (Shigeri et al., 2004) and which is co-expressed in
dopaminergic neurons of the ventral tegmental area which project to the nucleus accumbens
(Birgner et al., 2010). Alsiö et al. (2011) reported that mice in which the expression of this
transporter had been suppressed in the midbrain dopaminergic neurons showed a higher
aﬃnity to high-sucrose food and cocaine in an operant self-administration paradigm. To-
gether with our ﬁndings, this suggests that Slc17a6 is related to addictive-like behaviours.
The glutamate receptor interacting protein 2 (Grip2 ) had been down-regulated in alcohol-
drinking rats at ZT23. This protein might play a role in the targeting of AMPA-sensitive
glutamate receptors to the synapses (Dong et al., 1999). Grip2 has not been linked to
alcoholism or any other addiction so far to the best of our knowledge.
Also at ZT23, sirtuin 2 (Sirt2 ) had been down-regulated in the alcohol drinking rats.
The gene codes for a member of the sirtuin family of proteins and it was suggested that
Sirt2 acts as a deacetylase on diﬀerent substrates such as α-tubulin (Maxwell et al., 2011)
and histone H4 (Donmez and Outeiro, 2013). The protein family had been linked to cir-
cadian rhythmicity in previous studies although this was mainly due to studies on Sirt1
(Wijnen, 2009). Renthal et al. (2009) reported that both Sirt1 and Sirt2 were up-regulated
in the nucleus accumbens of cocaine-challenged mice. The authors could show in addition
that the sirtuins were responsible for an altered electrical excitability of the nucleus accum-
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bens neurons and that sirtinol, an inhibitor of the sirtuins, reduced the self-administration
of cocaine. Our ﬁnding is thus in line with this previous study that sirtains might play a
role in the establishment of drug addiction. But while the gene expression of Sirt2 had
been signiﬁcantly oscillating in the short-term paradigm rats in our study, we did not ﬁnd
a modulation of this oscillation by alcohol.
In the long-term paradigm, the brain-derived neurotrophic factor (Bdnf ) was down-
regulated in alcohol-drinking rats at ZT05. Bdnf had been previously linked to alcohol
abuse although there are conﬂicting reports about its expression levels upon chronic alco-
hol consumption (for an overview see Davis, 2008). Wolstenholme et al. (2011) reported
an inverse correlation between Bdnf expression in the nucleus accumbens and ethanol con-
sumption in mice. A similar ﬁnding had been reported for rats (Yan et al., 2005). But both
studies were based on a comparison of preferring to non-preferring animals and the au-
thors argued that low Bdnf levels might have existed before the alcohol consumption thus
constituting a protective eﬀect against alcohol addiction. Melendez et al. (2012) showed
a down-regulation of Bdnf in the prefrontal cortex of alcohol vapour-exposed mice and a
study in humans found lower Bdnf levels in the blood of alcohol dependent patients (Joe
et al., 2007) which would be in line with our ﬁnding from the nucleus accumbens.
The glycine transporter 1 (Slc6a9 ) was up-regulated in alcohol drinking rats at ZT11.
This transporter protein removes the inhibitory neurotransmitter glycine from synapses.
Previous studies have shown that glycine is involved in the dopamine surge in the nucleus
accumbens after ethanol consumption and that inhibition of Slc6a9 decreases the alcohol
intake in rats and reduces their relapse rate (Molander et al., 2007; Vengeliene et al., 2010).
Our results would concord to these ﬁndings although none of these studies had reported
signiﬁcant diﬀerential expression of Slc6a9.
The GABA B1 receptor1 (Gabbr1 ) was down-regulated in alcohol drinking rats at ZT17.
This ﬁnding is interesting as alcohol acts primarily on the GABAA receptor (Spanagel,
2009). In addition, baclofen, a GABAB receptor agonist, was proposed as a possible anti-
craving drug for recovering alcoholics (Ameisen, 2005). Our ﬁnding of a down-regulation
would make sense in this context but it is at odds with an earlier report that Gabbr1 is up-
regulated in the striatum of alcohol addicted mice (Ribeiro et al., 2012). A study conducted
on human post-mortem hippocampus tissue showed that Gabbr1 was signiﬁcantly down-
regulated in alcoholics (Enoch et al., 2012) which would be more in line with our ﬁnding
although Gabbr1 might well show contrasting expression levels in diﬀerent brain regions
of post-dependent individuals.
The AMPA-sensitive ionotropic glutamate receptor 4 (Gria4 ) was up-regulated in alco-
hol drinking rats at ZT17. We found only one previous study which had measured Gria4
gene expression under the inﬂuence of chronic alcohol consumption: Acosta et al. (2011)
reported, in line with our ﬁndings, that Gria4 was up-regulated in prefrontal cortex and
anterior cingulate cortex of voluntarily alcohol-consuming cynomolgus monkeys (Macaca
fascicularis).
Noteworthy is the absence of core clock genes on the lists of diﬀerentially regulated
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genes. Huang et al. (2010) had reported that the baselines of the core clock genes were
signiﬁcantly lower in the blood of alcohol addicts as compared to control subjects. We
could not corroborate these results with our data from the rat nucleus accumbens.
Outlook
All results taken together, our data indicate that the nucleus accumbens does not seem to
be the brain area where the interaction between circadian rhythms and the development
of alcohol dependence takes place. Nonetheless, our study demonstrated decisively how
important it is to consider the inﬂuence of the circadian phase when taking biopsies for gene
expression analysis. On the one hand, it is essential to choose which time of day produces
the most meaningful results, while on the other hand, it is crucial that all samples are
taken at approximately the same time.
As in the case of all negative research ﬁndings, the outcome of this study could be due
to a real absence of the investigated phenomenon or to a lack of sensitivity in our experi-
mental setup. Especially the inability to distinguish activity-level related gene expression
diﬀerences from circadian rhythm oscillations proved to be a big limitation to our study.
Based on the results of this study several future experiments would be of interest. An
option would be to repeat the measurements in the suprachiasmatic nucleus of long-term
drinking rats to see if alcohol eﬀects the rhythm generating clockwork at its core. Given the
negative results in the nucleus accumbens, the caudate putamen and the ventral tegmental
area would be further regions of interest where the interaction between circadian rhyth-
micity and development of alcohol addiction could take place. They could therefore be
investigated in a similar study setup. More measurement times would thereby increase the
accuracy of the Fourier analysis. The integration of a rat group kept in constant darkness
could help to distinguish activity-related from truly circadian oscillations of gene expres-
sion. In addition, this would allow to assess the impact of alcohol on animal behaviour
under a free-running circadian rhythm without external zeitgebers.
The ﬁnal aim of these proposed studies would be to improve the treatment options for
alcohol addicted patients. It makes therefore sense to switch to human subjects in follow-
up experiments. Large questionnaire studies on signs of circadian disturbance in drinking
and recovered alcoholics could improve our knowledge of the epidemiological aspects of the
relationship between addiction and circadian rhythm alterations. Another option would
be to screen for genes with circadian expression proﬁles in an easily available biological
material, such as blood, and compare the proﬁles of addicted patients to those of healthy
volunteers. In our next study we tried to lay the foundations for such an approach.
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3. Inﬂuence of circadian rhythmicity on
gene expression in human blood
3.1. Introduction to the study
As discussed in the previous project, alcohol addiction interferes with the proper func-
tioning of the body's intrinsic circadian rhythm. The disturbances of the day-night cycle
and the respective activity pattern often continue or even become worse after withdrawal
from alcohol (Asheychik et al., 1989; Egbert, 1993; Jones et al., 2003). This might be
partially the result of depressive mood states which are typical for the immediate days
after discontinuation of alcohol (Laine et al., 1999; Pang et al., 2013) as major depression
is well-known to be accompanied by insomnia (Jindal, 2009).
Given the lack of suﬃciently eﬀective psychological treatments and pharmaceutical drugs
to control the high relapse risk of recovering alcoholics, the investigation of the alcoholism-
related circadian distortions might lead to additional treatment approaches. Especially the
degree of the disturbance of the body's endogenous clock might be an important clinical
parameter as there is evidence that alcohol consumption and relapse risk are increasing with
the severity of insomnia (Allen and Wagman, 1975; Brower et al., 2001). High risk patients
with gravely deranged circadian rhythmicity could thus receive extra medical attention.
Such patients might also respond to chronotherapeutic interventions such as bright light
therapy or optimisation of the environmental factors of their sleep (sleep hygiene) (Schmitz
et al., 1997; Landolt and Gillin, 2001; Hasler et al., 2012). In addition, the analysis of
cellular circadian systems and their perturbation by alcohol might provide new molecular
targets for the pharmacotherapy of alcoholism, as already mentioned in the previous study.
Assessment of the severity of the circadian rhythm perturbation could be made on the
basis of questionnaires, sleep laboratory recordings and behavioural monitoring but all
these techniques would either yield inexact results or be too elaborate for a routine clinical
diagnosis. Measurements of melatonin or other oscillating hormone concentrations are
another option but would not yield new pharmaceutical targets. It is therefore of high
interest to look at the molecular level and assess how far the transcription patterns of
genes with circadian oscillating mRNA levels are disturbed.
The eﬀect of alcohol consumption and post-withdrawal states on circadian gene expres-
sion in the suprachiasmatic nucleus is well documented (Chen et al., 2004) but sampling
patient tissue of this region or any other brain structure is practically impossible. Blood,
on the other hand, is readily available and routinely taken in a hospital setting. In addi-
tion, Achiron and Gurevich (2006) as well as Sullivan et al. (2006) have shown that blood
gene expression mirrors the transcription proﬁle of the central nervous system. As many
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other tissues in the human body, blood also shows clear signs of circadian rhythmicity.
O'Neill and Reddy (2011) showed that red blood cells, which lack a cell nucleus in their
mature state, show nonetheless circadian rhythmicity in the redox state of peroxiredoxins.
And leucocytes have genes with circadian transcription levels (Watanabe et al., 2012).
The ﬁrst step in the identiﬁcation of genes whose circadian oscillating mRNA levels are
altered by alcohol consumption is the identiﬁcation of consistently diurnally ﬂuctuating
mRNAs in the blood of healthy subjects.
The aim of the present study was therefore to take blood samples from healthy test
persons throughout a period of 24 hours and to identify genes with circadian oscillating
transcription rates by microarray analysis. The result is a baseline curve of the candidate
genes which can then be compared in a follow-up study to blood gene expression patterns
in post-dependent individuals.
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The clinical part of this study was performed by our collaborators at the Clinic of Psychi-
atry and Psychotherapy of the University Hospital of Göttingen (Göttingen, Germany).
3.2.1. Recruitment of test persons
Healthy male volunteers aged between 35 and 50 years of age were recruited for this study.
All subjects were examined with standard psychiatric diagnostic tools for physical, psy-
chiatric and neurological disorders and only subjects without any positive ﬁndings were
invited for the subsequent study.
The original number of test subjects was set at ten but due to experimental diﬃculties
with the nocturnal blood taking procedure, ﬁve of the ﬁrst ten participants did not have
a physiological sleep. Seven more participants were recruited to counter this fact.
3.2.2. Blood taking procedure
The participants spent one night of adaptation in the sleep laboratory of the Clinic of
Psychiatry and Psychotherapy of the University Hospital of Göttingen. Blood taking
started the next morning at 8:00 hours. A peripheral venous catheter was placed in one
arm and two times 2.5 ml blood were taken every two hours till 8:00 hours in the next
morning. The blood was collected directly into PAXgene Blood RNA Tubes (PreAnalytiX,
Hombrechtikon, Switzerland). Throughout the experiment, the participants stayed in the
Hospital. In the evening, the subjects went to the sleep laboratory at 22:00 hours and
lights were switched oﬀ at 23:00 hours.
In the case of the ﬁrst ﬁve subjects, staﬀ would walk into the room every two hours during
the night to withdraw blood samples from the catheter. With the exception of subject 4,
the sleep of all other participants had been markedly disturbed by this procedure. Subject
6 dropped out of the study at 22:00 hours the second night.
For the following participants, the blood taking procedure during the night was modiﬁed:
A plastic tube was used to connect the peripheral venous catheter to a valve which was
situated behind a private screen. This allowed blood collection without disturbing the
sleep of the test subjects.
The sleep quality of all participants was monitored by electroencephalography (EEG).
Medical staﬀ at the sleep laboratory of the University Hospital of Göttingen assessed the
EEG recordings and categorised the patients in three groups with physiological, almost
physiological and not physiological sleep.
3.2.3. RNA isolation and puriﬁcation
The blood-ﬁlled PAXgene Blood RNA Tubes had been stored and shipped at −80 ◦C. They
were thawed overnight at 4 ◦C and RNA was isolated using the PAXgene Blood RNA Kit
(PreAnalytiX, Hombrechtikon, Switzerland) according to the manufacturer's protocol. The
RNA was subsequently puriﬁed using the RNeasy MinElute Cleanup Kit (Qiagen, Hilden,
Germany) following the manufacturer's instructions. In the ﬁnal step, RNA was eluted in
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14 µl of RNase-free water. The concentration and purity of the RNAs were analysed with
a Nanodrop 1000 Spectrophotometer (Peqlab, Erlangen, Germany) and the degree of RNA
degradation was assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA). Only samples with a ratio of absorption at 260 nm versus 280 nm in the
range of 1.8 to 2.2 as well as an RNA integrity number (RIN) above seven were considered
for microarray analysis. Not all samples from subject 04, 09 and 12 met those criteria.
As we did not want incomplete time series data we excluded these subjects and continued
with the samples from subject 08, 11, 13, 15, and 17 for the microarray experiment.
Total RNA samples isolated from blood contain a high amount of globin mRNA which
can impair the sensitivity of the microarray analysis. Hence, a variety of globin mRNA
reduction methods have been invented to treat the RNA before gene expression analysis.
We did not subject our RNA to globin mRNA reduction following the reasoning of Liu
et al. (2006) that such a treatment can induce bias as these techniques can also aﬀect
non-globin messenger RNAs.
3.2.4. Illumina HumanHT-12 v4 Expression BeadChip
As in the study on circadian rhythm and alcohol consumption in rats, RNA samples were
prepared for microarray analysis at the Genomics and Proteomics Core Facility of the
German Cancer Research Center (DKFZ) in Heidelberg, Germany. A description of the
protocol can be found in the corresponding material and method section of the previous
project (see page 17). Hybridisation was done on HumanHT-12 v4 Expression BeadChips
using the accompanying kit (Illumina, San Diego, CA, USA).
3.2.5. Microarray data pre-processing
The acquired data from the BeadChips were processed in the DKFZ Core Facility's R
pipeline. A description of the pipeline and its steps can be found in the material and method
section of the previous project (see page 18). All samples scored acceptable on Illumina's
BeadChip quality control features showing that the abundant presence of globin mRNA
did not cause a problem with the hybridisation. As in the previous project, the microarray
data were normalised based on the robust multi-array averaging (RMA) procedure which
includes a quantile normalisation and a log2 transformation (Irizarry et al., 2003).
3.2.6. Microarray annotation
In contrast to the previous microarray project, we kept the original Illumina annotation
provided by the DKFZ Core Facility as the Re-annotation and Mapping for Oligonucleotide
Array Technologies (ReMOAT) project did not oﬀer a recomputed annotation for the
HumanHT-12 v4 Expression BeadChip (Barbosa-Morais et al., 2010). In addition, the
standard annotation of the HumanHT-12 v4 Expression BeadChip was much better than
the one for the RatRef-12 Bead Array: The Human BeadChip contained 48 107 probes,
883 of which were control probes, 3 270 were labelled as UniGene cluster identities, 11 650
as locus identities, and 1 755 probes were labelled as predicted genes. The remaining 30 549
probes were well annotated.
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3.2.7. Statistical analysis
All statistical analyses were performed using LibreOﬃce 3 and R statistical programming
language version 2.15.0.
Principal component analysis
Principal component analysis was performed on the quantile normalised data using the
prcomp-function of the stats-package of R. For graphical presentation, the data points
representing the individual blood samples were plotted against the ﬁrst three principal
components using the cloud -function of the lattice-package. The labels were added and
the plot was coloured in inkscape 0.48.
Identiﬁcation of circadian oscillating genes
As in the previous project, the time-series gene expression data of all test-persons were
concatenated and then z-score transformed so that every gene had a mean expression of
zero and a standard deviation of one (Cheadle et al., 2003).
Genes with circadian oscillating expression levels were then identiﬁed using the fdr-
fourier -function of the cycle-package of R (Futschik and Herzel, 2008) based on a period
of 24 hours. The function calculated a Fourier score which became larger if a gene was
closer to a cosine curve of the given period length as well as a false discovery rate (FDR)
which was calculated on the basis of 100 permutations within the rows.
A more detailed description of the z-score transformation and the Fourier function can
be found in the corresponding section of the previous project (see chapter 2.2.8 on page
20).
Classiﬁcation of the oscillating genes according to their time of peak expression levels
Pairwise Pearson correlation distances were computed between the expression patterns of
the oscillating genes using the cor.dist-function of the bioDist-package of R. The hclust-
function of the stats-package was then used to hierarchically cluster the genes based on
these pairwise distances using complete linkage as the method of agglomeration.
For graphical presentation, a heatmap with the results was drawn using the heatmap.2 -
function of the R package gplots. Image labels were arranged in inkscape 0.48 and a den-
drogram of the hierarchical clustering was added to the side.
Analysis of enriched pathways and gene ontology terms
The lists with the oscillating genes were screened for over-represented enzymatic pathways
and gene ontology terms using the Database for Annotation, Visualization and Integrated
Discovery (DAVID) version 6.7 (http://david.abcc.ncifcrf.gov/) of the National In-
stitute of Allergy and Infectious Diseases (NIAID) in Bethesda (MD, USA) which has been
introduced in two publications by Huang da et al. (2009a,b). Gene lists were screened for
pathways of the Kyoto Encyclopedia of Genes and Genomes (KEGG) and biological path-
way, molecular function and cellular component gene ontology terms of level 5 using the
49
3. Inﬂuence of circadian rhythmicity on gene expression in human blood
whole Illumina HumanHT-12 array as a background. Results were considered signiﬁcant
if the Bonferroni corrected p-value was below 0.05 or the enriched structure had a false
discovery rate below 20%.
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In order to search for oscillating gene expression pattern in non-diseased individuals, blood
was taken from seventeen healthy volunteers (mean age = 40.25 years, standard deviation
= 5.69 years) during a period of 24 hours. As the experiment included an overnight stay in
a hospital and our focus was on analysing the mRNA concentrations during a normal daily
routine, the test persons' sleep quality was monitored by EEG. The age of subjects, as
well as the EEG-based categorisation of their sleep quality and the quality of the extracted
RNA can be found in table 3.1.
Table 3.1.: Overview of the sleep quality of the study participants.
subject number age in sleep proﬁle RNA of all time
- selected for years according to EEG points in good
microarray quality available
1 45 not physiological (not extracted)
2 48 not physiological (not extracted)
3 43 not physiological (not extracted)
4 41 physiological 7
5 47 not physiological (not extracted)
6 n.a.* n.a.* (not extracted)
7 47 not physiological 4
8 37 almost physiological but 4
patient woke up to early
9 44 physiological (not extracted)
10 45 not physiological 7
11 35 physiological 4
12 41 almost physiological 7
13 37 physiological 4
14 37 not physiological (not extracted)
15 29 almost physiological 4
16 33 not physiological (not extracted)
17 35 almost physiological 4
*) not available, as participant aborted the study in the evening.
Only the test persons number 8, 11, 13, 15 and 17 showed both acceptable sleep qual-
ity and acceptable RNA quality for each time point and were thus used for global gene
expression measurement with microarrays.
3.3.1. Principal component analysis
After normalisation of the microarray data we ﬁrst applied a principal component analysis
to see if the identity of the blood donor or the time of blood sampling had a higher overall
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Figure 3.1.: Scatter plot of the blood RNA samples projected on the ﬁrst three principal
components detected by principal component analysis (PCA).
eﬀect on the similarity of the global gene expression. The ﬁrst three principal components,
which identiﬁed the mathematically abstract directions along which the variation in the
data set was maximal, were plotted as the axes of a three dimensional coordinate system.
The microarray chips, representing each a blood sample, were then positioned in the coor-
dinate system and labelled according to the blood donor (ﬁgure 3.1a) or according to the
time of blood sampling (ﬁgure 3.1b). The graphs show that samples were clearly clustered
based on the blood donor but not based on the time point.
3.3.2. Detection of oscillating genes by Fourier transformation
As a next step, we wanted to identify those genes which showed a truly diurnally oscillat-
ing mRNA concentration. We used a fast Fourier transform algorithm which calculated
abstract Fourier scores, with higher scores indicating that a gene expression time-series
resembles more closely a cosine curve of a period of 24 hours. This yielded a list of 169
circadian oscillating genes based on a false discovery rate of 10%. The top 20 genes are
displayed in table 3.2. Besides the circadian clock gene PER2, which had its peak mRNA
concentration at 04:00 hours in the morning, the list contained a number of genes which
were representative for leukocytes. The mRNA concentration measurements of the ﬁrst
nine genes were plotted in ﬁgure 3.2.
To obtain an impression of the consistency of the gene expression pattern throughout
the diﬀerent subjects, PER2 gene expression was also represented in another graph with
individual time curves for each subject (ﬁgure 3.3). While the test persons all showed
the same tendency of higher PER2 gene expression in the hours after midnight, diﬀerences
existed between individual persons. Thus, subject 13 showed a dip in PER2 gene expression
at 04:00 hours and subject 17 showed a less pronounced circadian oscillation than the other
subjects.
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Table 3.2.: List of top 20 oscillating genes according to Fourier score.
Gene Description Fourier FDR* Peak
symbol score time
GZMB granzyme B 30.21 0.0000 12:00
LILRA5(1) leukocyte immunoglobuline-like receptor A5 28.46 0.0000 14:00
CST7 cystatin F 27.78 0.0067 12:00
DDIT4 DNA damage inducible transcript 4 26.92 0.0050 08:00
FGFBP2 ﬁbroblast growth factor binding protein 2 26.51 0.0040 12:00
CCL4L2 C-C motif chemokine ligand 4-like 2 26.18 0.0067 12:00
PER2 period circadian clock 2 25.68 0.0100 04:00
ZNF512 zinc ﬁnger protein 512 25.64 0.0088 24:00
TTC38(1) tetratricopeptide repeat domain 38 25.39 0.0089 12:00
PRF1 perforin 1 25.35 0.0080 14:00
TTC38(2) tetratricopeptide repeat domain 38 25.15 0.0082 12:00
FKBP5 FK506 binding protein 5 25.06 0.0075 10:00
NELL2 neural epidermal growth factor-like 2 24.96 0.0092 02:00
NKG7 natural killer cell group 7 sequence 24.90 0.0100 14:00
PINK1 PTEN induced putative kinase 1 24.80 0.0100 10:00
LILRA5(2) leukocyte immunoglobuline-like receptor A5 24.78 0.0100 16:00
BAG5 BCL2-associated athanogene 5 24.75 0.0106 04:00
TMEM91 transmembrane protein 91 24.72 0.0111 10:00
KIR2DL4 killer cell immunoglobulin-like receptor 2DL4 24.70 0.0105 12:00
CLIC3 chloride intracellular channel 3 24.47 0.0125 12:00
*) FDR = false discovery rate; LILRA5 and TTC38 were targeted by two diﬀerent probes on the array.
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Figure 3.2.: Daily mRNA concentration curves of selected genes. The grey asterisks indicate
the individual values while the black line shows the averaged curve. The black-white bar just
above the x-axis indicates the light-dark periods during the blood sampling.
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Figure 3.3.: PER2 gene expression curves of the ﬁve test persons.
3.3.3. Classiﬁcation of the oscillating genes according to their time of peak
expression levels
In a next step, we wanted to group the 169 oscillating genes into classes with similar
circadian expression patterns. We therefore calculated the pairwise Pearson correlation
coeﬃcients between the oscillating genes which had been selected in the previous step
and then used hierarchical clustering to split the list of genes into subgroups based on
the closeness of their Pearson correlation. The results were displayed in a heatmap (see
ﬁgure 3.4).
Based on the heatmap image, we visually deﬁned four groups which had each a char-
acteristic circadian oscillating expression pattern. Group 1 contained 68 genes which had
their peak expression at noon and their lowest expression levels around midnight. GZMB,
LILRA5 and CST7 were the most intensively oscillating members of this group, based
on their Fourier score. Group 2 contained 13 genes whose expression levels peaked in the
morning around 8:00 hours and whose lowest expression level was around 22:00 hours.
DDIT4 was part of this group. Group 3 contained 81 genes with a peak expression level
around midnight and the lowest expression at around 14:00 hours. ZNF512 and NELL2
were the most signiﬁcantly oscillating members of this group. Group 4 contained ﬁve genes
whose peak expression was also during the night but later as in the genes of group 3 and
whose low expression periods expanded well in the late afternoon. PER2 was part of this
group.
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Figure 3.4.: Heatmap of oscillating genes clustered according to their Pearson correlation
coeﬃcients. Each row stands for one gene and each column for one time point. Higher
gene expression is indicated by a more intensive red colouring while blue signiﬁes lower gene
expression. The vertical red bars on the left side indicate the four main - visually identiﬁed
- subgroups of genes which had their peak expression levels around noon (1), in the morning
(2), around midnight (3) and between 2 and 4 o'clock in the morning (4).
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3.3.4. Enriched pathways and gene ontology terms
We tried to characterise our lists of oscillating genes more closely by analysing if the genes
from our list belonged to speciﬁc enzymatic pathways or gene ontology terms. The analysis
was based on the web-based resources of the Database for Annotation, Visualization and
Integrated Discovery (DAVID).
The list of the 169 genes with daily oscillating mRNA concentrations did not show any
signs of enriched gene ontology terms or over-representation of genes of speciﬁc pathways.
When repeating the analysis for the four subgroups, only group 1, containing the genes with
a peak expression around noon, showed two over-represented pathways which remained
signiﬁcant after Bonferroni correction but not according to a false discovery rate calculation
(see table 3.3). No gene ontology terms were enriched in this group and none of the other
groups showed signs of enrichment of either gene ontology terms or enzymatic pathways.
Table 3.3.: Enriched KEGG pathways in the list of genes with a peak expression at noon.
number fold
KEGG Pathway of genes* p-value enrichment Bonferroni FDR
Graft-versus-host disease 4 0.00045 24.6 0.013 0.38
Natural killer cell
mediated cytotoxicity 5 0.00160 9.1 0.046 1.0
*) Number of genes from the candidate list of oscillating genes implicated in the KEGG pathway.
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3.4. Discussion of the study
The aim of this study was to identify genes with circadian oscillating expression levels in
the blood of healthy volunteers by microarray screening. The expression pattern of these
genes can then serve as a baseline for the comparison of transcription rates in alcohol
dependent individuals.
Principal component analysis
In order to obtain a ﬁrst impression of the generated data set, we had applied a principal
component analysis to look for the main sources of variance. We found that the blood
donor had a much higher impact on the overall gene expression proﬁle than the time of
day at which the blood sample was taken. This result corresponded to our expectations,
as we had assumed that only a fraction of the transcriptional activity in the blood cells
would show circadian rhythmicity. We therefore speculate that the vast majority of tran-
scriptional processes diﬀered only slightly between the time points leading to a higher
impact of inter-individual diﬀerences. Previous studies have shown that gene expression
varies signiﬁcantly in the same tissue of diﬀerent organisms of the same species and that
the cellular composition of leukocytes ﬂuctuates in healthy individuals depending on their
mental and physical state on the day of measurement (Kaplow, 1975; Fei et al., 1993; van
Rossum et al., 2008).
It also lies in the nature of oscillating processes that the same states - gene expression
levels in our case - are periodically recurring. The overall impact of this phenomenon on
the variation in the data set will therefore be smaller than the time-consistent diﬀerences
in gene expression between individuals.
Role of core circadian genes
In line with the aim of this study we identiﬁed a number of circadian oscillating genes
in the blood of the healthy test persons. It is noteworthy that the core clock genes, like
cryptochrome 1 and 2, ARNTL, CLOCK, RORα and REV-ERBA α were not present in
the list of circadian oscillating genes leaving PER2 as the only oscillating member of the
group of period genes. Blood cells are known to possess a self-sustaining circadian rhythm
whose generation does most likely also involve the core clock genes that build the molecular
basis for the rhythm creation in the suprachiasmatic nucleus. The detection of a circadian
expression pattern of PER2 ﬁts into this hypothesis and has been previously reported by
others (Teboul et al., 2005; Watanabe et al., 2012). Unlike in our study, these authors also
reported circadian modulation of other core clock genes such as BMAL1. A possible reason
for this diverging results is the fact that we used whole blood mRNA for our analysis while
Teboul et al. (2005) used peripheral blood mononuclear cells (lymphocytes, monocytes).
Existing circadian expression rhythms might therefore have been blurred in our approach
as diﬀerent types of immune cells could have diﬀerent daily expression patterns of the core
clock genes. Teboul et al. (2005) also reported that PER2 and BMAL1 gene expression
varied considerably between the test persons. Watanabe et al. (2012) used the same blood
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extraction system as we did but also reported that circadian rhythmicity of the core clock
genes diﬀered markedly between individuals. Unlike in our experiment their subjects were
forced to stay awake during the whole 24 hour measurement period.
Role of immune system genes
The screening for enriched pathways and gene ontology terms had only yielded two immune
system-related pathways which were detected in the group of genes with a peak expression
level at noon. Although the screening algorithms for common biological functions did
not ﬁnd further pathways or ontology terms, our top ﬁndings included a number of genes
related to the function of the immune system such as GZMB, PRF1 and LILRA5. The
large portion of immune genes on the list of circadian oscillating genes is plausible as
gene expression measurements in the whole blood will be dominated by transcription in
leukocytes as neither red blood cells nor platelets have a nucleus and therefore no gene
expression is taking place in these cells. It is also known that the number of circulating
haematopoietic stem cells, which are the progenitors of all other blood cells, oscillates with
a peak during the inactive phase in mammals (Scheiermann et al., 2013).
GranzymeB (GZMB) is a serine protease which is principally expressed in natural killer
cells and cytotoxic T lymphocytes and which is involved in the lymphocyte-mediated ini-
tiation of apoptosis in virus-infected cells (Bots and Medema, 2006). Perforin (PRF1 )
is also a protein product of cytotoxic T lymphocytes and natural killer cells and plays a
crucial role in the cytolysis of infected cells (Kawasaki et al., 1992; Trapani, 1995). A study
performed in rats had previously reported that both granzyme B and perforin showed cir-
cadian oscillating mRNA levels in lymphocytes (Arjona and Sarkar, 2005). In another
study, the same authors also reported that these circadian expression patterns were dis-
turbed after chronic ethanol consumption (Arjona et al., 2004) suggesting granzyme B and
perforing as two top candidate genes to serve as biomarkers for post-dependent circadian
rhythm perturbations.
Another gene which was found to have circadian oscillating expression levels was the
leukocyte immunoglobulin-like receptor A5 (LILRA5 ), which codes for a receptor that is
located on the surface of monocytes and that is implicated in the secretion of proinﬂam-
matory cytokines as part of the unspeciﬁc innate immune response. Its gene expression
maximum was shortly after noon and could lead to a peak alertness of the innate immune
system shortly afterwards when the receptor is ﬁtted into the outer cell membrane. Gibbs
et al. (2012) reported that cytokine secretion is much more pronounced at the beginning of
the active phase in mice (i.e. at night) than at the start of the resting phase. The fact that
the authors only used two measuring time points makes it diﬃcult to deduce a circadian
pattern but their ﬁnding is consistent with our report that innate immune response is more
alert during the active phase of a mammal.
The list of immune system related genes with strongly oscillating expression levels also
included cystatin F (CST7 ), a protease inhibitor which is expressed primarily in leukocytes
and whose role in immune function remains yet to be elucidated (Hamilton et al., 2008;
Colbert et al., 2009). The ﬁbroblast growth factor binding protein 2 (FGFBP2 ), which is
selectively secreted in cytotoxic T lymphocytes, was also part of this list, giving further
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support to our hypothesis that a large variety of immune system genes show daily oscillating
mRNA levels.
Further circadian oscillating genes
Nonetheless, our list of oscillating genes also contained candidates which were neither asso-
ciated with the transcriptional-translational network of the endogenous clock nor directly
associated with the immune system. An example is the transcription factor FOSB. The
gene, a transcription factor of the Fos family, was previously associated with the processing
of photic stimuli in the suprachiasmatic nucleus during the night phase in rats (Schwartz
et al., 2000). It is implicated in a great variety of cellular processes which makes it diﬃcult
to pin down its function to a single process. We therefore assume that the expression peak
of FOSB at noon indicated a general climax of leukocyte activity at this time of day.
Another gene, whose expression peaked shortly after noon, was the RAS oncogene family
member 24 (RAB24 ), which codes for a small G protein. Its expression has been reported
in macrophages where it plays a role in vesicular transport (Jacobsen et al., 2005). As in
the case of FOSB, the peak expression of this protein could indicate a more general peak
of immune system activity at that time of day.
Use of the combined expression pattern of several genes
It appears unlikely that the daily expression pattern of a single gene will be suﬃcient to
predict the degree of circadian disturbance in recovering alcoholics as we observed high
inter-individual diﬀerences in the oscillating genes. An assessment of circadian perturba-
tion based on blood gene expression will therefore need to rely on the comparison of a
more complex pattern based on the expression proﬁles of a combination of several genes.
A better picture of which genes should be included in this approach will be available once
the daily gene expression data have been collected from a group of alcohol addicted pa-
tients in the follow-up study. Given the profound impact of chronic alcohol consumption
on the immune system (Cook, 1998; Molina et al., 2010) it is likely that immune system-
related genes will dominate the list of genes which will be used for the expression pattern
comparison.
Suggestions for future studies
A possible modiﬁcation in the protocol of the follow-up study, which will sample the blood
of recovering alcoholics, is to extract the mRNA of a limited spectrum of blood cell types
such as peripheral blood mononuclear cells (PBMC). In the present study we used the
PAXgene Blood RNA Kit which extracts the mRNA of all blood cells leading to a high
amount of globin mRNA which is still present in matured red blood cells although these
cells have no longer any transcriptional activity as they lack a nucleus. Focusing on periph-
eral blood mononuclear cells would also allow to eliminate bias caused by varying numbers
of polymorphonuclear leukocytes (i.e. granulocytes) such as basophils, eosinophils, and
neutrophils.
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The participants of our study had also been free to choose among a variety of available
dishes from the hospital kitchen for lunch and dinner during the blood taking phase. As
it cannot be ruled out that blood gene expression was inﬂuenced by this dietary variety,
future studies might consider oﬀering only one standardised dish for all participants.
The test persons had been recruited on the preconditions that they have no sleep prob-
lems and are not shift workers. Independent of this, the participants had their individual
chronotypes ranging somewhere from early morning-active (lark-type) to evening-active
(owl-type). It is perceivable that this individual preferences could be correlated with spe-
ciﬁc circadian gene expression pattern in the blood. Future studies might therefore consider
assessing the chronotypes of the participants using questionnaires already available for this
purpose (Zavada et al., 2005; Dosseville et al., 2013).
Study limitation
The approach to use blood mRNA as a biomarker for circadian disruption in post-treatment
alcoholics has a crucial limitation which has to be taken into account when interpreting the
results. Human beings do not only diﬀer from each other by morphological features but
also have signiﬁcant diﬀerences in cellular features and gene expression characteristics. As
an alcohol addicted patient is analysed, there is no information how the speciﬁc circadian
gene expression pattern in his blood looked like when he was still healthy. It will therefore
be a demanding challenge to tell the inter-individual diﬀerences from the alterations due
to the disease status. The use of a combination of gene expression proﬁles will hopefully
mitigate this fact.
Outlook
The design of this study, requiring blood sampling at several time points throughout a
24 hour period, is too elaborate for a routine diagnostic tool. Nonetheless, a follow-up study
in recovering alcoholics will be interesting from a scientiﬁc point of view, as it will show
which circadian oscillating genes in blood will be most aﬀected by alcohol addiction. This
could also increase our understanding how alcoholism interacts with the immune system.
If the follow-up study reveals that a limited number of genes shows striking diﬀerences at
two or three time points during the day, a diagnostic application will become more likely.
Taking blood samples in the morning and the evening from an inpatient and analysing the
gene expression of a small number of genes by quantitative PCR could be feasible in many
psychiatric hospital settings.
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4. Gene expression proﬁling in high and
low impulsive rats
4.1. Introduction to the study
4.1.1. Introduction to the concept of impulsivity
Human beings diﬀer from each other not only in outward appearance but also in their
psychological attributes. Attempts to understand and classify such personality diﬀerences
have a long history dating back even before the times of Hippocrates and his humoral
theory. An important step was made by Allport and Allport (1921) with the deﬁnition
of personality traits as deﬁned, characteristic sub-features of the human personality which
can be assessed by questionnaires. While the Allport brothers proposed a vast number
of possible traits, the use of factor analysis allowed to reduce the number of personality
traits which do not correlate with each other. Today, the Five Factor Model which deﬁnes
openness, conscientiousness, extraversion, agreeableness, and neuroticism as the ﬁve core
factors is widely accepted (McCrae and Costa, 1987). Nonetheless, further traits have been
suggested, such as impulsivity which shall be the subject of this study.
Impulsivity can be deﬁned in simple words as `a tendency to act prematurely without
foresight ' (Dalley et al., 2011). A more classical deﬁnition describes impulsivity as a
personality trait characterised by a tendency for `actions which are poorly conceived, pre-
maturely expressed, unduly risky or inappropriate to the situation and that often result in
undesirable consequences' (Durana and Barnes, 1996). While impulsivity is considered a
personality trait, it can be seen as a multifactorial psychological construct: multifactorial
because it is an umbrella term which encompasses a variety of closely related but inde-
pendent psychological factors such as a failure to adequately process and interpret sensory
information before acting, a lack of motor inhibition, and a lack of patience (Evenden,
1999). And impulsivity can be considered a psychological construct as it is an explanatory
variable which is not directly observable. Nonetheless, a person's degree of impulsivity is
a behavioural pattern which is relatively stable over time, thus justifying the classiﬁcation
as a personality trait.
4.1.2. Measurements of impulsivity
In order to scientiﬁcally analyse impulsivity it is important to ﬁnd ways to measure this
personality trait. This can be done by using either self-report questionnaires or neuropsy-
chological tests.
A widely used self-report questionnaire is the Barratt Impulsiveness Scale (BIS)
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(Patton et al., 1995). Its current version, the BIS-11, consists of 30 questions with four pos-
sible answers: (1) rarely/never, (2) occasionally, (3) often, and (4) almost always/always.
Factor analysis allowed to derive six ﬁrst-order factors from the questions and these can be
even further summarised to three second-order factors (see table 4.1). These factors can
be considered as subdivisions of the trait of impulsivity.
Table 4.1.: Factors of the Barratt Impulsiveness Scale (BIS-11).
Number of Questions First-order factors Second-order factors
5 attention
attentional
3 cognitive instability
7 motor
motor
4 perseverance
6 self-control
non-planning
5 cognitive complexity
source: Patton et al. (1995)
A measure of impulsive behaviour is provided by the Delay discounting task which
demands subjects to choose between an immediate small reward or a delayed larger reward.
Impulsive individuals will go for the small award. This test can be adapted for animal
models (Ainslie, 1974; Evenden and Ryan, 1996). Another version of this test is based
on probability discounting. This time subjects have to choose between small but likely or
larger but less likely rewards.
There are also neurophysiological tests like the Go/No-Go test. In this paradigm
subjects are asked to perform as fast as possible a certain action such as pressing a button
upon appearance of a speciﬁc visual stimulus such as a circle on a screen. But from time
to time the original stimulus will be replaced by a diﬀerent input, for example a rectangle
instead of the circle. In this case the test subject should not respond (Rubia et al., 2001).
A variation of this paradigm is the Stop Signal Reaction Time task. Again subjects
are requested to react as fast as possible to a stimulus but in this test from time to time a
second, diﬀerent stimulus will appear shortly after the ﬁrst one. In this case participants
are asked to not respond to the ﬁrst signal. So participants are for example asked to press a
button if a light appears on a screen in front of them. But sometimes the light appearance
is followed after a short delay by a sound and in this case the subjects are required to do
nothing (Nichols and Waschbusch, 2004). Both of these tests measure the attentional and
the motor-control aspect of impulsivity. They can be applied to humans as well as other
animals (Eagle et al., 2008).
The present work is based on another neurophysiological impulsivity test which was
developed speciﬁcally for rodents: the 5 Choice serial reaction time task (5CSRTT)
(Robbins, 2002). In this test, a rat or mouse is placed in a box with a set of ﬁve lights on
one side and a food magazine on the opposite side (ﬁgure 4.1a). The session is initiated
when the animal accesses the food magazine. Five seconds later one of the ﬁve lights will
light up for 0.5 s after which the animal has ﬁve seconds to poke against the corresponding
light with its nose. A correct response will be rewarded with a food pellet. A premature
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Food
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(a) 5CSRTT apparatus
inter-trial interval
(5 s)
rat enters
food magazine
to start session
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(0.5 s)
correct response
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5 s time
time-out
(5 s) 
time-out
(5 s) 
_
premature response
(b) 5CSRTT paradigm
Figure 4.1.: The 5-choice serial reaction time task (5CSRTT). (a) Sketch of apparatus
adapted from Bari et al. (2008). (b) Test procedure adapted from Robbins (2002).
response during the ﬁve second inter-trial interval before any light has been lit, a wrong
choice (incorrect response) or a failure to respond (omission) will lead to a time-out of ﬁve
second during which the main box light will go out. After this, the trial resumes with a
new inter-trial interval of ﬁve seconds until the session is over (ﬁgure 4.1b). A detailed
description of the test can be found in Bari et al. (2008). The test allows to collect a
multitude of data such as the number of correct and incorrect responses or the number of
omissions. For our study we were interested in the number of premature responses which
is considered to be a measurement of impulsivity (Evenden, 1999).
4.1.3. Brain regions implicated in impulsivity
Anatomical information about human brain structures implicated in impulsive behaviour
derive almost exclusively from functional magnetic resonance imaging (fMRI) studies. A
study by Costa Dias et al. (2012) linked the brain's reward system and especially the nu-
cleus accumbens to impulsivity as measured by a delay discounting task. This is no surprise
as the behavioural test is based on making a decision between a small but immediately
available or a bigger but later-arriving reward. It is therefore likely that high impulsive in-
dividuals show diﬀerences in their reward processing. But impulsivity is also correlated to
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the prefrontal cortex which plays a dominant role in executive control and decision making.
Castellanos and Tannock (2002) showed how a disturbance of these prefrontal processes
can lead to the maladaptive impulsive behaviour which can be observed in attention deﬁcit
hyperactivity disorder (ADHD).
Animal models oﬀer the possibility to use brain lesions in order to identify those regions
which play a vital role in impulsivity. Comparable to the human fMRI studies, rodent
lesion studies indicate an important role for the nucleus accumbens. The core region of
this brain structure seems to play an even greater role in rats. But there is also evidence for
a link between prefrontal cortex structures such as the infralimbic cortex and impulsivity
(Dalley et al., 2011). Winstanley et al. (2006) summarised the roles played by diﬀerent rat
brain regions in regard to impulsive behaviour (see adopted table 4.2).
Table 4.2.: Summary of the inﬂuence of diﬀerent rat brain regions on impulsivity. Table
adapted from (Winstanley et al., 2006).
Stop-signal Delay discounting 5 Choice serial
Brain region reaction time task Task reaction time task
Prelimbic cortex 7 7 7
Infralimbic cortex ? 7 4
Anterior cingulate cortex ? 7 4
Orbitofrontal cortex ? 4 4
Nucleus accumbens 7 4 4
Subthalamic nucleus ? 4 4
4 = inﬂuence, 7 = no eﬀect, ? = unknown
4.1.4. Impulsivity and genetics
As in every trait which plays a role in psychiatric disorders, the question has been brought
forward in how far a person's degree of impulsivity is the result of a genetic disposition
and how far it is a result of the environment. Most information in this regard stems from
studies which were analysing a potential genetic inﬂuence on attention deﬁcit hyperactiv-
ity disorder (Hinshaw, 2003; Heiser et al., 2006). A meta-analysis of twin and adoption
studies conducted by Bezdjian et al. (2011) found that approximately half of the variance
in peoples level of impulsivity is due to genetic disposition. The genetic link seemed to be
more important in males, which are also reported to score higher on several subsets of im-
pulsivity than females (Cross et al., 2011). Candidate gene studies have led to inconsistent
results but suggested an involvement of the dopaminergic and serotonergic system (Varga
et al., 2012). In line with this hypothesis, Varga et al. (2012) reported an association be-
tween polymorphisms in the D4 dopamine receptor (DRD4 ) and the 5-hyrodxytryptamine
receptor 1B (HTR1B) and impulsivity. A similar result was obtained in a study on DRD4
and tyrosine hydroxylase (TH ) polymorphisms in dogs (Wan et al., 2013). In the frame
of a large scale genome-wide association study, Heinrich et al. (2013) reported that an
intronic variation in the AMBRA1 gene, coding for the autophagy/beclin-1 regulator 1, was
linked to the degree of impulsivity in the test subjects. The level of D2 dopamine receptors
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in the striatum has also been linked to impulsivity (Triﬁlieﬀ and Martinez, 2013).
4.1.5. Impulsivity and psychiatric disorders
A high level of impulsivity obviously has a negative overall aﬀect on people's lives as it
incites them to make decisions which they will regret later on. But being impulsive itself
is not a pathological condition. In fact, Dickman and Meyer (1988) reportet that it can
be of an advantage in situations which demand rapid information processing. Nonetheless,
high impulsivity plays a role in several psychiatric disorders.
Attention deﬁcit hyperactivity disorder (ADHD) is characterized by severe deﬁcits
in attention and hyperactivity. The Diagnostic and Statistical Manual of Mental Disorders
(DSM-IV-TR) distinguishes three subtypes of ADHD (American Psychiatric Association,
2000):
1. predominantly inattentive type
2. predominantly hyperactive-impulsive type
3. combined type
Type II and III are closely linked to excessive impulsivity and symptoms of this trait
are part of their diagnostic criteria as outlined by the DSM-IV-TR: `1. Often blurts out
answers before questions have been ﬁnished.', `2. Often has trouble waiting one's turn'
and `3. Often interrupts or intrudes on others (e.g., butts into conversations or games)'
(American Psychiatric Association, 2000).
Impulsivity has also been brought in connection with bipolar disorder where it is es-
pecially important during manic phases (Moeller et al., 2001; Najt et al., 2007). The often
reported excessive and impulse-driven purchases during manic episodes are a good exam-
ple of this. Impulsivity is also present in the DSM-IV-TR deﬁnition of another psychiatric
condition, the borderline disorder: `Impulsivity in at least two areas that are poten-
tially self-damaging (e.g., spending, sex, substance abuse, reckless driving, binge eating)'
(American Psychiatric Association, 2000).
Of particular interest is the link between impulsivity and drug addiction, the latter
being the overall theme of the present thesis. A role of impulsivity in the initiation of drug
consumption is easily conceivable as it leads individuals to choose the immediate rewarding
eﬀects of a drug despite well-known long term negative consequences. It is a well established
fact that high impulsive people have a higher risk of becoming drug addicted (Ersche et al.,
2010; Dalley et al., 2011). This relationship becomes more complicated as the addiction
progresses as it has been shown that drug consumption itself makes people more impulsive
(Perry and Carroll, 2008). In addition, higher levels of impulsivity have been shown to
correlate with a higher relapse rate in treated drug addicts (Doran et al., 2004; Bankston
et al., 2009).
4.1.6. Research goals
The aim of the present study was to ﬁnd a link between the degree of impulsivity in a
rodent model of this trait and underlying gene expression diﬀerences in relevant brain
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areas of the animals. We therefore analysed global gene expression in the brains of rats
bred for extremes in high and low impulsive behaviour. The measurements were done
using microarrays and quantitative PCR. The analysed brain regions were the infralimbic
cortex and the nucleus accumbens core and shell. All three regions had been previously
connected to impulsivity (Dalley et al., 2011). We speculated to ﬁnd expression diﬀerences
of genes involved in dopaminergic and serotonergic signalling as well as genes which are
part of other neurotransmitter systems and subsequent intra-cellular signalling cascades.
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4.2.1. Behavioural testing
The behavioural part of this experiment was performed by our collaborators from the
Cambridge Neuroscience network in Cambridge, United Kingdom. Starting with an out-
bred strain of Lister hooded rats, the group of Jeﬀ Dalley had set up a breeding scheme to
generate animals showing extremes of either high or low impulsive behaviour.
Rats were selected according to their number of premature responses in the 5-choice serial
reaction time task (5CSRTT). The animals received 60 to 70 training sessions before the
actual three weeks behavioural assessment followed. During this testing phase the rats were
tested Monday through Friday with always one 30 min session during the animals active
dark phase. On Wednesday, the sessions lasted 60 minutes and the number of premature
responses was counted. Rats having less than 30 premature responses were considered
to be low impulsive while rats with more than 50 such responses were considered high
impulsive.
After behavioural characterisation, rats were sacriﬁced in the middle of their active night
phase and the brains were extracted. We received the brains from the sixth generation
of the bidirectional breeding program for whole gene expression proﬁling of impulsivity-
related brain areas.
4.2.2. Brain dissection
Frozen rat brains were sectioned into 120 µm thick coronal slices at an ambient temperature
of −20 ◦C in a Leica CM 3000 Cryostat (Leica, Wetzlar, Germany). The infralimbic cortex
and the nucleus accumbens core and shell region were identiﬁed based on images from a
Rat Brain Atlas (Paxinos and Watson, 1998) and extracted with 0.75 to 1.5 mm diameter
tissue punches (Stoelting, Wood Dale, IL, USA).
4.2.3. RNA isolation and puriﬁcation
RNA was isolated by phenol-chloroform extraction (Chomczynski and Sacchi, 1987). 1 ml
of TRIzol® Reagent (Life Technologies, Darmstadt, Germany), a monophasic solution of
phenol and the chaotropic agent guanidinium thiocyanate, was added to the punched tissue
samples and the suspensions were homogenised by multiple passages through a 22 gauge
needle. Samples were ﬁlled up with 200 µl of chloroform, mixed and centrifuged to obtain a
separation of the aqueous upper and the organic lower phase. The RNA containing upper
phases were carefully collected and puriﬁed with an RNeasy MinElute Cleanup Kit (Qiagen,
Hilden, Germany) according to the manufacturer's instructions. The concentration and
purity of the RNAs were analysed with a Nanodrop 1000 Spectrophotometer (Peqlab,
Erlangen, Germany) and the integrity of the RNAs was assessed with an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Only samples with a ratio of
absorption at 260 nm versus 280 nm in the range of 1.8 to 2.2 as well as an RNA integrity
number (RIN) above eight were considered for microarray analysis.
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4.2.4. Aﬀymetrix Gene Chips
RNA samples from six high and six low impulsive animals were prepared for microar-
ray analysis using the GeneChip® 3´ IVT Express Kit (Aﬀymetrix, High Wycombe, UK)
following the manufacturer's protocol. In brief, 100 ng RNA were reverse transcribed to
ﬁrst-strand complementary DNA (cDNA) using oligo-thymidine primers connected to the
promoter region of the T7 bacteriophage. After second-strand cDNA synthesis, an in-
vitro transcription was performed for 16 hours using T7 RNA polymerase with part of the
uridine triphosphate (UTP) labelled with biotin. The thus produced biotinylated com-
plementary RNA (called aRNA in the Aﬀymetrix protocol) was puriﬁed and quantiﬁed
with a Nanodrop 1000 Spectrophotometer (Peqlab, Erlangen, Germany). 15 µg of each
sample were subsequently fragmented to increase assay sensitivity. The fragmented aRNA
was handed over to the Core Laboratory for Microarray-Analysis of the University Medical
Centre Mannheim for the hybridisation and scanning process. 12.5 µg of fragmented aRNA
were hybridised to GeneChip Rat Genome 230 2.0 Arrays (Aﬀymetrix, High Wycombe,
UK) and incubated for 16 hours using Aﬀymetrix's GeneChip Hybridization, Wash, and
Stain Kit and the corresponding protocol. After washing, the GeneChips were scanned in
an Aﬀymetrix GeneChip Scanner 3000 run with Aﬀymetrix GeneChip Command Console
Software and red out as cell intensity (CEL) ﬁles.
4.2.5. Microarray data pre-processing
Quality control
Aﬀymetrix scan software produced low-resolution JPEG images of the scanned arrays.
These images were visually controlled for stains. While several arrays had little hybridisation-
free spots, none of the arrays had more than one tenth of its surface blurred which is a
common limit above which assays should no longer be analysed.
The obtained cell intensity (CEL) ﬁles were quality assessed using a web-based Aﬀymetrix
quality control pipeline (www.arrayanalysis.org) from the Department of Bioinformatics of
Maastricht University (Maastricht, Netherlands). The pipeline's R scripts were down-
loaded and run in R2.14.2 software environment. The pipeline consisted of the following
items and their complementary probes:
 Detection of spiked-in sample preparation probes: Lysine (Lys), Phenylalanine (Phe),
Threonine (Thr), and Diaminopimelic acid (Dap) should be detected in the following
intensity order: Lys < Phe < Thr < Dap.
 Detectability of the lowest concentrated spiked-in sample preparation probe lysine.
 Detection of the 3´ and 5´ end of beta-actin: The ratio 3´/ 5´ should not exceed
three.
 Detection of the 3´and 5´end of GAPDH: The ratio 3´/ 5´ should not exceed 1.25.
 Detection of spiked-in hybridisation probes: The enzymes BioB, BioC, and BioD
from the biotin synthesis pathway of Escherichia coli as well as the creX gene from
bacteriophage P1 should be detected in the following intensity order: BioB < BioC
< BioD < creX.
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 Detectability of the lowest concentrated spiked-in hybridisation probe BioB.
 Less than 10% variation in the percentage of probes called present between the
diﬀerent arrays.
 Less than 20% variation in the background spread between the arrays. Background
spread is calculated on the basis of the mismatch probes between the arrays.
 Limited spread of the log-transformed scaling factors: The diﬀerent arrays are scaled
with constants so that all arrays have the same mean intensity. The decadic loga-
rithms of the scaling factors should never exceed three.
All samples passed the quality control features.
Annotation
Following the reasoning of Dai et al. (2005) and Sandberg and Larsson (2007) that Aﬀy-
metrix's original annotation lacks accuracy and has no stringent probe set to gene re-
lationship, we used updated probe set deﬁnitions from the Brainarray project (http:
//brainarray.mbni.med.umich.edu), which is a web-based re-annotation resource main-
tained by the University of Michigan. We summarised the probe intensities according to
Brainarray's custom-made chip deﬁnition ﬁle version 14.1.0 (CDF) which was based on
Entrez Gene genomic locations.
Normalisation and averaging of bead level values
Data were subsequently quantile normalised using the robust multiarray average-function
of the aﬀy package from the Bioconductor project (Gautier et al., 2004). Genes with
expression values below 80 were excluded to avoid confounding array background noise
and data were subsequently log2 transformed for the statistical analysis.
As a result, we obtained a ﬁnal number of 7 961 genes for the infralimbic cortex, 7 928
genes for the nucleus accumbens core and 7 926 genes for the nucleus accumbens shell.
4.2.6. Statistical analysis and data mining of microarrays
All statistical analysis were performed using LibreOﬃce 3 and R statistical programming
language version 2.14.2.
Principal component analysis
As in the circadian microarray studies of the previous chapters, principal component anal-
ysis was performed using the prcomp-function of the stats package of R. The calculation
was based on the data of the four high and the four low impulsive rats with the most
pronounced phenotypes. Data points representing the microarray data sets obtained from
the individual animals were plotted against the ﬁrst three principal components. An image
legend was added and the plot was coloured in inkscape 0.48.
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T-tests and fold change calculations
Candidate genes were selected on the basis of uncorrected Student's t-tests using the Welch
adaptation as we assumed unequal variances in the diﬀerent groups. We compared the
expression data of the four high and four low impulsive rats with the most pronounced
phenotypes. The fold change, corresponding to the ratio of average gene expression in
high-impulsivity versus average gene expression in low impulsivity rats, was calculated for
each gene according to the following formula:
fold change =
1
n
∑n
i=1 xhigh impulsivity, i
1
n
∑n
i=1 xlow impulsivity, i
The variables xhigh impulsivity and xlow impulsivity corresponded to the non-logarithmic ex-
pression values for the examined gene and n corresponded to the number of replicates
which was four in both group as we had limited this analysis to the animals with the most
pronounced high and low impulsive phenotypes.
Volcano plots were created in R based on the calculated p-values and fold changes with
the x-axis representing the log2(fold change) values and the y-axis the log10(p values).
Candidate genes for true diﬀerential expression between the two impulsivity groups were
selected on the basis of an uncorrected t-test p-value below 0.05 and an absolute fold change
above 1.2.
Analysis of enriched pathways and gene ontology terms
As in the previous subproject, the lists with candidate genes were screened for over-
represented enzymatic pathways and gene ontology terms using the Database for Annota-
tion, Visualization and Integrated Discovery (DAVID) version 6.7 (http://david.abcc.
ncifcrf.gov/) (Huang da et al., 2009a,b). The lists were screened for pathways of the
Kyoto Encyclopedia of Genes and Genomes (KEGG) and biological pathway, molecular
function and cellular component gene ontology terms of level 5. As a background we used
all genes of our array which had passed the microarray quality control and were above the
background cut-oﬀ.
Correlation analysis
Gene expression data were also correlated with the number of premature responses in the
5CSRTT by Spearman's rank correlation coeﬃcient. The values were calculated by using
the cor.test-function of the stats package of R. In contrast to the above mentioned t-test,
we used the data of all six high and six low impulsive animals for the correlation analysis.
4.2.7. Quantitative PCR validation
To conﬁrm the core microarray ﬁndings, we assessed gene expression levels of selected
candidate genes with quantitative PCR. 100 ng total RNA were reverse transcribed using
the High Capacity RNA-to-cDNA Master Mix (Life Technologies, Darmstadt, Germany)
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according to the manufacturer's protocol. The resulting cDNA was diluted 1:10. Can-
didate genes were quantiﬁed on an Applied Biosystems 7900 HT Real-time PCR system
(Life Technologies) using the Power SYBR® Green PCR Master Mix (Life Technologies).
Reactions were performed in a total volume of 10µl with 3 µl diluted cDNA and a ﬁnal con-
centration of 400 nmol/l of both the forward and the reverse primer. Actb, Rpl6 and Ubb
were used as housekeeping genes and all samples were run in triplicates with the following
temperature proﬁle: 10 min at 95 ◦C followed by 40 cycles of 15 sec dissociation at 95 ◦C
and one minute annealing and elongation at 60 ◦C. Melting curve analysis was performed
after each run to check for unwanted PCR side products. The primer sequences of the
candidate genes are presented in table 4.3 and the primer sequences of the housekeeping
genes can be found in table 4.4.
Table 4.3.: Primer sequences of the candidate genes
Gene Primer forward Primer reverse
Adpgk CCAGCCTGACCTGGTGGTCCTT CCCAAGAGAAGCCACTGCGGG
Akap5 GTGGTTTGGGTCCGTGCTCCT AGCTGTTCACGGCGTTGTCTC
Cacng3 GGTGGGCACGGACTACTGGC CTGCGGTGGAACTCGCTGGC
Dusp19 CTCAACGTCGCGTATGGAGT CCCTGCGTTACAGTGGACAA
Frzb TGACGTGACCGCCATTGTGGA AGGAGGGAGTCCGTGGGTGT
Gna11 TGCCCACAACTGGCATCATC TTCTCGTTGTCCGACTCCAC
Gprc5b CACGCCATTCCAGAGATCCA TAGTCCCACCATTGAGCACG
Gucy1a3 TGTCCCTGATGCCTCCCTGCT ATCTGTCCACACACGGCGACC
Jdp2 TGCAGCCAGATGCCGGAACA CGATACAGGTGGGCCGGTGG
Map4k5 AGCACAGGCTCCACAGTTAC GCAGAATGCGGTCAGGAAAC
Olfml1 CCACTACAACATGCCCAGGA TGCCAGCATCCTTCATCCAA
P2ry12 AGGGCTTTGGCAACGAAACCA GTTGGCACCAGGCACCTCCA
Pde1a ACATGTGTGGATTGCTCCCGTG ACAGCGTGGACAATGCTGCGA
Rasd1 CCCAGCAGAGGGTTAGTTGG AATGCCCTGTTAGTCCTGGC
Rasgrp3 CCTCGGGAAAGCGGCGACAC CCCGGAACTCCTCAGTCATGCG
Rasl10a CGACATCTGCAGCCCGGACA GATGGGTGCCTCTGGCGCTC
Rnd3 GTGGGCGACAGCCAGTGTGG TGGCTGCTCCGATCTGCTTCG
Sept4 CAGAGTGCTGGAGGCCCGTG ATCCAATGGCCGGAGCCCGT
Taok1 CGAGCGCCAGGCCAGAGAAA TGCCCTGTTCCGTCCGTCCC
Table 4.4.: Primer sequences of the housekeeping genes
Gene Primer forward Primer reverse
Actb GCGTCCACCCGCGAGTACAAC CGACGACGAGCGCAGCGATA
Rpl6 GAAGAAGCCACTTCGCAAGCCC TGAGACCGCAGGTAGCCCTGG
Ubb CCCTGGAGGTGGAGCCCAGT CACCCCTCAGGCGGAGGACCA
Applied Biosystem's Sequence Detection System (SDS) Software Version 2.2.2. was used
to analyse the SYBR green ﬂuorescence levels that had been measured during the PCR
run. Cycle of threshold (Ct) values were calculated for each well as the theoretical number
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of cycles when a deﬁned ﬂuorescence threshold was reached. The triplicate measurements
were averaged by arithmetic mean. Reactions were then normalised to the endogenous
controls by calculation of ∆Ct-values using the following formula:
∆Ct = Ctcandidate gene − 3
√
CtActb · CtRpl6 · CtUbb
The formula calculated the geometric average of the housekeeping genes following a sug-
gestion from Vandesompele et al. (2002) who had shown that this leads to more consistent
average values.
The ∆Ct values were then analysed by Student's t-test and fold change in the same way
as the microarray data. The analysis was again limited to the data of the four high and
four low impulsive animals with the most pronounced phenotypes.
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4.3. Results
4.3.1. Results of the 5-choice serial reaction time task (5CSRTT)
In order to study the molecular underpinnings of impulsive behaviour in rat brains, a col-
laboration had been set up with the research group of Jeﬀ Dalley from the Cambridge
Neuroscience network (Cambridge, UK). The Cambridge group had set up a bidirectional
breeding scheme to generate rats showing extremes of either high or low impulsive be-
haviour. We received the brains from twelve rats of the sixth generation along with the
data of their performance in the 5CSRTT. In order to classify the rats according to their im-
pulsivity phenotype they had undergone three 5CSRTT assessment sessions (ﬁgure 4.2a).
The number of premature responses in the second and third session were averaged and
animals having more than 55 premature responses were classiﬁed 'high impulsive' whereas
animals scoring below 45 were considered 'low impulsive' (ﬁgure 4.2b). All shown animals
were used for microarray screening but only animals with unambiguous results in all three
5CSRTT test session (solid lines in ﬁgure 4.2a) were used for group comparisons.
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Figure 4.2.: Number of premature responses in the 5-choice serial reaction time task
(5CSRTT). Shown are the data of the rats whose brains were selected for microarray analysis.
Black lines = rats bred for high impulsivity,
grey lines = rats bred for low impulsivity,
dotted lines = rats with ambiguous impulsivity phenotype,
hatched bar in (b) = separation margin (45-55) between impulsivity phenotypes.
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4.3.2. Principal component analysis
The normalised gene expression data of all brain regions of the four high and the four low
impulsive rats with the most pronounced phenotypes were analysed by principal component
analysis in order to identify the main sources of variance in the data set. The microarray
data sets corresponding each to a brain region of a rat were projected on a three-dimensional
Cartesian coordinate system based on the ﬁrst three principal components. Labelling of
the samples according to the behavioural phenotype of the rats led to a random-looking
positioning of the high and low impulsivity cases (ﬁgure 4.3a). Labelling of the samples
according to the brain region led to clearly distinguishable clusters for each brain region
(ﬁgure 4.3b). The cluster for the infralimbic cortex was the most detached while the nucleus
accumbens core and shell lied close to each other.
This showed that brain region but not impulsivity had a profound inﬂuence on the overall
gene expression pattern in our samples.
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Figure 4.3.: Scatter plots of the rats projected on the ﬁrst three principal components de-
tected by principal component analysis (PCA). (a) Labelling according to the impulsivity
phenotype and (b) according to the brain regions. ILC = infralimbic cortex, NacC = nucleus
accumbens core, NacS = nucleus accumbens shell.
4.3.3. Volcano plots
In the next step we wanted to see if impulsivity aﬀects the infralimbic cortex and the
nucleus accumbens core and shell to the same degree or if one of these brain regions stands
out. We therefore displayed the whole expression data for each brain region in Volcano
plots, where the x-axis corresponds to the log-transformed ratio of the average expression
values for each gene and the y-axis displays the negative decadic logarithm of the p-value
of a student's t-test for the gene (ﬁgure 4.4).
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None of the brain regions exhibited a level of overall diﬀerential gene expression noticeable
superior to the others but there was a slightly higher diﬀerential gene expression in the
nucleus accumbens core.
(a) Infralimbic cortex (b) Nucleus accumbens core (c) Nucleus accumbens shell
Figure 4.4.: Volcano plots showing overall expression diﬀerences between high and low im-
pulsive rats. Each dot corresponds to one gene. Dots above the vertical grey line correspond
to genes whose diﬀerential expression had an uncorrected p-value below 0.05.
4.3.4. Filtering by t-test derived p-values and fold-changes
In order to deﬁne diﬀerentially expressed genes, the data were ﬁltered according to a p-
value cut-oﬀ of 0.05 and an absolute value of the fold change of 1.2 (i.e. gene expression
ration < 0.833 or > 1.200). As already seen in the volcano plots, the nucleus accumbens
core showed the highest number of diﬀerentially expressed genes (n = 250 out of 7 928
genes in total) followed by the infralimbic cortex (n = 91 out of 7 961 genes in total) and
the nucleus accumbens shell (n = 64 out of 7 926 genes in total). Speciﬁc numbers for up-
and down-regulation of genes as well as diﬀerentially expressed genes that were found in
more then one brain region can be found in ﬁgure 4.5.
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Figure 4.5.: Diﬀerentially expressed genes in the three investigated brain regions according
to t-test (p-value < 0.05) and fold change (absolute value of fold change > 1.2). ILC =
infralimbic cortex, NacC = nucleus accumbens core, NacS = nucleus accumbens shell.
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A selection of candidate genes from the ﬁltering is presented in ﬁgure 4.6: the expression
levels of frizzled-related protein(Frzb) and G-protein coupled, purinergic receptor P2Y 12
(P2ry12 ) were upregulated in all three brain regions of high impulsive rats although Frzb
did not reach the signiﬁcance criterion of a p-value below 0.05 in the nucleus accumbens
core. Some genes were only diﬀerentially regulated in one brain region as the G protein-
coupled receptor, family C, group 5, member B (Gprc5b) which was down-regulated in the
infralimbic cortex of high impulsive rats, the RAS guanyl releasing protein 3 (Rasgrf3 )
which was up-regulated in the nucleus accumbens core of high impulsive animals and the
ADP-dependent glucokinase (Adpgk) which was down-regulated in the nucleus accumbens
shell of high impulsive rats.
4.3.5. KEGG pathways & gene ontology terms
The DAVID Bioinformatics Resources website was used to analyse the t-test and fold
change ﬁltered lists of candidate genes for the three investigated brain regions. None of
the lists showed signiﬁcant enrichment of pathways of the Kyoto Encyclopedia of Genes and
Genomes (KEGG). The screening for enriched gene ontology (GO) terms did not reveal any
ﬁndings which stayed signiﬁcant after correction for multiple testing with the Bonferroni
method. The only GO term which almost retained signiﬁcance was the biological process
termed `intracellular signalling cascade' in the infralimbic cortex (table 4.5).
Table 4.5.: Enriched gene ontology terms
gene number fold
GO category ontology of genes p-value enrichment Bonferroni
infralimbic cortex
biological process intracellular 14 0.00019 3.3 0.078
signalling cascade
4.3.6. Correlation analysis
In a next step, the gene expression measurements were set in relation to the number of pre-
mature responses in the 5CSRTT of the corresponding rats. The infralimbic cortex showed
a higher number of highly correlated genes (Spearman's rho either > 0.8 or < -0.8) than
the nucleus accumbens regions (see table 4.6). A number of genes was found in both the
group comparisons by t-test and fold change and the correlation analysis (see table 4.7).
Among these genes was the G-protein coupled, purinergic receptor P2Y 12 (P2ry12 ) which
showed an increase in expression levels in relation to the number of premature responses
in the the infralimbic cortex and nucleus accumbens core of the rats and was thus posi-
tively correlated. Further positively correlated ﬁndings in the infralimbic cortex were the
mitogen-activated protein kinase 1 (Mapk1 ) and the NADP(+) dependent, mitochondrial
malic enzyme 3 (Me3 ). In the nucleus accumbens shell, the voltage-dependent calcium
channel gamma subunit 3 (Cacng3 ) was among the up-regulated common ﬁndings.
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Nucleus accumbens core
Nucleus accumbens shell
Infralimbic cortex
(p = 0.009) (p = 0.026) (p = 0.011)
(p = 0.087) (p = 0.010) (p = 0.001)
(p = 0.049) (p = 0.011) (p = 0.028)
Figure 4.6.: Selection of genes that were diﬀerentially regulated between high and low im-
pulsive rats according to the microarray anaylsis. P2ry12 showed signiﬁcant expression levels
in all three brain regions and Frzb in two brain regions. The expression diﬀerence of Gprc5b,
Rasgrp3, and Adpgk was each only signiﬁcant in one brain region.
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We had used the non-parametric rank correlation test by Spearman for the correlation
analysis as the number of premature responses had markedly deviated from a normal
distribution. As this test was only based on the ranking of the gene expression values and
the number of premature responses, it was likely to yield a great number of false positives.
We therefore used this analysis as an additional corroboration and focused on those genes
which came also up in the group comparisons by t-test and fold change.
Table 4.6.: Number of genes correlated with the number of premature responses.
positive correlation negative correlation
Brain region (Spearman's rho > 0.8) (Spearman's rho < -0.8)
Infralimbic cortex 94 (21) 53 (8)
Nucl. accumbens core 25 (6) 13 (2)
Nucl. accumbens shell 24 (4) 22 (2)
In parentheses: number of genes that also appeared in the list of t-test and fold change ﬁltered results.
4.3.7. Relation of gene expression ﬁndings to quantiative trait loci
Our collaborators in Cambridge conducted a QTL analysis on the rats. A segment on
chromosome 1 spanning from approximately mega base pair position 126.2 · 106 to 178.3 ·
106, corresponding approximately to chromosomal locus 1q31 to 1q35, seemed to be in
linkage with impulsivity. The normalised microarray data contained 163 genes that lay in
this region. Only a fraction of these genes had been considered signiﬁcantly diﬀerentially
expressed between high and low impulsive rats according to t-test and fold change ﬁltering
(see table 4.8). No such diﬀerentially expressed genes were found in the nucleus accumbens
shell.
4.3.8. Validation of microarray results by quantitative PCR
We performed quantitative PCR measurements on several of our top ﬁndings from the
microarray analysis. A group of four genes was chosen which was analysed in all three
brain regions. The other candidate genes were speciﬁcally selected for one brain region
and only tested there.
While most of the selected genes failed to be signiﬁcantly diﬀerentially expressed in the
three brain regions, we could conﬁrm the major trends of the microarray experiment as
gene ratios almost exclusively went in the right direction. Frzb and P2ry12 were conﬁrmed
to be higher expressed in all three analysed brain regions in high impulsive animals by the
quantitative PCR although the result of P2ry12 was not signiﬁcant in the infralimbic
cortex. We could also conﬁrm the regulation pattern of G protein-coupled receptor, family
C, group 5, member B (Gprc5b) and septin 4 (Sept4 ) in this brain region, while voltage-
dependent calcium channel gamma subunit 3 (Cacng3 ) and Rho family GTPase 3 (Rnd3 )
showed almost signiﬁcant diﬀerential regulation. In the nucleus accumbens core, we had
an almost signiﬁcant result for the Ras guanyl releasing protein 3 (Rasgrp3 ) which was
up-regulated in high impulsive rats. In the shell region of the nucleus accumbens we could
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Table 4.7.: Overlap between the correlation analysis and the group comparison by t-test and
fold change.
infralimbic cortex nucl. accumbens core nucl. accumbens shell
up1 down2 up1 down2 up1 down2
Ankrd33b Cdc42ep1 P2ry12 Ankrd35 Aldh3b1 Fundc1
Bzw1 Cdc42ep2 Pdcd4 Zfp212 Cacng3 Larp6
Fam13c1 Fem1c Sphkap Klf13
Gipc1 Fndc3a Spryd4 LOC500300
Gna11 Mpp6 Tfpi
Gramd1b Pmp22 Tmem176
Hsd11b1 Rdx
Icam5 Taf15
Kbtbd3
Kctd13
Limk2
Mapk1
Me3
P2ry12
Pcdh8
Plcxd2
Prkd2
Rab3ip
Rnf217
Suds3
Syne1
1 up-regulated and 2 down-regulated in high impulsive rats
Table 4.8.: Genes with signiﬁcantly diﬀerential expression that lie in the impulsivity-
associated quantitative trait loci region on chromosome 1
position t-test fold change
Brain region gene symbol in 106 base pairs p-value high/low impulsivity
Gprc5b 177.2 0.011 0.79
infralimbic cortex Me3 146.4 0.027 1.20
Pde3b 172.6 0.037 1.25
Chd2 128.7 0.018 0.81
nucleus accumbens Olfml1 165.0 0.006 1.21
core Pde3b 172.6 0.004 1.40
Tm6sf1 138.1 0.049 1.45
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conﬁrm a down-regulation of the ADP-dependent glucokinase (Adpgk) in high impulsive
animals.
Nonetheless, the conﬁrmation of some genes failed completely as even the fold change
directions were conﬂicting between the microarray and the quantitative PCR data: The
dual speciﬁcity phosphatase 19 (Dusp19 ) and the guanine nucleotide binding protein alpha
11 (Gna11 ) could not be conﬁrmed in any of the analysed brain regions. The mitogen-
activated protein kinase kinase kinase kinase 5 (Map4k5 ) was not conﬁrmed in the infral-
imbic cortex and the nucleus accumbens core, the two brain regions where it had been
analysed. In addition, the soluble guanylate cyclase 1 alpha 3 (Gucy1a3 ) and the TAO
kinase 1 (Taok1 ) were not detected as diﬀerentially expressed in the striatal core region.
A diﬀerential expression of Cacng3 in the striatal shell region could also not be conﬁrmed.
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Figure 4.7.: Quantitative trait loci on chromosome 1 which were linked to the number of
premature responses in high and low impulsive rats. LOD scores higher than 3, i.e. above the
grey line, were considered to be in linkage with the trait and were underlined with a hatched
box. Data from Jeﬀ Dalley (University of Cambridge) and Silvia Pitzoi (Imperial College
London).
tested in all brain regions
Figure 4.8.: Infralimbic cortex
Figure 4.9.: Results of the quantitative PCR measurements (grey bars) in relation to the
microarray data (dashed red bars) in the infralimbic cortex . Indicated are the levels of
signiﬁcance of the qPCR results: + < 0.1, * < 0.05, ** < 0.01.
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tested in all brain regions
(a) Nucleus accumbens core
tested in all brain regions
(b) Nucleus accumbens shell
Figure 4.10.: Results of the quantitative PCR measurements (grey bars) in relation to the
microarray data (dashed red bars) in the nucleus accumbens core and shell . Indicated
are the levels of signiﬁcance of the qPCR results: + < 0.1, * < 0.05.
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In the present study we analysed genome-wide gene expression in selected brain areas of
rats bred for extremes in high and low impulsive behaviour. In a ﬁrst approach, we were
locking at the overall amount of gene expression diﬀerences between the two groups and
not at the level of individual genes.
Principal component analysis
The projection of the rats according to the ﬁrst three principal components showed a clear
separation according to the brain regions but no separation according to the impulsivity
phenotype. While brain anatomy was therefore responsible for the largest part of the overall
variance in the gene expression data set, only a small portion of genes was involved in the
behavioural trait of impulsivity. This was not surprising as the gene expression diﬀerences
underlying the functional and anatomical diﬀerences of the brain regions should be much
more pronounced than the subtle changes in neuronal receptor densities and signalling
cascades which might inﬂuence the degree of impulsive behaviour. The separation of the
tissue samples according to the brain regions reﬂected the architectural diﬀerences as the
nucleus accumbens core and shell regions are separated but closely linked regions while the
infralimbic cortex is situated further apart.
Volcano plots and candidate gene lists
The presentation of the t-test p-values and fold changes of all genes in the form of volcano
plots did not show a noteworthy greater inﬂuence of any of the brain regions on impulsivity.
All analysed brain regions showed a number of diﬀerentially regulated genes but their
number and location was about the same. Nonetheless, the list of diﬀerentially expressed
genes contained approximately three times more genes for the core region of the nucleus
accumbens than for the shell region or the infralimbic cortex. This suggests that the
nucleus accumbens core showed the greatest cellular diﬀerences between the phenotypes.
This ﬁnding was in line with lesion studies performed by Christakou et al. (2004) and by
Pothuizen et al. (2005) which had already stressed the importance of the core region in
impulsive behaviour.
On the other hand, the correlation of our gene expression data with the number of pre-
mature responses of the corresponding animals had shown the greatest number of candidate
genes in the infralimbic cortex. This ﬁnding received also support from the literature (Dal-
ley et al., 2011). Chudasama et al. (2003) had shown that lesions of the infralimbic cortex
led to higher impulsivity. A similar eﬀect can be provoked with the administration of a
NMDA receptor antagonists in this brain region (Murphy et al., 2005).
Individual gene ﬁndings
The analysis of the data set by t-tests and fold change ﬁltering yielded a list of candidate
genes for each analysed brain region. TheG-protein coupled purinergic P2Y receptor
12 (P2ry12 ) was signiﬁcantly up-regulated in all three brain regions in the high impulsive
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rats and this result was conﬁrmed by quantitative PCR analysis. In the infralimbic cortex
and nucleus accumbens core, P2ry12 was also signiﬁcantly positively correlated with the
number of premature responses. The gene codes for a G protein-coupled receptor which
is activated by adenosine diphosphate (ADP). It has ﬁrst been described in the context
of haemostasis research which showed that extracellular nucleotides such as ADP can
act as messenger molecules and activate purinergic receptors on blood cells which will
cause platelet aggregation (Nicholas, 2001). It has since been discovered that extracellular
nucleotide signalling and P2ry12 play a role in multiple cellular functions. Haynes et al.
(2006) showed in a mouse knock-out model that P2ry12 is essential for microglial activation
as a response to cortical damage and in line with this ﬁnding Amadio et al. (2010) reported
that loss of this receptor is an aggravating factor in grey matter lesions caused by multiple
sclerosis. But no link has been established between the receptor and impulsivity or any
psychiatric disorder so far. We could therefore have come across a yet unknown role of
this receptor in brain function. Another possibility is that we face an instance of random
genetic drift and that the diﬀerences in P2ry12 gene expression levels were enriched by the
breeding program although the gene is not linked to impulsivity. Subjecting the knock-out
mouse model from Haynes et al. (2006) to the 5-choice serial reaction time task (5CSRTT)
would be a good way to see whether this gene has an eﬀect on impulsive behaviour.
Another gene which was signiﬁcantly up-regulated in all three brain regions was the
frizzled-related protein (Frzb). This protein was ﬁrst described based on its analogy
to Drosophila's frizzled protein (Hoang et al., 1996) and functionally characterised as an
secreted antagonist in the Wnt signalling pathway (Leyns et al., 1997; Lin et al., 1997).
Interestingly, catenin (cadherin associated protein), beta 1 (Ctnnb1 ), a downstream eﬀector
in the Frzb-mediated part of the Wnt signalling pathway, was also signiﬁcantly up-regulated
in the infralimbic cortex (p-value = 0.049, ratio = 1.13). It was shown that Wnt signalling is
involved in axon remodelling and synaptic diﬀerentiation (Hall et al., 2000). Ataman et al.
(2008) showed that Wnt signalling plays a role in pre- and post-synaptic modiﬁcations as a
result of synaptic activity. It should also be noted that Frzb had already been connected to
impulsivity in a study on inbreed mouse strains (Loos et al., 2009). Given these facts, we
believe that it is unlikely that Frzb was only linked to impulsivity as a result of random drift.
The gene would therefore be a core candidate for functional validation. Unlike in the case
of P2ry12, no established transgenic knock-out model for the frizzled-related protein exists
to the best of our knowledge. It would be therefore preferable to alter the Frzb activity by
virus-mediated RNA interference which allows to silence the gene in adult animals without
the need to consider a possible role of the gene during the embryonic development. The
impulsivity of the thus-treated animals could be tested with the 5CSRTT. Local injection of
the viral vector containing the Frzb RNA-complementary sequence would allow to correlate
the degree of impulsivity more speciﬁcally to the activity of this gene in brain areas such
as the infralimbic cortex and the nucleus accumbens.
The list of quantitative PCR validated, diﬀerentially regulated genes also contained the
G protein-coupled receptor, family C, group 5, member B (Gprc5b) which was
down-regulated in the infralimbic cortex of high impulsive rats. This receptor, which is
activated by retinoic acid (Bräuner-Osborne and Krogsgaard-Larsen, 2000), shows high
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expression levels in the neocortex (Robbins et al., 2002). It has been suggested that the
receptor interacts with the frizzled G protein of the Wnt signalling pathway (Harada et al.,
2007) and thus acts on the same pathway as the Frzb protein described above.
A further ﬁnding in the infralimbic cortex was a signiﬁcant down-regulation of septin 4
(Sept4 ), a member of a group of guanosine triphosphate binding cell structure proteins
which has been linked to neuro-degenerative diseases but not to psychiatric disorders or
impulsivity so far (Sitz et al., 2008).
Two further genes of the infralimbic cortex candidate list reached almost signiﬁcance in
the quantitative PCR experiment. We found an up-regulation of the voltage-dependent
calcium channel gamma subunit 3 (Cacng3 ) and a down-regulation of the Rho
family GTPase 3 (Rnd3 ) in high impulsive rats. While both genes are implicated in
signalling the have not been linked to impulsivity previously.
A further gene which reached almost signiﬁcance in the nucleus accumbens core in the
quantitative PCR was the RAS guanyl releasing protein 3 (Rasgrp3 ) which was up-
regulated in high impulsive rats. Like Rasgrf2, which had been linked to alcohol intake
in a meta-analysis of genome-wide association studies (Schumann et al., 2011) and whose
expression level was analysed in one of our post-mortem tissue studies (see section 5.1.3
and ﬁgure 5.2 on page 96), Rasgrp3 codes for a guanine nucleotide exchange factor and
is thus implicated in G protein coupled signalling. Both genes are situated next to each
other in the mitogen activated kinase-like protein (MAPK ) signalling pathway of the Kyoto
Encyclopedia of Genes and Genomes (KEGG). As our laboratory already has a transgenic
animal model consisting of Rasgrf2 −/− mice (Stacey et al., 2012), these animals could be
tested in the 5CSRTT to further assess the inﬂuence of theMAPK pathway on impulsivity.
The quantitative PCR of the shell region also conﬁrmed a signiﬁcant down-regulation
of the ADP-dependent glucokinase (Adpgk) in high impulsive rats. But while this
gene had been previously linked to hypoxia, no such connection to psychiatric disorders or
impulsivity had been brought forward till today (Ronimus and Morgan, 2004).
KEGG Pathways and enriched gene ontology terms
There had been no enriched biological pathways of the Kyoto Encyclopedia of Genes and
Genomes in our lists of candidate genes but a gene ontology term of the category `biological
process' had been detected with an almost signiﬁcant corrected p-value in the infralimbic
cortex: `intracellular signalling cascade'. This ﬁnding suggests that the communication
between cells is altered in this brain region according to the level of impulsivity of the
rat. This would be in line with our original hypothesis that we would ﬁnd diﬀerences in
neurotransmitter signalling systems.
Based on the strong diﬀerential regulation of Frzb, it is noteworthy that the Wnt sig-
nalling pathway was also not discovered as an enriched feature. In addition, the pathway
analyses did not reveal a speciﬁc enrichment of genes belonging to the dopaminergic and
serotonergic signalling. We can therefore not conﬁrm our hypothesis form the beginning
that it would be this kind of biological mechanisms which would be implicated in the
generation of impulsivity in the infralimbic cortex and the nucleus accumbens.
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Genes linked to a quantitative trait loci on chromosome 1
We also screened if some of the candidate genes lay in a section of chromosome 1 (1q31 -
1q35) that had been found to be linked to the trait of impulsivity by our collaborators in
Cambridge. This trait has not been analysed by a genome wide association study so far and
the only available rat data for comparison originate from attention deﬁcit hyperactivity
disorder rat models which analysed diﬀerent sub-features and brought up diﬀerent loci
(Moisan et al., 2003; Vendruscolo et al., 2006). One of our main ﬁndings in the infralimbic
cortex had been Gprc5b which had also been conﬁrmed in the quantitative PCR experiment
and which had been described above. Further candidate genes from this brain region, that
were situated in this chromosomal section, included the NADP-dependent mitochondrial
malic enzyme 3 (Me3 ) which had been linked to neonatal lesions in an animal model of
schizophrenia but not to impulsivity or ADHD so far (Wong et al., 2005). The cGMP-
inhibited phophodiesterase 3B (Pde3b) which catalyses the hydrolysis of cyclic nucleotide
monophosphats and which is situated in this chromosomal region was up-regulated in both
infralimbic cortex and nucleus accumbens core. While Pde3b was brought in connection
with hypothalamic leptin-signalling it has not been linked to impulsivity or any psychiatric
disorder before (Sahu, 2011). There were three other genes which came up only in the
nucleus accumbens core: The chromodomain helicase DNA binding protein 2 (Chd2 ), a
chromatin remodelling protein which plays a vital role in embryogenesis (Marfella et al.,
2006). The olfactomedin-like 1 (Olfml1 ), whose zebraﬁsh homologue was reported to be
involved in retinal axon elongation via the Wnt signalling pathway (Nakaya et al., 2008).
Olfml1 was among the genes re-analysed by quantitative PCR. While the gene's expression
levels showed a similar ratio as in the microarrays the statistical diﬀerence of expression
was not conﬁrmed. And ﬁnally the transmembrane 6 superfamily member 1 (Tm6sf1 ), a
gene discovered by a sequencing project with no known protein function until now (Carim-
Todd et al., 2000). There had been not a single gene lying in the speciﬁc chromosomal
region which was signiﬁcantly diﬀerentially regulated in the nucleus accumbens shell data.
Taken together, the relation of our gene expression data to the quantiative trait loci on
chromosome 1 yielded only few genes and most of these genes seemed to have no apparent
relation to impulsivity or psychiatric disorders in general. A possible explanation would
be that the associated SNPs are related to trans-acting transcription regulators which
exert their inﬂuence somewhere else in the genome. Candidate genes like the Tm6sf1
could therefore just be false-positives contained in the list of gene expression ﬁndings.
In addition, it has to be noted, that the selected quantitative trait loci had moderate
LOD scores in the range of 3 to 4. While such scores are generally considered to indicate
an association between the chromosomal region and the analysed quantitative trait, the
association has nonetheless to be considered rather weak.
Limitations of the study
The present study had several limitations. While we had originally planned to compare
six high to six low impulsive animals, we limited the group size to four for the t-test and
fold change calculations due to ambiguous behavioural results in the other rats. Such a
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low number of replicates per group limited the ability of the statistical test to detect subtle
but otherwise relevant gene expression diﬀerences.
Our study was also not replicated in another cohort of bidirectionally bred impulsive
rats. Such a repetition would have allowed to diﬀerentiate chance ﬁndings from genes that
are truly involved in the phenotype.
And ﬁnally, the rats of the high impulsivity group did not diﬀer very strongly in the num-
ber of premature responses in the 5-choice serial reaction time task from their low impulsive
counterparts. The behavioural phenotype was therefore only weakly expressed and results
of the groups even overlapped between the test sessions in some cases. The behavioural
diﬀerentiation appears especially weak when compared to rat lines bred for high and low
levels of voluntary alcohol consumption. In these rat lines, the alcohol-preferring animals
consume up to ten times more alcohol than their non-preferring counterparts (Rodd et al.,
2004; Björk et al., 2010; Crabbe et al., 2010).
Follow-up experiments
As already mentioned during the discussion of the candidate genes, it is not possible to
determine from the microarray data if a gene ﬁnding is really implicated in the analysed
phenomena or if it is just a false positive. This determination can only be achieved by
functional validation. That means either silencing or artiﬁcially enhancing the expression
of the candidate gene and observing the eﬀect that it has on the queried phenotype, which
was the level of impulsivity in this study. Based on our results and the available literature,
P2ry12, Frzb and Gprc5b present the most promising candidates for such an approach.
Another option would be to repeat parts of this experiment with more homogeneous brain
tissue. A technique such as laser capture microdissection could be used to extract only
one type of neurons such as the medium spiny neurons of the nucleus accumbens. The low
amount of such tissue would probably forbid the analyses by microarrays but the analysis
of a low number of genes by quantitative PCR would be possible. This would allow to
correlate our ﬁndings more speciﬁcally to unique neuronal cell types.
Conclusion
In the present study, we used microarray analysis to proﬁle gene expression in the infralim-
bic cortex and the nucleus accumbens core and shell of high and low impulsive rats selected
from the sixth generation of an impulsivity breeding program. Our data did not show a
clear dominance of one of these brain regions in the association of their gene expression
to the impulsivity but suggested that their inﬂuence diminished from infralimbic cortex
via the core to the shell region of the nucleus accumbens. Several candidate genes were
discovered in these regions such as P2ry12, Frzb and Gprc5b with the latter gene being
situated in a chromosomal region associated with impulsive behaviour. Those candidate
genes led to the hypothesis that modiﬁcation of the Wnt signalling pathway might play a
role in the modulation of impulsivity levels.
We thus showed that a purely behavioural, non-pathological phenotype such as impulsivity
can be associated with characteristic gene expression pattern in the brain. This implies
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that this personality trait reverberates on the cellular level. Part of the discovered candi-
date genes might therefore hint at new pharmacotherapeutic targets for the treatment of
ADHD, drug addiction and other psychiatric disorders in which impulsivity plays a pivotal
role.
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5. Candidate gene expression studies in
human post-mortem brain tissue
5.1. Introduction to candidate gene studies
5.1.1. Measuring gene expression in human post-mortem brain tissue
The key to a better understanding of addictive disorders lies in the human brain. Biomedi-
cal research is therefore in need of brain tissue to learn more about the connection between
the behavioural phenotype of addiction and underlying alterations on the cellular level.
Taking brain tissue samples from living persons is not feasible as this would require brain
surgery which is always a delicate and risky medical intervention. The risk is not justiﬁed
as addictions don't constitute an acutely live-threatening danger as for example a brain tu-
mour. In addition, the brain areas involved in addiction show cellular alterations but they
are far from being defunct and their integrity is needed for the well-being of the patient.
The gene expression studies presented in the previous chapters circumvented this prob-
lem by analysing brain tissue from animals or peripheral tissue from humans in the hope
that the results can be extrapolated to the human brain. Another option is to take human
brain tissue samples after the death of a person. This approach has already been applied
by Paul Broca (1824 - 1880) in the 19th century (Broca, 1861). While Broca based his
analysis on visually distinguishable anatomical diﬀerences in brain areas of patients the
present study focused on subtle molecular modiﬁcations which should be detectable by
measuring messenger RNA concentrations.
It is important to keep in mind that such analyses are subjected to a number of limi-
tations which lie in the nature of the post-mortem tissue. While the primary goal is to
link diﬀerent expression levels of a candidate gene to the disease status or genotype of the
brain donor, the diﬀerence in mRNA concentration can also be caused by a number of
other factors (Stan et al., 2006):
 Post-mortem interval: As a person dies the body's tissue is cut-oﬀ from oxygen
and nutritional supply which is vital for proper cell function and the maintenance
of intact cell bodies. As a consequence, the cells can no longer protect their RNAs
from the abundantly present RNases which leads to a rapid degeneration of the
ribonucleic acids. The interval between time of death and the autopsy has therefore
a great inﬂuence on RNA concentration. This eﬀect is also dependent on the ambient
temperature as tissue decomposition and RNA decay proceed more quickly at higher
temperatures.
 Death struggle: The way of dying has an important impact on gene expression
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levels. A rapid death, as in the case of a sudden cardiac death, is less likely to cause
widespread gene expression changes than a slow and agonising death struggle.
 Comorbidities and medical treatments: RNA levels can further be inﬂuenced
by the history of medical treatment and the presence of prescription as well as ille-
gal drugs in the body at the time of death. Additional diseases can also inﬂuence
the RNA composition. Especially in the group of control subjects, which are often
selected to have a similar age of death as the diseased cases, death was often caused
by a non-psychiatric medical condition such as cardiac failure.
 Heterogeneity of the tissue: While it is possible to locate and extract tissue from
speciﬁc brain areas, the punched-out samples will still be made up by a mixture of
neurons and glia cells and possibly even some other cell types originating from tiny
blood vessels or belonging to the immune system. This makes it diﬃcult to draw
conclusions about gene expression levels in speciﬁc cell types.
There are several ways to address these limiting factors. Increasing the sample size is
likely to reduce the impact of confounding factors on the overall result under condition
that these factors aﬀect disease and control cases randomly. Statistical analysis of the
mRNA concentrations in the samples with a regression analysis can take these factors into
account as covariates. Another option is to select a core set of samples excluding cases
whose post-mortem interval exceeded a set limit, who were linked to confounding disease or
whose toxicological examination revealed the presence of prescription or illegal drugs. The
heterogeneity of the brain tissues can be addressed by using laser capture microdissection
or similar methods for the isolation of speciﬁc cell types. But this is only possible if the
cell types can be distinguished from each other and if the dissection yields enough high
quality mRNA for subsequent quantiﬁcation.
Nonetheless, post-mortem tissue samples can be used to validate research ﬁndings from
animal studies and as a follow up of genetic epidemiology studies. With the advent of
genome-wide association studies (GWAS), large numbers of associations between speciﬁc
variations of single-nucleotide polymorphisms (SNPs) and disease have been discovered.
However, most associated SNP variants do not result in a change of the amino acid chain
of a protein but lie outside of exon regions. It is therefore likely that the disease-related SNP
variants modify the interaction between the DNA and transcription factors thus inﬂuencing
the transcription rates of surrounding genes (Manolio, 2010). Post-mortem brain samples
permit to investigate the expression levels of such linked genes in brain areas relevant to
psychiatric disorders.
5.1.2. Investigated brain regions
The present study was based on the analysis of tissue from four diﬀerent brain regions: The
anterior cingulate cortex, Brodmann's area 9, the caudate nucleus and the ventral striatum.
These structures shall be brieﬂy introduced here.
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Anterior cingulate cortex
The corpus callosum, which connects the two brain hemispheres, is coated from above by
each cerebral hemisphere with a cortical structure called the cingulate cortex (from the
Latin word cingulum = belt as it girds the corpus callosum like a belt). This structure
belongs to the phylogenetically oldest part of the cerebral cortex, the archicortex. It forms,
together with the hippocampus, the amygdala, the fornix ﬁbres and parts of the thalamus,
the limbic system which is the centre of emotion processing.
The cingulate cortex can be cytoarchitectonically and functionally divided into three
parts: the anterior cingulate cortex (ﬁgure 5.1a) with its characteristic spindle neurons
(Allman et al., 2001), the midcingulate cortex and the posterior cingulate cortex (Vogt
et al., 2004; Vogt and Paxinos, 2012). Both the anterior and the posterior cingulate cortex
receive their main input from the thalamus and have output projections to prefrontal areas.
The ventral part of the anterior cingulate cortex also sends projections to the amygdala
(Vogt et al., 1987; Vogt and Pandya, 1987).
While the more posterior structures were linked to episodic memory retrieval and the
perception of physical pain (Nielsen et al., 2005), the anterior cingulate cortex seems to be
crucial for the regulation of emotion and cognitive processing (Bush et al., 2000). It comes
as no surprise that cytoarchitetonical alterations in the anterior cingulate cortex have been
linked to psychiatric disorders such as schizophrenia (Yan et al., 2012). The anterior area
has also been linked to drug addiction and more speciﬁcally alcohol abuse (Goldstein and
Volkow, 2002). It has been proposed that cellular modiﬁcations in the anterior cingulate
cortex are crucial for the maintenance of addiction in long-term alcoholics (Kalivas and
Volkow, 2005).
Brodmann's area 9
The second region investigated in our studies is a cytoarchitecturally homogeneous area
of the frontal lobe which was ﬁrst characterised by Korbinian Brodmann (1868 - 1918) as
area frontalis granularis (Brodmann, 1909). This area, which is commonly referred to as
Brodmann's area 9 (ﬁgure 5.1b), shows the classical six layered structure of the cerebral
cortex with the exception that layer V can be visually separated into an outer, neuron rich
and an inner sparsely populated layer (Brodmann, 1909). The pyramidal cells from this
layer are the main source of eﬀerents to the striatum (Patestas and Gartner, 2006).
Brodmann's area 9 has been reported to be in connection with a number of psychiatric
disorders, including major depression, bipolar disorder and schizophrenia (Fitzgerald et al.,
2006; Kim et al., 2010; Uranova et al., 2004). The region is also of interest in alcoholism
research. Dao-Castellana et al. (1998) showed that chronic alcohol-drinking patients had
speciﬁc metabolic abnormalities in the dorsolateral prefrontal cortex, which roughly cor-
responds to Brodmann's area 9, and linked these alterations to neuropsychological and
behavioural impairments often found in alcoholics. George et al. (2001) reported that this
brain region showed increased activity in alcohol-dependent subjects while viewing alcohol-
related cues. A molecular analysis of this brain region using mass spectrometry revealed
concentration diﬀerences of sets of proteins in post-mortem tissue of alcohol-dependent sub-
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jects (Alexander-Kaufman et al., 2006, 2007). These cellular alterations in Brodmann's
area 9 might lead to an impairment of impulse control which could explain their connection
to addictive behaviour (Koob and Volkow, 2010).
Caudate nucleus
The caudate nucleus (ﬁgure 5.1c) is a cluster of neurons which stretches in a semicircle
from the putamen to the amydala within each cerebral hemisphere. It is part of a function-
ally tightly connected network of nuclei, called the basal ganglia, which is responsible for
voluntary motor control. The caudate nucleus receives its primary input from dopaminer-
gic neurons originating in the midbrain structures of the ventral tegmental area and the
substantia nigra (Smith and Parent, 1986; Packard and Knowlton, 2002). A large portion
of its eﬀerents go to the primary motor cortex but it also contains a signiﬁcant number of
neurons which send their signal back to the midbrain (Royce and Laine, 2004).
The caudate nucleus has been associated with learning and memory formation as well
as the control of movements and cognition (Packard and Knowlton, 2002; Graybiel, 2005).
Anatomic and metabolic alterations in this area have been linked to psychiatric conditions
such as obsessive compulsive disorder (Hansen et al., 2002; Radua and Mataix-Cols, 2009).
The caudate nucleus is also connected to reward processing (Nakamura and Hikosaka,
2006). Not surprisingly, alterations in this region have been associated with alcohol addic-
tion (Weiner et al., 1980; Acheson et al., 2009). Gilman et al. (2012) showed in a study
based on a behavioural test combined with a functional magnetic resonance scan that alco-
hol increased risk-taking behaviour in healthy social drinkers while it decreased the activity
level of the caudate nucleus at the same time.
Ventral striatum
Finally, we also analysed post-mortem tissue from the ventral striatum. The striatum is a
core structure of the basal ganglia system which consists of the above-mentioned caudate
nucleus and the putamen (ﬁgure 5.1d). In the most ventrorostral part of the striatum,
where the caudate nucleus and the putamen merge, lies a small region which is called the
nucleus accumbens (Trepel, 2008). This nucleus had already been the region of interest in
the study on the inﬂuence of alcohol exposure and circadian rhythmicity on gene expression
in the rat brain and the study which proﬁled gene expression in high and low impulsive
rats. As it is diﬃcult to identify and isolate exclusively this small nucleus in the human
brain, the pathologists provided us with tissue from a region which they labelled ventral
striatum. This term encompasses primarily the nucleus accumbens but the tissue could
also contain the adjacent olfactory tubercle as well as further ventrorostral tissue of the
putamen and the caudate nucleus (Heimer and Wilson, 1975; Ubeda-Bañon et al., 2007).
More then 90% of the neurons of the ventral striatum are medium spiny neurons whose
neurotransmitter is γ-aminobutyric acid (GABA) (Lape and Dani, 2004; Sazdanovi¢ et al.,
2011). The neurons are responsible for the main output of the ventral striatum. Their
axons project to the globus pallidus and the substantia nigra pars reticulata from where the
signal is further transferred to the thalamus and then to the motor cortex. Dopaminergic
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(a) Anterior cingulate cortex (b) Brodmann's area 9
(c) Caudate nucleus (d) Putamen*)
Figure 5.1.: Analysed brain regions. The region of interest is coloured in black in each ﬁgure.
*) For purpose of presentation, the putamen is shown instead of the ventral striatum which
was analysed in this study. The later structure lies at the ventrorostral end of the putamen
(see text for details). 1
neurons projecting from the ventral tegmental area and the substantia nigra pars compacta,
both situated in the midbrain, form the main input to the ventral striatum (Lobo and
Nestler, 2011).
The ventral striatum plays a central role in the sensation of reward and pleasure. It has
been shown that those sensations correlate with an increase in dopamine signaling from
the ventral tegmental area to the ventral striatum (Arias-Carrión et al., 2010). Given the
rewarding eﬀect of drugs of abuse, the ventral striatum plays a key role in the establishment
and maintenance of drug addiction (Everitt et al., 1999), including the addiction to alcohol
(Koob, 2013).
1 All ﬁgures are made from content published under the Creative Commons Attribution 2.1 Japan li-
cense on the BodyParts3D/Anatomography website (http://lifesciencedb.jp/bp3d/?lng=en) by
the Database Center for Life Science (Tokyo, Japan). Figures 5.1a and 5.1b were modiﬁed from
versions originally published on wikipedia (en.wikipedia.org/wiki/Anterior_cingulate_cortex,
en.wikipedia.org/wiki/Brodmann_area_9) and ﬁgures 5.1c and 5.1d were self-made on Body-
Parts3D/Anatomography.
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5.1.3. Candidate genes
The present study analysed four candidate genes which shall be brieﬂy introduced here.
AUTS2
The ﬁrst gene of interest was the autism susceptibility gene 2 (AUTS2 ). Sultana et al.
(2002) were the ﬁrst to report on this gene which, as the authors suggest, might be dis-
rupted in rare cases of autism. It is situated on chromosome 7q in a region which has previ-
ously been linked to autism (International Molecular Genetic Study of Autism Consortium
(IMGSAC), 2001). Recently, this gene has gained attention from addiction research, as
a SNP in the fourth intron of AUTS2 was associated with the amount of daily alcohol
consumption in a meta-analysis of genome-wide association studies: rs6943555 showed a
signiﬁcant linkage (p-value = 4.2 · 10−8) with its minor A allele associated with a 5.5%
lower alcohol consumption (Schumann et al., 2011).
In spite of these reports that link AUTS2 to psychiatric disorders the function of the
gene remains hitherto unknown. Neither the fact that AUTS2 has homologs in various
vertebrate species nor its DNA sequence have yielded any information on this matter.
The present study did not address this question but aimed to investigate if the allelic
variation at SNP rs6943555 leads to a diﬀerence in AUTS2 gene expression. To analyse
this research question, AUTS2 mRNA concentration was measured in post-mortem tissue
of Brodmann's area 9 by quantitative PCR and related to the allelic variation in SNP
rs6943555.
RASGRF2
The same genome-wide association study which brought up AUTS2 in connection with al-
cohol dependence suggested a connection of another gene to this disorder: the Ras protein-
speciﬁc guanine nucleotide-releasing factor 2 (RASGRF2 ). This protein transforms an
inactive small GTPase from the RAS family to its active form by exchanging its bound
guanosine diphosphate (GDP) with a guanosine triphosphate (GTP) (ﬁgure 5.2). RAS-
GRF2 acts thus as an upstream modulator of the MAPK/ERK pathway. This eﬀect has
been shown to take place in the medium spiny neurons of the striatum and was linked to
long-term behavioural responses to cocaine (Fasano et al., 2009; Fasano and Brambilla,
2011).
Schumann et al. (2011) reported a possible connection between SNP26907 lying in the
RASGRF2 gene and alcohol consumption: The minor T allele is associated with a 2.6%
decrease in alcohol consumption with a nominal p-value of 2.2 · 10−4. The SNP26907 lies
in an intronic region between exon three and four of the full-length transcript. Another
guanine nucleotide exchange factor, RASGRP3, which is closely related to RASGRF2, had
been diﬀerentially regulated in our study on impulsive behaviour in rats (see ﬁgure 4.6 on
page 79 and ﬁgure 4.10a on page 84). As outlined in this previous study, impulsivity is a
risk factor for alcohol addiction.
This study therefore investigated whether the presence of the minor T allele of SNP26907
inﬂuences alcohol consumption by modifying the expression level of RASGRF2. To analyse
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GTPGDP
Guanine-nucleotide exchange factor:
e.g. RASGRF2
GTPase activating protein
G protein
(inactive)
G protein
(active)
Figure 5.2.: Activation cycle of G proteins. RASGRF2 acts as an guanine nucleotide ex-
change factor activating a small GTPase of the RAS family.
this research question, RASGRF2 mRNA concentration was measured in post-mortem
tissue of Brodmann's area 9 by quantiative PCR and related to the allelic variation in
SNP26907.
TACR1
In 1931, Ulf von Euler and John H. Gaddum reported the discovery of a substance in
rabbit intestine and brain tissue which had the ability to cause slow contractions of the
longitudinal muscle of the rabbit's intestines but which was not inhibited by atropine (von
Euler and Gaddum, 1931). The causative agent was subsequently named substance P
with the "P" refering to the fact that it was ﬁrst isolated in the form of a powder. The
substance is a unadecapeptide made up of the following amino acid chain: Arg-Pro-Lys-
Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2. The Phe-X-Gly-Leu-Met-NH2 sequence, with X
standing for an either aliphatic or aromatic amino acid, at the C-terminal region is the
characteristic identifying sequence of a whole family of neuropeptides called tachykinins,
to which substance P belongs.
Substance P is the endogenous ligand for the tachykinin receptor 1 (TACR1 ), which
is also named neurokinin 1 receptor (NK1R). It's a G protein coupled receptor (Takeda
et al., 1991) which acts at least via the following three second-messenger systems: (1)
stimulation of phosphatidyl inositol via phospholipase C, (2) mobilisation of arachidonic
acid via phospholipase A2 and (3) increase of cAMP levels via stimulation of adenylate
cyclase (Quartara and Maggi, 1997). Besides TACR1, substance P also binds with a weaker
aﬃnity to the two other tachykinin receptors, TACR2 and TACR3.
There is vast evidence linking substance P to the processing and perception of pain
information (e.g. Carr and Lipkowski 1990; Otsuka and Yanagisawa 1990) but from the
perspective of addiction research it is most notable that substance P seems to enhance
glutamate-mediated excitatory neurotransmission via an upregulation of glutamatergic
NMDA receptor function (Randi¢ et al., 1990). It was suggested that substance P plays a
noticable role in the body's reaction to psychological stress and that pharmacological inhi-
bition of the tachykinin receptor 1 can alleviate anxiety- and depression-related responses
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in rodents (Holmes et al., 2003) and in humans (Furmark et al., 2005).
George et al. (2008) provided evidence that pharmacological inhibition of the tachykinin 1
receptor might be a therapy for the treatment of alcohol dependent patients as this inhi-
bition decreased the behavioural sensitivity to stress. In addition, our collaborators from
the National Institute on Alcohol Abuse and Alcoholism (NIAAA) found a possible link
between SNP rs3771807 situated in the intronic region between exon 2 and 3 of the TACR1
and brain activation in response to alcohol cues (unpublished data).
We therefore hypothesised that, given the implication of tachykinin 1 receptor in be-
havioural sensitivity to stress and indirectly alcohol addiction, TACR1 is diﬀerentially
expressed in the brain of alcohol dependent patients when compared to control subjects
and we carefully speculate that the expression levels of TACR1 is also dependent on the
genotype of SNP rs3771807 in the TACR1 gene.
To analyse our research question, we performed TACR1 mRNA concentration measure-
ments by quantitative PCR in the anterior cingulate cortex, Brodmann's area 9, caudate
nucleus and ventral striatum of deceased alcoholics and control subjects and related the
ﬁndings to the disease status. Additional quantitative PCR measurements of TACR1 as
well as genotyping of SNP rs3771807 was carried out in Brodmann area 9 of a larger,
non-alcohol related sample set and the association between gene expression and genotype
was subsequently analysed.
GRIN3A
Alcohol interacts with a large variety of receptors in the human body. One of the strongest
interactions is an inhibition of the N-methyl-D-aspartate (NMDA)-responsive ionotropic
glutamate receptors (Spanagel, 2009). This group of glutamate-activated receptors, which
is deﬁned by the fact that its members are also activated by the artiﬁcial agonist NMDA,
are heterotetramers made up of a combination of the subunits presented in table 5.1 (Pach-
ernegg et al., 2012; Andersson et al., 2001).
Table 5.1.: Subunits of the NMDA glutamate receptors
Gene name Subunit variant Description
GRIN1 NR1 glutamate receptor, ionotropic NMDA1
GRIN2A NR2 glutamate receptor, ionotropic NMDA2A
GRIN2B NR2 glutamate receptor, ionotropic NMDA2B
GRIN2C NR2 glutamate receptor, ionotropic NMDA2C
GRIN2D NR2 glutamate receptor, ionotropic NMDA2D
GRIN3A NR3 glutamate receptor, ionotropic NMDA3A
GRIN3B NR3 glutamate receptor, ionotropic NMDA3B
The GRIN2 subunits are responsible for binding the neurotransmitter glutamate while
the GRIN1 subunit binds the co-agonist glycine.
A consequence of alcohol's inhibition of the NMDA receptor mediated signalling is an
increased cell-surface density of those receptors in the brain after chronic ethanol expo-
sure (Freund and Anderson, 1996; Qiang et al., 2007). NMDA antagonists have therefore
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been proposed as a post-withdrawal treatment for alcohol dependent patients. But clini-
cal trials of neramexane, a noncompetitive NMDA receptor antagonist, did not show any
eﬀect (Spanagel and Kiefer, 2008). Tests in rat lines bred for high alcohol consump-
tion showed that neramexane suppresses alcohol consumption in ALKO Alcohol Accepting
(AA) rats but not in Marchigian Sardinian alcohol-preferring (msP) rats (Spanagel, 2009).
Microarray-based gene expression proﬁling in cortical tissue of both rat lines revealed a
signiﬁcant upregulation of Grin3a in msP rats compared to AA rats (Björk et al., 2010).
We therefore hypothesised that GRIN3A is signiﬁcantly diﬀerentially expressed in the
brain of alcohol dependent individuals. GRIN3A mRNA concentration measurements were
carried out in the anterior cingulate cortex, Brodmann's area 9, caudate nucleus and ventral
striatum of deceased alcoholics and control subjects by quantitative PCR and the ﬁndings
were related to the disease status of the subjects.
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5.2. Materials and Methods
The human candidate gene studies were based on tissue samples from two diﬀerent brain
banks. Table 5.2 shows the available brain regions from these two tissue resources.
Table 5.2.: Available post-mortem tissue
New South Wales
Human Brain Tissue Bank Tissue Ressource Centre
Brain region (HBTB) (NSW TRC)
Comparison suicide vs. control alcoholic vs. control
Anterior cingulate cortex  4
Brodmann's area 9 4 4
Caudate nucleus  4
Ventral striatum  4
5.2.1. Post-mortem samples from the Human Brain Tissue Bank
Tissue samples were obtained from the Human Brain Tissue Bank (HBTB) from the De-
partment of Anatomy, Semmelweis University, Budapest, Hungary (humanbraintissuebank-
budapest.sote.hu). The brain bank oﬀers tissue from suicide victims and control subjects
who died of various other causes. In addition, the following data are given for each sub-
ject: sex, age at time of death, time-span between estimated time of death and the autopsy
(post-mortem interval), exact cause of death according to post-mortem examination.
At the beginning of our studies, we possessed 104 samples from Brodmann area 9.
Seventy-ﬁve samples (45 male/30 female) were from control subjects and 29 (19 male/10
female) from suicides (see table A.1 on page 119 in the annex).
5.2.2. Post-mortem samples from the New South Wales Tissue Resource
Tissue samples were obtained from the New South Wales Tissue Resource Centre (NSW
TRC) at the University of Sydney, Australia (sydney.edu.au/medicine/pathology/trc/in-
dex.php). The brain bank provides tissue from deceased patients with a history of alcohol
dependence and from age-matched control subjects (Sheedy et al., 2008). Alcohol depen-
dent subjects were diagnosed retrospectively using the Diagnostic Instrument for Brain
Studies - Revised (DIBS-R) which is a post-mortem analysis based on medical records
and interviews with persons of reference. The classiﬁcation criteria are in line with the
Diagnostic and Statistical Manual for Mental Disorders, fourth edition (DSM-IV) (Dedova
et al., 2009). Similar to the Hungarian Brain Bank, the New South Wales Tissue Resource
Centre also provides information on age of death and sex but also on ethnic origin, brain
pH, smoking habits, time-span between estimated time of death and autopsy as well as a
report on the cause of death and the results of the toxicological analysis.
For our studies, we used tissue from 20 male subjects of European descent consisting of 10
alcohol dependent and 10 control cases. All alcohol dependent subjects had consumed more
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than 80 g of alcohol per day while the control cases had all a daily consumption below 20 g.
Except from one suicide in the control group, all subjects died of non-psychiatric medical
conditions. The post-mortem interval of all selected subjects was below 36 hours and no
blood alcohol or signiﬁcant amounts (concentration > 1.0 mg/l) of psychiatric medication
had been reported (see table A.2 on page 123 in the annex).
5.2.3. DNA isolation and puriﬁcation
Brain samples from the Human Brain Tissue Bank (HBTB) were used to relate the geno-
type of SNPs lying in the vicinity of AUTS2, RASGRF2 and TACR1 to the gene expression
of these genes.
For DNA extraction, small pieces of the brain samples, corresponding roughtly to 25mg
of tissue, were cut oﬀ with a scalpel at an ambient temperature of −20 ◦C in a Leica CM
3000 Cryostat (Leica, Wetzlar, Germany). DNA was then extracted using the DNeasy
Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol.
5.2.4. Single nucleotide-polymorphism genotyping
For the TACR1 study, the genotype of SNP rs3771807 was detected by quantitative PCR
using the TaqMan® Universal PCR Master Mix and the TaqMan® SNP Genotyping
Assay with the product number `C___2974562_10 ' (both: Life Technologies, Darmstadt,
Germany) consisting of a pair of primers and two diﬀerentially labelled ﬂuorescent probes
which bind to either of the two variants of the investigated SNP. Master mix, genotyping
assay and the samples were mixed in a total volume of 25 µl according to the manufacturer's
protocol. The genotyping PCR was performed on an Applied Biosystems 7900 HT Real-
time PCR system (Life Technologies) using the following temperature proﬁle: 10 min at
95 ◦C followed by 40 cycles of 15 sec dissociation at 92 ◦C and one minute annealing and
elongation at 60 ◦C. Genotypes were called by Applied Biosystems' Sequence Detection
System (SDS) Software Version 2.2.2.
The genotyping of SNP rs6934555 in the vicinity of AUTS2 and rs26907 in the vicinity
of RASGRF2 was done by our collaborators at the Institute of Psychiatry, King's College
London (London, UK).
5.2.5. RNA isolation and puriﬁcation
Small pieces of the brain samples, corresponding to roughly 50mg of tissue, were cut oﬀ
with a scalpel at an ambient temperature of −20 ◦C in a Leica CM 3000 Cryostat (Leica,
Wetzlar, Germany). Samples were kept at −80 ◦C until further use when the tissue samples
were homogenised by repeated trituration in 1ml of TRIzol® Reagent (Life Technologies,
Darmstadt, Germany) using ﬁrst a 20 gauge and then a 22 gauge needle. Samples were
subsequently ﬁlled up with 200µl of chloroform, mixed and centrifuged to separate the
RNA containing aqueous upper phase from the organic lower phase. The upper phases were
carefully collected and puriﬁed with an RNeasy MinElute Cleanup Kit (Qiagen, Hilden,
Germany).
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The concentration of the RNAs was determined with a Nanodrop 1000 Spectrophotome-
ter (Peqlab, Erlangen, Germany). RNA quality was assessed on the basis of the 260 nm to
280 nm absorption ratio and further analysed with an Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA).
For the Human Brain Tissue Bank collection, only RNA samples with a RNA integrity
number (RIN) above 6.5 were taken into account and the RIN values were included as a
co-factor in the statistical analysis. In the case of the New South Wales Tissue Resource
Centre collection, all RNA samples had RIN values above six and were therefore included
in the quantitative PCR analysis.
5.2.6. Quantitative PCRs
The messenger RNA concentration of all four candidate genes (AUTS2, RASGRF2, TACR1
and GRIN3A) was assessed by quantitative PCR.
Experimental procedures
For the HBTB samples, a DNase treatment was performed before the reverse transcription
to reduce the contamination of the RNA samples with DNA. 1.5 µg of each RNA sample
was treated with RQ1 RNase-free DNase (Promega, Mannheim, Germany) according to
the manufacturer's recommendations. 1.0µl of the 10 µl reaction volume were subsequently
used for reverse transcription which was performed using the High Capacity RNA-to-cDNA
Kit (Life Technologies, Darmstadt, Germany) following the manufacturer's protocol. For
the NSW-TRC samples it was not necessary to perform a DNase digestion step as the
primers had been speciﬁcally designed to ﬁt only to messenger RNA molecules after the
splicing-out of the introns. Therefore, 100 ng of each NSW-TRC RNA sample were directly
transcribed using the High Capacity RNA-to-cDNA Kit. All cDNA samples from both
tissue collections were diluted 1:5.
The expression levels of the candidate genes were measured on an Applied Biosystems
7900 HT Real-time PCR system (Life Technologies) using the Power SYBR® Green PCR
Master Mix (Life Technologies). Reactions were performed in a total volume of 20 µl with
5 µl diluted cDNA and a ﬁnal concentration of 400 nmol/l of both the forward and the
reverse primer. GAPDH was used as a housekeeping gene and run in duplicates while
all candidate genes were tested in triplicates. The PCRs of the AUTS2 and RASGRF2
assays were performed with the following temperature proﬁle: 15 min at 95 ◦C followed
by 40 cycles of 30 sec at 95 ◦C and 30 sec annealing and elongation at 60 ◦C. The PCRs
of the GRIN3A and the TACR1 assays were performed with the following temperature
proﬁle: 10 min at 95 ◦C followed by 40 cycles of 15 sec dissociation at 95 ◦C and one minute
annealing and elongation at 60 ◦C. Melting curve analysis was performed after each run to
check for unwanted PCR side products. Data were normalised to the endogenous control
by subtraction. Primer sequences of the candidate genes and GAPDH are presented in
table 5.3.
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Table 5.3.: Primer sequences of the genes of interest
Gene Primer forward Primer reverse
AUTS2 CGAGAAAATGACCGCAATCT GCTGTTCTGTCCTGGCTTGA
GAPDH* CATGAGAAGTATGACAACAGCCT AGTCCTTCCACGATACCAAAGT
GRIN3A TCATGTGGCCACTCCACTGGACA TCGCCCTTGGGAGTCAAACCAA
RASGRF2 GCTTGTATACCTCTCTCTCCTGGT ACGCCCATTTTCCAGGTA
TACR1 TCAATGACAGGTTCCGTCTGGGCTT ATAGTCGCCGGCGCTGATGA
*) Reference (= housekeeping) gene
Normalisation
Applied Biosystems' Sequence Detection System (SDS) Software Version 2.2.2. was used
to analyse the SYBR green ﬂuorescence levels that had been registered during the PCR
run. Cycle of threshold (Ct) values were calculated for each well as the theoretical number
of cycles when a deﬁned ﬂuorescence threshold was reached. Duplicates (housekeeping
gene) or triplicates (candidate genes) were averaged by arithmetic mean. Reactions were
normalised to the housekeeping gene by calculation of the ∆Ct value which was deﬁned
as:
∆Ct = Ctcandidate gene − Cthousekeeping gene
5.2.7. Statistical analyses
All data were analysed with R statistical programming language version 2.14.2.
Analysis of Human Brain Tissue Bank samples
In the case of the quantitative PCR data acquired from the Human Brain Tissue Bank
samples, the inﬂuence of potentially confounding co-factors was preliminarily assessed by
Student's t-tests for categorical variables and Pearson correlation tests for continuous vari-
ables and subsets of the original data sets were taken where necessary.
As the residuals of the ∆Ct values showed a substantial deviation from a normal dis-
tribution, we quantile transformed the data to a normally distributed set of random data
with µ = 0 and σ = 1 (Bolstad et al., 2003; Peng et al., 2007). The transformed data
were then analysed with a general linear model with the quantile normalised ∆Ct values
as the dependent variable and the gene dose of the investigated SNP as the predictor
variable. Depending on the preliminary t-tests and the sample subset further potentially
confounding predictor variables were included in the models (see result section for details).
The statistical analysis of the AUTS2 and RASGRF2 data was originally done by our
collaborator Anbarasu Lourdusamy (Institute of Psychiatry, King's College London, Lon-
don, UK) and his version was used for the publication of the results in Schumann et al.
(2011) and Stacey et al. (2012). I reproduced these analyses for this thesis obtaining the
same outcome which is described in the results section.
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Analysis of New South Wales Tissue Resource Centre samples
In contrast to the Human Brain Tissue Bank which had provided us with tissue of one
brain region from 104 subjects, the New South Wales Tissue Resource Centre had given
tissue of four brain regions but only from 20 subjects (10 diseased/10 control) which had
been selected with the intent to minimise the number of confounding factors. Taken this
diﬀerent prerequisites into account, we analysed the New South Wales Tissue Resource
Centre samples with Student's t-tests.
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5.3. Results
In the context of our post-mortem gene expression study we measured AUTS2, RASGRF2,
TACR1 and GRIN3A mRNA in our brain banks (see table 5.4).
Table 5.4.: Overview of qPCR experiments in human samples
New South Wales
Human Brain Tissue Bank Tissue Ressource Centre
Candidate gene (HBTB) (NSW TRC)
Brain region BA9 ACC, BA9, CAU, VST
AUTS2 4 
RASGRF2 4 
TACR1 4 4
GRIN3A  4
ACC = anterior cingulate cortex, BA9 = Brodmann's area 9,
CAU = caudate nucleus, VST = ventral striatum
5.3.1. AUTS2
AUTS2 mRNA was quantiﬁed by quantitative PCR in tissue from Brodmann's area 9.
Table 5.5 shows the average of the Ct values for AUTS2 and the reference gene GAPDH
as well as for the normalised ∆Ct values (=AUTS2GAPDH ) for each allelic combination
at rs6934555.
Table 5.5.: AUTS2 gene expression:
mean Ct value ± standard deviation for the three genotypes of rs6934555
Genotype Count AUTS2 GAPDH AUTS2GAPDH
AA 57 25.78 ± 0.91 19.03 ± 0.98 6.75 ± 0.82
AT 33 25.79 ± 1.04 19.21 ± 1.44 6.59 ± 0.93
TT 6 25.50 ± 1.24 19.30 ± 1.96 6.20 ± 1.00
The data were then quantile transformed to allow for the statistical analysis of the
inﬂuence of the genotype on AUTS2 gene expression with a general linear model. The
following variables were included in the model: rs6934555 genotype, sex, age, post-mortem
interval and RNA integrity number. Genetic ancestry (p-value = 0.819) and cause of death
(suicide versus control; p-value = 0.773) had no inﬂuence on AUTS2 gene expression and
were not included in the regression analysis. The statistical analysis showed that the minor
A allele of SNP rs6943555 led to a signiﬁcant increase in AUTS2 mRNA concentration (p-
value = 0.023). RNA integrity also aﬀected the AUTS2 mRNA levels signiﬁcantly. This is
expected as the amount of detectable mRNA decreases with increased sample degradation.
See table 5.6 and ﬁgure 5.3 for details.
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Table 5.6.: Inﬂuence of predictor variables on AUTS2 gene expression
Variable Estimate Std. Error p-Value
Gene dose -0.326 0.140 0.023 *
Sex(male) 0.112 0.185 0.548
Age -0.006 0.005 0.294
PMI1) -0.058 0.035 0.103
RIN2) 0.369 0.127 0.005 **
* < 0.05, ** < 0.01
1) PMI = post-mortem interval
2) RIN = RNA integrity number
Figure 5.3.: Genotype-speciﬁc AUTS2 messenger RNA levels in post-mortem human pre-
frontal cortex tissue (Brodmann Area 9). Lower normalised ∆Ct values indicate higher ex-
pression levels. Dotted horizontal lines indicate group averages.
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5.3.2. RASGRF2
RASGRF2 mRNA was quantiﬁed by quantitative PCR in tissue from Brodmann's area 9.
Table 5.7 shows the average of the Ct values for RASGRF2 and the reference gene GAPDH
as well as for the normalised ∆Ct values (=RASGRF2GAPDH ) for each allelic combi-
nation at rs26907.
Table 5.7.: RASGRF2 gene expression:
mean Ct value ± standard deviation for the three genotypes of rs26907
Genotype Count RASGRF2 GAPDH RASGRF2GAPDH
AA 3 29.27 ± 1.33 20.72 ± 2.56 8.55 ± 1.43
AG 24 26.94 ± 1.05 19.08 ± 1.06 7.86 ± 0.57
GG 69 26.97 ± 1.18 19.05 ± 1.17 7.93 ± 0.79
Like in the case of AUTS2, data were then quantile transformed to allow for the statistical
analysis of the inﬂuence of the genotype on gene expression with a general linear model.
The analysis showed an almost signiﬁcant inﬂuence of cause of death (suicide versus control;
p-value = 0.083) on RASGRF2 gene expression. As we detected an additional signiﬁcant
inﬂuence of sex (p-value = 0.019), we restricted the regression analysis to the male control
samples. A linear model of RASGRF2 gene expression based on rs26907 genotype, age,
post-mortem interval and RNA integrity number showed no inﬂuence of the genotype on
gene expression (p-value = 0.859). Genetic ancestry had no inﬂuence on RASGRF2 gene
expression (p-value = 0.660) and was not included in the analysis. See table 5.8 for details.
Table 5.8.: Inﬂuence of predictor variables on RASGRF2 gene expression
Variable Estimate Std. Error p-Value
Gene dose -0.048 0.267 0.859
Age -0.007 0.012 0.564
PMI1) -0.031 0.083 0.706
RIN2) 0.075 0.230 0.745
1) PMI = post-mortem interval
2) RIN = RNA integrity number
5.3.3. TACR1
TACR1 mRNA was quantiﬁed in post-mortem tissue samples of alcohol addicted patients
and control subjects. We analysed the expression of this gene in the anterior cingulate
cortex, Brodmann's area 9, the caudate nucleus and the ventral striatum. Table 5.9 shows
the Ct values for TACR1, the reference gene GAPDH and the normalised ∆Ct values
(=TACR1GAPDH ) of each brain region for the ten control and the ten alcohol addicted
subjects.
Only the anterior cingulate cortex had a signiﬁcantly diﬀerential expression of TACR1 :
gene expression was up-regulated in this brain region in the alcohol-dependent patients
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Table 5.9.: TACR1 gene expression:
mean Ct value ± standard deviation for alcoholics and control subjects
Brain Disease
region status TACR1 GAPDH TACR1GAPDH p-Value
ACC
control 29.76 ± 1.72 19.13 ± 1.51 10.63 ± 1.14
alcohol 29.09 ± 1.09 20.75 ± 2.24 8.34 ± 2.51 0.017 *
Ba9
control 28.26 ± 0.38 19.02 ± 0.19 9.24 ± 0.27
alcohol 28.81 ± 0.86 19.43 ± 0.84 9.38 ± 0.41 0.348
CAU
control 26.80 ± 0.55 19.45 ± 0.33 7.35 ± 0.48
alcohol 27.14 ± 0.99 19.68 ± 0.88 7.47 ± 0.49 0.589
VSt
control 26.62 ± 0.81 19.11 ± 0.58 7.51 ± 0.54
alcohol 27.27 ± 1.07 19.56 ± 0.92 7.71 ± 0.83 0.543
ACC = anterior cingulate cortex, Ba9 = Brodmann's area9,
CAU = caudate nucleus, VSt = ventral striatum, * < 0.05
(Student's t-test: p-value = 0.017). The expression values are depicted in ﬁgure 5.4.
TACR1 mRNA was also quantiﬁed in the collection of Brodmann's area 9 post-mortem
samples from the Human Brain Tissue Bank in Budapest. A preliminary assessment with
Student's t-tests showed an almost signiﬁcant inﬂuence of cause of death (suicide versus
control; p-value = 0.062) on TACR1 gene expression. We therefore restricted the regression
analysis to the control samples. Table 5.10 shows the average of the Ct values for TACR1
and the reference gene GAPDH as well as for the normalised ∆Ct values (=TACR1
GAPDH ) in the control samples for each allele combination at rs3771807.
Table 5.10.: TACR1 gene expression in the control samples:
mean Ct value ± standard deviation for the three genotypes of rs3771807
Genotype Count TACR1 GAPDH TACR1GAPDH
CC 47 31.50 ± 1.11 20.91 ± 1.23 10.59 ± 0.60
CG 21 31.31 ± 1.02 20.93 ± 1.21 10.38 ± 0.68
GG 0   
Like in the case of AUTS2 and RASGRF2, data were then quantile transformed to allow
for the statistical analysis of the inﬂuence of the genotype on gene expression with a general
linear model. The model relating TACR1 gene expression to the rs3771807 genotype, age,
post-mortem interval, RNA integrity number and ancestry showed no inﬂuence of genotype
on gene expression (p-value = 0.681). Ancestry had been included in the model as a stand-
alone t-test had shown an almost signiﬁcant inﬂuence (p-value = 0.081). This eﬀect was no
longer present in the model (p-value = 0.219). Sex had no inﬂuence and was not included
in the analysis. See table 5.11 for details.
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p = 0.017 
Figure 5.4.: TACR1 gene expression in post-mortem tissue samples of alcohol dependent
patients and control subjects. ACC = anterior cingulate cortex, BA9 = Brodmann's area 9,
CAU = caudate putamen, VSt = ventral striatum. Lower normalised ∆Ct values indicate
higher expression levels. Dotted horizontal lines indicate group averages.
Table 5.11.: Inﬂuence of predictor variables on TACR1 gene expression
Variable Estimate Std. Error p-Value
Gene dose 0.105 0.254 0.681
Age -0.013 0.008 0.114
PMI1) 0.081 0.063 0.203
RIN2) 0.012 0.185 0.949
ANCESTRY -0.690 0.554 0.219
1) PMI = post-mortem interval
2) RIN = RNA integrity number
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5.3.4. GRIN3A
We also assessed GRIN3A gene expression in the post-mortem tissue samples of alcohol
addicted patients and control subjects. Table 5.12 shows the Ct values for GRIN3A, the
reference gene GAPDH and the normalised ∆Ct values (=GRIN3AGAPDH ) of each
brain region for the ten control and the ten alcohol addicted subjects.
Table 5.12.: GRIN3A gene expression:
mean Ct value ± standard deviation for alcoholics and control subjects
Brain Disease
region status GRIN3A GAPDH GRIN3AGAPDH p-Value
ACC
control 30.35 ± 3.76 19.13 ± 1.51 11.22 ± 2.44
alcohol 29.49 ± 2.42 20.75 ± 2.24 8.74 ± 2.86 0.052
+
Ba9
control 26.95 ± 0.47 19.02 ± 0.19 7.92 ± 0.42
alcohol 28.04 ± 1.46 19.43 ± 0.84 8.62 ± 0.78 0.024 *
CAU
control 31.68 ± 0.57 19.45 ± 0.33 12.22 ± 0.61
alcohol 31.81 ± 1.51 19.68 ± 0.88 12.13 ± 0.78 0.770
VSt
control 30.52 ± 1.72 19.11 ± 0.58 11.41 ± 1.81
alcohol 30.72 ± 2.58 19.56 ± 0.92 11.16 ± 2.10 0.772
ACC = anterior cingulate cortex, Ba9 = Brodmann's area9,
CAU = caudate nucleus, VSt = ventral striatum, + < 0.10, * < 0.05
The analysis revealed a signiﬁcant down-regulation of GRIN3A in Brodmann's area 9 of
alcohol addicted patients and an almost signiﬁcant up-regulation in the anterior cingulate
cortex of those patients. See also ﬁgure 5.5.
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p = 0.052 p = 0.024
Figure 5.5.: GRIN3A gene expression in post-mortem tissue samples of alcohol dependent
patients and control subjects. ACC = anterior cingulate cortex, BA9 = Brodmann's area 9,
CAU = caudate putamen, VSt = ventral striatum. Lower normalised ∆Ct values indicate
higher expression levels. Dotted horizontal lines indicate group averages.
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5.4. Discussion of candidate gene studies
5.4.1. AUTS2
Our quantitative PCR analysis showed that AUTS2 gene expression in the dorsal prefrontal
cortex is inﬂuenced by the genotype of SNP rs6943555, which lies in the fourth intron of
the AUTS2 gene. The minor A allele correlated with a decreased AUTS2 gene expression.
Schumann et al. (2011) showed in a genome wide association study meta-analysis that the
minor A allele is associated with lower alcohol consumption. We thus speculate, that this
allele lies in a sequence which acts as a cis-regulatory element for AUTS2 gene expression
and that the lower concentration of AUTS2 modiﬁes human behaviour in a way that less
alcohol is consumed.
This hypothesis is corroborated by a meta-analysis of gene expression proﬁles in mouse
models with well-established diﬀerences in voluntary alcohol consumption rats. AUTS2
showed signiﬁcant gene expression diﬀerences in whole brain extracts from the diﬀerent
mouse models. Another study showed that downregulation of the AUTS2 homologous gene
tay in Drosophila melanogaster led to reduced alcohol sensitivity (both studies: Schumann
et al., 2011).
Taken together, these results suggest that AUTS2 is implicated in alcohol use and abuse.
The next step in the analysis of the relationship of AUTS2 to alcohol dependence is a
characterisation of the gene function of AUTS2. Bedogni et al. (2010) used web-based
tools to characterise the protein: AUTS2 is probably not secreted nor integrated in the
cell membrane as no signal peptide was detected. But its N-terminus contains several
nuclear localisation sequences (NLS) suggesting that AUTS2 is a nuclear protein. The
authors managed to conﬁrm this localisation by antibody staining.
A possible next step in the characterisation of the AUTS2 function would be x-ray
cristallography to determine the exact form of the mature protein. This might allow to
deduce the molecular function from its functional groups. Another option would be the
application of two-hybrid assays to determine the molecular partners of this protein.
5.4.2. RASGRF2
The statistical analysis of our quantitative PCR experiment did not reveal a rs29607
genotype-speciﬁc regulation of RASGRF2 in the dorsal prefrontal cortex. We had hypoth-
esised that the known eﬀect of rs26907 on alcohol consumption (Schumann et al., 2011) is
mediated by a cis regulatory mechanism targeting the near-by RASGRF2 promoter. Our
results do not corroborate this hypothesis.
In contrast to our ﬁndings in human brain tissue, RASGRF2 mRNA levels in total
brain extracts from high alcohol-preferring (HAP1) lines were shown to be higher than
those of low alcohol-preferring (LAP1) mouse lines (Mulligan et al., 2006; Stacey et al.,
2012). Given the technical constraints of human post-mortem tissue, which were discussed
in the introduction, we cannot rule out that we missed an existing diﬀerence in RASGRF2
expression due to experimental limitations. It is also possible that a diﬀerential expres-
sion exists in another not-investigated brain region. Consultation of our own microarray
112
5.4. Discussion of candidate gene studies
databases, which are based on rodent models of alcohol consumption, did not reveal a
diﬀerential regulation of RASGRF2 upon alcohol exposure, thus supporting our ﬁnding in
humans.
Stacey et al. (2012) also reported a reduced excitability of dopaminergic neurons in the
ventral tegmental area in RASGRF2-/- mice. This eﬀect correlated with a pronounced
reduction in the alcohol consumption of the animals. The authors speculated that this
mechanism is dependent on a disregulation of the ERK pathway as pharmacological inhi-
bition of this pathways mimicked the alterations in dopaminergic neuron excitability which
had been observed in the knock-out animals. In addition, the authors showed that a haplo-
type block surrounding rs26907 was signiﬁcantly associated with an elevated BOLD signal
in the ventral striatum during reward anticipation in adolescents. The fact that the same
haplotype was associated with increased alcohol consumption in teenagers conﬁrmed our
hypothesis that the genomic area around rs26907 is associated with alcohol consumption.
Our research thus suggests that while there is ample evidence for an implication of SNP
rs29607 and the surrounding gene RASGRF2 in addiction, the mechanism of action is not
dependent on altered gene expression levels of this protein in Brodmann's area 9.
As this is partly in disagreement with ﬁndings from animal studies it would be interesting
to repeat our measurements in another human brain database to obtain more certainty.
The already existing RASGRF2-/- mouse model could be used to measure phosphorylated
versus non-phosphorylated ERK proteins to investigate non-transcription related signalling
events in the presence and absence of RASGRF2.
5.4.3. TACR1
We could partly conﬁrm our hypothesis that alcohol addiction modiﬁes substance P sig-
nalling via a diﬀerential expression of TACR1 but we did not ﬁnd any correlation between
TACR1 gene expression in Brodmann area 9 and the SNP rs3771807. While Brodmann's
area 9, caudate nucleus and ventral striatum showed no signs of diﬀerential regulation of
TACR1 we found a signiﬁcant up-regulation of this gene in the anterior cingulate cortex
of alcohol dependent patients. This brain region is crucial for such tasks as emotional
self-control and motivation (Allman et al., 2001) which could suﬀer from an increased sub-
stance P driven stress level which is indicated by the elevated TACR1 receptor expression.
The lack of diﬀerential expression in the ventral striatum suggests that alcohol-induced
modiﬁcation of substance P signalling and alcohol-related alterations in this area do not
interact with each other.
Our ﬁndings thus corroborate the results of previous studies. Seneviratne et al. (2009)
reported that binding of an antagonist to the TACR1 receptor reduced alcohol self-
administration in mice and craving for alcohol in humans. And Baek et al. (2010) showed
that miRNA-mediated down-regulation of the TACR1 receptor reduced alcohol consump-
tion in mice. The fact that we did not ﬁnd a genotype-speciﬁc TACR1 expression does not
corroborate the hypothesis of our collaborators at the National Institute on Alcohol Abuse
and Alcoholism (NIAAA) that the SNP rs3771807 might be linked to brain activation in
response to alcohol cues via a modulation of TACR1 gene expression.
113
5. Candidate gene expression studies in human post-mortem brain tissue
Our results thus reﬁne previous ﬁndings by indicating that only the anterior cingulate
cortex but not striatal or frontal cortex regions are aﬀected by an interaction between
alcohol and the TACR1 receptor.
These results suggest that pharmacological inhibition of the tachykinin receptor might be
a target for the treatment of alcohol dependent patients. It would be therefore of interest
to analyse the eﬀect of TACR1 inhibitors on drinking levels in rodent models of alcohol
consumption.
5.4.4. GRIN3A
We could show that GRIN3A is signiﬁcantly down-regulated in the dorsal prefrontal cor-
tex and almost signiﬁcantly up-regulated in the anterior cingulate of alcohol dependent
patients. Expression levels in the caudate nucleus and the ventral striatum did not show
signs of alteration. So we can partially conﬁrm our hypothesis that a chronic alcohol
exposure modiﬁes GRIN3A expression.
The up-regulation of GRIN3A in the anterior cingulate cortex upon chronic alcohol con-
sumption can be interpreted as a compensation: The cells of this region compensate the
dampening eﬀect of alcohol on the NMDA receptors by over-production of this receptor
subunit (Qiang et al., 2007). The fact that such an eﬀect cannot be seen in the ven-
trial striatum could be explained by the relative low level of glutamate signalling in this
brain structure (Lape and Dani, 2004). In line with this hypothesis, we also found com-
parably higher GRIN3A Ct values, signifying a lower GRIN3A mRNA concentration, in
this structure in comparison to the other brain regions. The signiﬁcant down-regulation
of GRIN3A in the dorsal prefrontal cortex cannot be explained by the compensation for
reduced NMDA receptor signalling eﬃcacy and we can only speculate if this is due to
an altered NMDA receptor subunit composition in this brain area. The only comparable
human analysis is from Mueller and Meador-Woodruﬀ (2004) who showed that GRIN3A
is strongly up-regulated in the dorsal prefrontal cortex of psychiatric patients suﬀering
from schizophrenia. It is thus interesting to compare our results to studies from rodent
models of alcohol consumption which were treated with the NMDA receptor antagonist
neramexane: lower expression levels of GRIN3A were observed in cortical tissue of rats
from the ALKO Alcohol Accepting (AA) strain which is susceptible to neramexane treat-
ment compared to the non-responsive Marchigian Sardinian alcohol-preferring (msP) rat
strain (Spanagel, 2009; Björk et al., 2010). This might suggest that low cortical GRIN3A
levels are favourable for a neramexane based therapy of alcohol abuse.
Our study therefore delivered supporting evidence for a modulation of GRIN3A gene
expression by alcohol addiction and led to a more precise characterisation of these alter-
ations.
But the down-regulation of GRIN3A in the dorsal prefrontal cortex of alcohol dependent
patients demands further investigation. It would be therefore of great interest to measure
the other NMDA receptor subunits in post-mortem tissue of alcohol addicted and control
subject.
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This thesis consisted of three microarray studies and four candidate gene expression mea-
surements in the context of alcohol addiction and its risk factors.
The ﬁrst study analysed how alcohol consumption changed the daily course of gene ex-
pression in the nucleus accumbens of short-term and long-term drinking rats. The study
was based on overall gene expression measurements by microarray technology and its main
conclusion was that the data did not support a speciﬁc disruption of circadian gene ex-
pression by alcohol.
The second study, also based on a microarray experiment, established diurnal gene
expression curves in the blood of healthy human volunteers. As in the ﬁrst study, the
focus was on genes with circadian oscillating expression levels. The obtained expression
proﬁles can now serve as a baseline for future studies assessing the impact of chronic alcohol
abuse on circadian gene expression in human blood.
The third study, again based on a microarray experiment, had focused on gene expression
diﬀerences in the prefrontal cortex and nucleus accumbens of rats selectively breed for high
and low levels of impulsivity. We discovered several candidate genes, notably P2ry12, Frzb
and Gprc5b, which were signiﬁcantly associated with the degree of impulsivity in the rats.
These candidate genes can now be further validated by screening the degree of impulsivity
in rodents where the genes have been silenced.
In the forth study, we analysed the expression levels of AUTS2, GRIN3A, RASGRF2
and TACR1 in human post-mortem brain tissue by quantitative PCR. We found signiﬁcant
expression diﬀerences in AUTS2 related to the single nucleotide polymorphism (SNP)
rs6943555 which had been associated with alcoholism in a genome-wide association study.
No such diﬀerences were found for RASGRF2 related to SNP rs26907 which had also come
up in the same genome-wide association study. TACR1 was signiﬁcantly up-regulated
in the anterior cingulate cortex of alcohol-dependent patients but its expression was not
linked to SNP rs3771807 which had also been associated with alcoholism. GRIN3A was
signiﬁcantly down-regulated in the dorsal prefrontal cortex of alcohol-dependent patients.
6.1. Study limitations
All subprojects of this thesis were based on the measurement of messenger RNA concentra-
tions. The focus was either on preselected candidate genes or on a hypothesis-free screening
of genome-wide gene expression. During this studies, we faced a number of limiting factors
which are typical for gene expression studies in psychiatric research.
In general, we found only small to moderate changes in gene expression resulting in weak
p-values and small fold changes between the diﬀerent conditions. This is not surprising as
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psychiatric disorders are associated with subtle changes in neuronal function which become
evident in slightly altered expression of genes involved in neurotransmitter production,
secretion and reception, synaptic function and cellular signal processing.
6.1.1. Microarray studies
Our microarray ﬁndings can therefore not be expected to show the same level of diﬀerential
expression as it is the case in studies on cancer (Zhang et al., 2011) or neurological disorders
such as Parkinson's disease (Taccioli et al., 2011). The meaningfulness of our results was
also curtailed by the fact that the messenger RNAs were isolated from brain tissue samples
consisting of multiple cell-types. If voluntary alcohol consumption increases for example
the expression of a gene of interest in medium-spiny neurons of the nucleus accumbens, we
might have been unable to detect this eﬀect as the signal could have been blurred by the
gene's messenger RNA from other neurons and glia cells.
The weak p-values and limited fold change ratios in psychiatric gene expression studies
also aggravate the multiple testing problem. As the expression levels of thousands of genes
are compared between two or more treatment conditions, it becomes diﬃcult to distinguish
true biological diﬀerences from ﬁndings due to random chance. A number of methods have
been proposed to reduce the number of false positives such as the Bonferroni correction
(Abdi, 2007) or the false discovery rate (FDR) (Benjamini and Hochberg, 1995) procedure
but these methods would have eliminated all ﬁndings in our microarray data sets. We
therefore used an uncorrected threshold of statistical signiﬁcance of 0.05 combined with
an cut-oﬀ value for the absolute fold change of 1.2 as an exploratory approach. These
values were weaker than the recommended standards of the DAVID bioinformatics project
(Huang da et al., 2009a).
Remarkably, the microarray study on impulsive rats led to more pronounced expression
diﬀerences than the study on alcohol drinking rats (compare ﬁgure 4.4 on page 77 with
ﬁgure 2.12 on page 34). This is surprising as the animals in the impulsivity study did not
undergo a pharmacological challenge. A possible explanation is that the selective breeding
of the high and low impulsivity rats had a much higher impact on gene expression than
the voluntary consumption of alcohol in an inbred rat strain. We can also not rule out
that the Aﬀymetrix chips used for the impulsivity study had a higher detection eﬃcacy
than the illumina chips used for the alcohol study.
6.1.2. Candidate gene studies in post-mortem tissue
The candidate gene studies, on the other hand, were not so dramatically aﬀected by the
multiple testing problem. Nonetheless, the validity of our gene expression measurements
in the post-mortem tissues was also subject to several limitations. As in the microarray
studies we had used brain region-speciﬁc but not cell type-speciﬁc tissue samples. Gene
expression can also be heavily inﬂuenced by the way of death which means that post-
mortem samples could reveal as much about the way of dying of an individual as about
his way of living (Tomita et al., 2004). Unlike in studies on animal models, there is
no experimental control of confounding factors such as age, sex, comorbidities, diet, life
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style and post-mortem interval. While statistical models can help to reduce this problem,
they fail to include factors for which data are not available. And last but not least, the
neurological foundation of alcohol addiction are likely to vary from one patient to another
given the multifarious progress forms of this psychiatric disorder.
6.2. Conclusions for further studies
Despite of these limitations, we had been able to identify new candidate genes and detect
signiﬁcant expression diﬀerences in human post-mortem tissues in the subprojects. In
addition, several recommendations for future gene expression studies in psychiatric research
can be made based on this thesis. As discussed above, the currently available microarray
technology is plagued by a variety of issues including the multiple testing problem, the
vast amount of probes lacking biological signiﬁcant annotation and a probe design which
reﬂects an outdated state of knowledge concerning the rodent genome. It is therefore worth
considering to abandon the whole genome gene expression measurement approach in favour
of testing smaller, previously selected sets of genes. This could be done using techniques
such as SYBR Green or TaqMan PCR arrays or RNA in situ hybridisation assays which
all allow for the parallel testing of up to several hundred genes (Spurgeon et al., 2008;
Arikawa et al., 2008; Itzkovitz and van Oudenaarden, 2011).
Using cell type-speciﬁc RNA samples for gene expression measurements would signif-
icantly increase the biological conclusiveness of the studies. Laser capture microdissec-
tion might be an interesting method to achieve this goal (McCullumsmith and Meador-
Woodruﬀ, 2011; Pietersen et al., 2011).
6.3. Outlook
While this work dealt with the neurobiological aspects of alcohol addiction, it is important
to stay aware of the multifariousness of this disorder. It is an intricate mesh of childhood
diﬃculties, social surroundings, economic background and psychological factors which to-
gether with a genetic susceptibility drive individuals into addiction.
Successful treatment of alcoholism will need to take all of these factors into account.
Obviously, pharmaceutical intervention with anti-craving drugs has the potential to be a
critical component of such a therapy regime and it is the task of psychopharmacological
research to pave the way for the development of the appropriate drugs.
In this context, the present work added to the general understanding of the molecular
underpinnings of alcohol addiction and showed that neuronal gene expression remains an
important ﬁeld of discovery in psychiatric research. Its scientiﬁc outcome as well as the
proposed follow-up studies will hopefully contribute its share to the development of more
eﬃcient treatment options for alcohol addicts.
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A. Appendix - Human brain tissue banks
Table A.1.: Annotation of brains from the Human Brain Tissue Bank, Budapest
Brain ID Classi- Sex Age PMI1 Cause of death and other
ﬁcation (years) (hours) noteworthy medical conditions
1 control male 63 2 cardiac insuﬃciency, coronary scle-
rosis, earlier myocardial infarction
10 control female 42 2 cardiac insuﬃciency, coronary scle-
rosis, chronic myocardial infarction
11 control male 47 2 acute cardiac insuﬃciency, chronic
myocardial infarction
12 control male 80 2 acute cardiac insuﬃciency, senile,
hypertensive arteriosclerosis
19 control male 56 2 acute myocardial infarction
44 control female 74 6 cardiorespiratory insuﬃciency
47 control female 64 2 heart failure
48 suicide female 72 4 drug overdose
49 control male 52 4 acute myocardial infarction
50 control female 33 1 acute myocardial infarction
51 control female 60 3 acute cardiac insuﬃciency
52 suicide male 45 4 drug overdose
53 suicide male 48 3 drug overdose, alcohol
54 suicide male 47 6 hanging - asphyxia, acute paralytic
stroke
55 suicide male 66 6 hanging - asphyxia
56 suicide male 42 3 hanging - asphyxia, acute paralytic
stroke
57 suicide female 28 6 drug overdose, alcohol, acute heart
failure
58 control female 76 3 traﬃc accident
59 control male 50 4 acute heart failure, senile, hyperten-
sive arteriosclerosis
60 control male 46 4 senile, hypertensive arteriosclerosis;
acute myocardial infarction
61 control male 65 1 pulmonary embolism, arteriosclero-
sis, heart failure
Continued on next page
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Brain ID Classi- Sex Age PMI1 Cause of death and other
ﬁcation (years) (hours) noteworthy medical conditions
63 control male 58 1 acute cardiac insuﬃciency, chronic
myocardial infarction
69 control male 55 1 acute myocardial infarction, earlier
myocardial infarction
71 control male 59 1 coronary stenosis, acute myocardial
infarction
72 control male 83 1 acute cardiac and acute respiratory
insuﬃciency, chronic heart failure
73 control male 43 1 traﬃc accident
74 control male 68 2 chronic heart failure, coronary scle-
rosis
75 control female 38 2 acute cardiac insuﬃciency, chronic
myocardial infarction
76 control female 89 2 cardiac insuﬃciency, coronary arte-
riosclerosis
77 control male 57 1 acute cardiac insuﬃciency, cirrhosis
78 control male 50 1 peritonitis, cardiac and respiratory
insuﬃciency, atrophic cirrhosis
81 control male 40 1 acute myocardial infarction, hyper-
tensive arteriosclerosis
85 control male 68 3 acute myocardial infarction, senile,
hypertensive arteriosclerosis
93 suicide female 43 5 hanging - asphyxia
94 control male 65 1 heart failure, cardiac and respira-
tory insuﬃciency
95 control male 40 4 smoke intoxication
96 control female 58 1 acute myocardial infarction, arte-
riosclerosis
98 control male 74 3 acute myocardial infarction
99 control male 71 2 acute heart failure, arteriosclerosis
105 suicide female 42 3 hanging - asphyxia
106 control male 64 1 acute heart failure, acute cardiac in-
suﬃciency, coronary stenosis
108 control female 63 1 heart failure, chronic myocardial in-
farction
109 control male 67 1 pneumonia, senile, hypertensive ar-
teriosclerosis, cirrhosis
111 control male 55 3 cardiac insuﬃciency
Continued on next page
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Brain ID Classi- Sex Age PMI1 Cause of death and other
ﬁcation (years) (hours) noteworthy medical conditions
112 control male 45 3 respiratory insuﬃciency, coronary
stenosis, acute myocardial infarction
113 control male 81 5 acute cardiac insuﬃciency, previous
myocardial infarction
115 control female 62 6 schizophrenia, Parkinson's disease,
pneumonia
118 suicide male 35 6 hanging - acute respiratory insuﬃ-
ciency
123 control male 58 2 myocardial infarction, earlier
chronic myocardial infarction
136 suicide male 36 6 hanging - asphyxia
138 suicide male 52 3 hanging - asphyxia, acute paralytic
stroke
139 suicide male 79 4 hanging - asphyxia
140 suicide male 49 6 hanging - asphyxia, acute paralytic
stroke
143 suicide male 43 3 hanging - asphyxia
144 suicide male 42 4 hanging - acute paralytic stroke,
acute respiratory insuﬃciency
145 suicide female 36 2 drug overdose - aspiration pneumo-
nia, asphyxia
147 control female 80 1 acute respiratory insuﬃciency, se-
nile, hypertensive arteriosclerosis
151 control male 47 2 pneumonia, earlier myocardial in-
farction, cirrhosis
152 suicide male 32 6 hanging - asphyxia
154 control female 72 4 acute myocardial infarction, earlier
heart failure, arteriosclerosis
155 suicide female 83 6 hanging - asphyxia
156 control male 47 1 heart failure, coronary sclerosis
157 suicide female 48 7 drug overdose
158 suicide male 71 1 jumping from a height
159 suicide male 48 6 hanging - asphyxia
160 control male 50 2 myocardial infarction
162 control male 83 5 Alzheimer-like dementia
163 control female 81 5 global vascular dementia
164 control male 85 3 heart failure
165 control female 88 3 cardiac insuﬃciency, heart failure
167 suicide female 65 5 hanging - asphyxia
Continued on next page
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Brain ID Classi- Sex Age PMI1 Cause of death and other
ﬁcation (years) (hours) noteworthy medical conditions
168 control female 94 6 dementia
169 control female 81 6 dementia with Lewy bodies
170 control male 37 8 electric shock
171 suicide male 31 8 hanging - asphyxia
174 suicide male 57 16 hanging - asphyxia
175 suicide female 49 6 drug overdose
176 suicide male 35 2 drug overdose
177 control female 89 2 cerebral arteriosclerosis, dementia
178 suicide male 43 4 hanging
180 control male 73 6 acute cardiac failure
181 suicide female 42 11 drug overdose
185 control male 80 6 stroke
186 control female 56 5 myocardial infarction
187 control male 62 6 respiratory and cardiac insuﬃciency
188 control female 86 5 Alzheimer's disease, cardiovascular-
respiratory insuﬃciency
189 control female 79 5 cardiac and respiratory insuﬃciency
190 control female 71 7 stroke - cardiovascular-pulmonary
insuﬃciency
191 control female 93 7 Alzheimer's disease, cardiovascular-
respiratory insuﬃciency
192 control male 81 5 heart failure, cardiogenic shock
194 control male 64 4 pneumonia
195 control male 83 6 respiratory and cardiac insuﬃciency
197 control male 64 6 myocardial infarction
198 control female 68 3 pneumonia, respiratory insuﬃciency
199 control female 76 6 heart failure
200 control female 93 6 cardiorespiratory insuﬃciency, pul-
monary embolism
209 control male 52 5 myocardial infarction
211 control female 56 6 cardiac and respiratory insuﬃciency
212 control female 87 6 dementia, myocardial insuﬃciency
213 control male 75 5 bipolar aﬀective psychosis
214 control female 86 4 dementia, myocardial insuﬃciency
215 control female 44 5 myocardial infarction
216 control male 53 5 pulmonary embolism
217 control male 60 5 myocardial infarction
1) PMI = post-mortem interval, i.e. time between death and autopsy
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Table A.2.: Annotation of brains from the New South Wales Tissue Resource Centre
(all subjects were male)
Brain Classi- Age PMI1 Clinical cause Toxicological
ID ﬁcation (years) (hours) of death analysis
182 Alcoholic 66 11.5 pneumonia no blood alcohol
234 Alcoholic 39 24 aortic stenosis not available
243 Alcoholic 70 33.5 respiratory failure no blood alcohol
259 Alcoholic 56 15 ischaemic heart disease, no blood alcohol,
emphysema nordiazepam<0.1mg/l
287 Alcoholic 50 17 ischaemic heart disease not available
417 Alcoholic 58 20 ischaemic heart disease, no blood alcohol,
cirrhosis guaifenesin 8.5mg/l,
ibuprofen 3.5mg/l,
paracetamol 16mg/l,
430 Alcoholic 43 29 intra-abdominal not available
haemorrhage,
sepsis, hepatitis
522 Alcoholic 58 21.5 acute and chronic no blood alcohol,
pancreatitis no drugs
547 Alcoholic 73 19 ischaemic bowel disease, not available
cardiovascular disease
591 Alcoholic 45 18.5 not available not available
97 Control 38 13.5 cardiovascular disease not available
190 Control 68 22 suicide by hanging, citalopram 0.4mg/l,
asphyxia thioridazine 0.6mg/l,
277 Control 50 19 ischaemic heart disease no blood alcohol
295 Control 34 20.5 acute exacerbation not available
of asthma
301 Control 53 16 dilated cardiomyopathy no blood alcohol,
lidocaine 0.9mg/l,
sotalol 3.8µmol/l
329 Control 48 24 ischaemic heart disease not available
367 Control 57 18 ischaemic heart disease HIV negative
510 Control 60 21.5 ischaemic heart disease not performed
518 Control 66 23 ischaemic and hyper- irbesartan 0.6mg/l,
tensive heart disease sulphapyridine detected
598 Control 56 19 arteriosclerotic no blood alcohol,
coronary disease no drugs
1) PMI = post-mortem interval, i.e. time between death and autopsy
123

Bibliography
H. Abdi. Encyclopedia of Measurement and Statistics. Thousand Oaks (CA, USA): Sage,
2007.
A. Acheson, J.L. Robinson, D.C. Glahn, W.R. Lovallo, and P.T. Fox. Diﬀerential activation
of the anterior cingulate cortex and caudate nucleus in persons with a family history of
alcoholism during a gambling simulation: Studies from the Oklahoma Family Health
Patterns Project. Drug Alcohol Depend, 100(1-2):1723, 2009.
A. Achiron and M. Gurevich. Peripheral blood gene expression signature mirrors central
nervous system disease: the model of multiple sclerosis. Autoimmun Rev, 5(8):51722,
2006.
G. Acosta, D.P. Freidman, K.A. Grant, and S.E. Hemby. Alternative splicing of AMPA
subunits in prefrontal cortical ﬁelds of cynomolgus monkeys following chronic ethanol
self-administration. Front Psychiatry, 2:72, 2011.
G.W. Ainslie. Impulse control in pigeons. J Exp Anal Behav, 21(3):4859, 1974.
K. Alexander-Kaufman, G. James, D. Sheedy, C. Harper, and I. Matsumoto. Diﬀerential
protein expression in the prefrontal white matter of human alcoholics: a proteomics
study. Mol Psychiatry, 11(1):5665, 2006.
K. Alexander-Kaufman, S. Cordwell, C. Harper, and I. Matsumoto. A proteome analysis
of the dorsolateral prefrontal cortex in human alcoholic patients. Proteomics Clin Appl,
1(1):6272, 2007.
R.P. Allen and A.M. Wagman. Do sleep patterns relate to the desire for alcohol? Adv Exp
Med Biol, 59:495508, 1975.
J.M. Allman, A. Hakeem, J.M. Erwin, E. Nimchinsky, and P. Hof. The anterior cingulate
cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad
Sci, 935:10717, 2001.
F.H. Allport and G.W. Allport. Personality traits: their classiﬁcation and measurement.
J Abnorm Soc Psychol, 16:640, 1921.
J. Alsiö, K. Nordenankar, E. Arvidsson, C. Birgner, S. Mahmoudi, B. Halbout, C. Smith,
G.M. Fortin, L. Olson, L. Descarries, L.É. Trudeau, K. Kullander, D. Lévesque, and
A. Wallén-Mackenzie. Enhanced sucrose and cocaine self-administration and cue-induced
drug seeking after loss of VGLUT2 in midbrain dopamine neurons in mice. J Neurosci,
31(35):12593603, 2011.
125
Bibliography
S. Amadio, C. Montilli, R. Magliozzi, G. Bernardi, R. Reynolds, and C. Volonté. P2Y12
receptor protein in cortical gray matter lesions in multiple sclerosis. Cereb Cortex, 20
(6):126373, 2010.
O. Ameisen. Complete and prolonged suppression of symptoms and consequences of
alcohol-dependence using high-dose baclofen: a self-case report of a physician. Alco-
hol Alcohol., 40(2):14750, 2005.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders
DSM-IV-TR Fourth Edition. American Psychiatric Pub, 2000.
O. Andersson, A. Stenqvist, A. Attersand, and G. von Euler. Nucleotide Sequence, Ge-
nomic Organization, and Chromosomal Localization of Genes Encoding the Human
NMDA Receptor Subunits NR3A and NR3B. Genomics, 78(3):17884, 2001.
R.F. Anton, G. Oroszi, S. O'Malley, D. Couper, R. Swift, H. Pettinati, and D. Goldman.
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response
in the treatment of alcohol dependence: results from the Combined Pharmacotherapies
and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen
Psychiatry, 65(2):13544, 2008.
O. Arias-Carrión, M. Stamelou, E. Murillo-Rodríguez, M. Menéndez-González, and E. Pöp-
pel. Dopaminergic reward system: a short integrative review. Int Arch Med, 3:24, 2010.
E. Arikawa, Y. Sun, J. Wang, Q. Zhou, B. Ning, S.L. Dial, L. Guo, and J. Yang. Cross-
platform comparison of SYBR Green real-time PCR with TaqMan PCR, microarrays and
other gene expression measurement technologies evaluated in the MicroArray Quality
Control (MAQC) study. BMC Genomics, 9:328, 2008.
A. Arjona and D.K. Sarkar. Circadian oscillations of clock genes, cytolytic factors, and
cytokines in rat NK cells. J Immunol, 174(12):761824, 2005.
A. Arjona, N. Boyadjieva, and D.K. Sarkar. Circadian rhythms of granzyme B, perforin,
IFN-gamma, and NK cell cytolytic activity in the spleen: eﬀects of chronic ethanol. J
Immunol, 172(5):28117, 2004.
R. Asheychik, T. Jackson, H. Baker, R. Ferraro, T. Ashton, and J. Kilgore. The eﬃcacy
of L-tryptophan in the reduction of sleep disturbance and depressive state in alcoholic
patients. J Stud Alcohol, 50(6):52532, 1989.
B. Ataman, J. Ashley, M. Gorczycy, P. Ramachandran, W. Fouquet, S.J. Sigrist, and
V. Budnik. Rapid activity-dependent modiﬁcations in synaptic structure and function
require bidirectional Wnt signaling. Neuron, 57(5):70518, 2008.
M.N. Baek, K.H. Jung, D. Halder, M.R. Choi, B.H. Lee, B.C. Lee, M.H. Jung, I.G. Choi,
M.K. Chung, D.Y. Oh, and Y.G. Chai. Artiﬁcial microRNA-based neurokinin-1 receptor
gene silencing reduces alcohol consumption in mice. Neurosci Lett, 475(3):1248, 2010.
126
Bibliography
S.M. Bankston, D.D. Carroll, S.G. Cron, L.K. Granmayeh, M.T. Marcus, F.G. Moeller,
J.M. Schmitz, P. Swank, and P.R. Liehr. Substance abuser impulsivity decreases with a
nine-month stay in a therapeutic community. Am J Drug Alcohol Abuse, 35(6):41720,
2009.
N.L. Barbosa-Morais, M.J. Dunning, S.A. Samarajiwa, J.F. Darot, M.E. Ritchie, A.G.
Lynch, and S. Tavaré. A re-annotation pipeline for Illumina BeadArrays: improving the
interpretation of gene expression data. Nucleic acids research, 38(3):e17, 2010.
A. Bari, J.W. Dalley, and T.W. Robbins. The application of the 5-choice serial reaction
time task for the assessment of visual attentional processes and impulse control in rats.
Nature Protocols, 3(5):75967, 2008.
F. Bedogni, R.D. Hodge, B.R. Nelson, E.A. Frederick, N. Shiba, R.A. Daza, and R.F.
Hevner. Autism susceptibility candidate 2 (Auts2) encodes a nuclear protein expressed
in developing brain regions implicated in autism neuropathology. Gene Expr Patterns,
10(1):915, 2010.
Y. Benjamini and Y. Hochberg. Controlling the false discovery rate: a practical and
powerful approach to multiple testing. J Roy Statist Soc Ser B, 57(1):289300, 1995.
K.C. Berridge. The depate over dopamine's role in reward: the case for incentive salience.
Psychopharmacology (Berl.), 191(3):391431, 2007.
S. Bezdjian, L.A. Baker, and C. Tuvblad. Genetic and environmental inﬂuences on impul-
sivity: a meta-analysis of twin, family and adoption studies. Clin Psychol Rev, 31(7):
120923, 2011.
I. Biaggioni. Circadian clocks, autonomic rhythms, and blood pressure dipping. Hyperten-
sion, 52(5):7978, 2008.
C. Birgner, K. Nordenankar, M. Lundblad, J.A. Mendez, C. Smith, M. le Grevès, D. Gal-
ter, L. Olson, A. Fredriksson, L.E. Trudeau, K. Kullander, and A. Wallén-Mackenzie.
VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral acti-
vation. Proc Natl Acad Sci U S A, 107(1):38994, 2010.
K. Björk, A.C. Hansson, andW. H. Sommer. Genetic variation and brain gene expression in
rodent models of alcoholism implications for medication development. Int Rev Neurobiol,
91:12971, 2010.
B.M. Bolstad, R.A. Irizarry, M. Astrand, and T.P. Speed. A comparison of normaliza-
tion methods for high density oligonucleotide array data based on variance and bias.
Bioinformatics, 19:185193, 2003.
M. Bots and J.P. Medema. Granzymes at a glance. J Cell Sci, 119(Pt 24):50114, 2006.
M.P. Broca. Remarques sur le siège de la faculté de langage articulé, suivies d'une ob-
servation d'aphémie (perte de parole). Bulletins de la Société anatomique de Paris, 6:
330357, 1861.
127
Bibliography
K. Brodmann. Vergleichende Lokalisationslehre der Großhirnrinde in ihren Prinzipien
dargestellt auf Grund des Zellenbaues. Verlag von Johann Ambrosius Barth, 1909.
K.H. Brower, M.S. Aldrich, E.A. Robinson, R.A. Zucker, and J.F. Greden. Insomnia,
self-medication, and relapse to alcoholism. Am J Psychiatry, 158(3):399404, 2001.
H. Bräuner-Osborne and P. Krogsgaard-Larsen. Sequence and expression pattern of a novel
human orphan G-protein-coupled receptor, GPRC5B, a family C receptor with a short
amino-terminal domain. Genomics, 65(2):1218, 2000.
R.M. Bujis, C.G. van Eden, V.D. Goncharuk, and A. Kalsbeek. The biological clock tunes
the organs of the body: timing by hormones and the autonomic nervous system. J
Endocrinol, 177(1):1726, 2003.
G. Bush, P. Luu, and M.I. Posner. Cognitive and emotional inﬂuences in anterior cingulate
cortex. Trends Cogn Sci, 4(6):215222, 2000.
L. Carim-Todd, M. Escarceller, X. Estivill, and L. Sumoy. Cloning of the novel gene
TM6SF1 reveals conservation of clusters of paralogous genes between human chromo-
somes 15q24>q26 and 19p13.3>p12. Cytogenet Cell Genet, 90(3-4):25560, 2000.
D.B. Carr and A.W. Lipkowski. Neuropeptides and pain. Agressologie, 31(4):1737, 1990.
F.X. Castellanos and R. Tannock. Neuroscience of attention-deﬁcit/hyperactivity disorder:
the search for endophenotypes. Nat Rev Neurosci, 3(8):61728, 2002.
C. Cheadle, M.P. Vawter, W.J. Freed, and K.G. Becker. Analysis of microarray data using
Z score transformation. J Mol Diagn, 5(2):7381, 2003.
C.P. Chen, P. Kuhn, J.P. Advis, and D.K. Sarkar. Chronic ethanol consumption impairs
the circadian rhythm of pro-opiomelanocortin and period genes mRNA expression in the
hypothalamus of the male rat. J Neurochem, 88(6):154754, 2004.
C.P. Chen, P. Kuhn, J.P. Advis, and D.K. Sarkar. Prenatal ethanol exposure alters the
expression of period genes governing the circadian function of beta-endorphin neurons
in the hypothalamus. J Neurochem, 97(4):102633, 2006.
P. Chomczynski and N. Sacchi. Single-step method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162(1):156159, 1987.
A. Christakou, T.W. Robbins, and B.J. Everitt. Prefrontal cortical-ventral striatal in-
teractions involved in aﬀective modulation of attentional performance: implications for
corticostriatal circuit function. J Neurosci, 24(4):77380, 2004.
Y. Chudasama, F. Passetti, S.E. Rhodes, D. Lopian, A. Desai, and T.W. Robbins. Disso-
ciable aspects of performance on the 5-choice serial reaction time task following lesions of
the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: diﬀerential
eﬀects on selectivity, impulsivity and compulsivity. Behav Brain Res, 146(1-2):10519,
2003.
128
Bibliography
J.D. Colbert, A. Plechanovová, and C. Watts. Glycosylation directs targeting and acti-
vation of cystatin f from intracellular and extracellular sources. Traﬃc, 10(4):42537,
2009.
R.T. Cook. Alcohol abuse, alcoholism, and damage to the immune systema review. Alcohol
Clin Exp Res, 22(9):192742, 1998.
T.G. Costa Dias, V.B. Wilson, D.R. Bathula, S.P. Iyer, K.L. Mills, B.L. Thurlow, C.A.
Stevens, E.D. Musser, S.D. Carpenter, D.S. Grayson, S.H. Mitchell, J.T. Nigg, and
D.A. Fair. Reward circuit connectivity relates to delay discounting in children with
attention-deﬁcit/hyperactivity disorder. Eur Neuropsychopharmacol, S0924-977X(12):
30069, 2012.
J.C. Crabbe, R.L. Bell, and C.L. Ehlers. Human and laboratory rodent low response to
alcohol: is better consilience possible? Addict Biol, 15(2):12544, 2010.
D.K. Crawford, J.R. Trudell, E.J. Bertaccini, K. Li, D.L. Davies, and R.L. Alkana. Ev-
idence that ethanol acts on a target in Loop 2 of the extracellular domain of alpha1
glycine receptors. J Neurochem, 102(6):2097109, 2007.
C.P. Cross, L.T. Copping, and A. Campbell. Sex diﬀerences in impulsivity: a meta-analysis.
Psychol Bull., 137(1):97130, 2011.
C.A. Czeisler, J.F. Duﬀy, T.L. Shanahan, E.N. Brown, J.F. Mitchell, D.W. Rimmer, J.M.
Ronda, E.J. Silva, J.S. Allan, J.S. Emens, D.J. Dijk, and R.E. Kronauer. Stability,
precision, and near-24-hour period of the human circadian pacemaker. Science, 284
(5423):217781, 1999.
M. Dai, P. Wang, A. D. Boyd, G. Kostov, B. Athey, E. G. Jones, W. E. Bunney, R. M.
Myers, T. P. Speed, H. Akil, S. J. Watson, and F. Meng. Evolving gene/transcript
deﬁnitions signiﬁcantly alter the interpretation of GeneChip data. Nucleic Acids Res,
33(20):e175, 2005.
J.W. Dalley, B.J. Everitt, and T.W. Robbins. Impulsivity, compulsivity, and top-down
cognitive control. Neuron, 69(4):68094, 2011.
M.H. Dao-Castellana, Y. Samson, F. Legault, J.L. Martinot, H.J. Aubin, C. Crouzel,
L. Feldman, D. Barrucand, G. Rancurel, A. Féline, and A. Syrota. Frontal dysfunction
in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological
ﬁndings. Psychol Med., 28(5):103948, 1998.
M. Daoust, E. Legrand, M. Gewiss, C. Heidbreder, P. DeWitte, G. Tran, and P. Durbin.
Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised
rats. Pharmacology, biochemistry, and behavior, 41(4):66974, 1992.
M.I. Davis. Ethanol-BDNF interactions: Still More Questions than Answers. Pharmacol
Ther, 118(1):3657, 2008.
129
Bibliography
I. Dedova, A. Harding, D. Sheedy, T. Garrick, N. Sundqvist, C. Hunt, J. Gillies, and C.G.
Harper. The importance of brain banks for molecular neuropathological research: The
New South wales tissue resource centre experience. Int J Mol Sci, 10(1):36684, 2009.
M. Devaney, D. Graham, and J. Greeley. Circadian variation of the acute and delayed
response to alcohol: investigation of core body temperature variations in humans. Phar-
macol Biochem Behav, 75(4):8817, 2003.
S.J. Dickman and D.E. Meyer. Impulsivity and speed-accuracy tradeoﬀs in information
processing. J Pers Soc Psychol, 54(2):27490, 1988.
Die Drogenbeauftragte der Bundesregierung. Drogen- und Suchtbericht Mai 2012. Druck-
erei Conrad Gmbh, Berlin, 2012.
H. Dong, P. Zhang, I. Song, R.S. Petralia, D. Liao, and R.L. Huganir. Characterization
of the glutamate receptor-interacting proteins GRIP1 and GRIP2. J Neurosci, 19(16):
693041, 1999.
G. Donmez and T.F. Outeiro. SIRT1 and SIRT2: emerging targets in neurodegeneration.
EMBO Mol Med, 5(3):34452, 2013.
N. Doran, B. Spring, D. McChargue, M. Pergadia, and M. Richmond. Impulsivity and
smoking relapse. Nicotine Tob Res, 6(4):6417, 2004.
F. Dosseville, S. Laborde, and R. Lericollais. Validation of a Chronotype Questionnaire
Including an Amplitude Dimension. Chronobiol Int, 30(5):63948, 2013.
G.E. Duﬃeld, J.D. Best, B.H. Meurers, A. Bittner, J.J. Loros, and J.C. Dunlap. Circa-
dian programs of transcriptional activation, signaling, and protein turnover revealed by
microarray analysis of mammalian cells. Curr Biol, 12(7):5517, 2002.
J. Durana and P. Barnes. The Impulsive Client: Theory, Research, and Treatment, chapter
A neurodevelopmental view of impulsivity and its relationship to the superfactors of
personality. American Psychological Association (APA), 1996.
D.M. Eagle, A. Bari, and T.W. Robbins. The neuropsychopharmacology of action inhibi-
tion: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology
(Berl.), 199(3):43956, 2008.
A.M. Egbert. The older alcoholic: recognizing the subtle clinical clues. Geriatrics, 48(7):
636, 1993.
L.A. Ehrman, M.T. Williams, T.L. Schaefer, G.A. Gudelsky, T.M. Reed, A.A. Fien-
berg, P. Greengard, and C.V. Vorhees. Phosphodiesterase 1B diﬀerentially modulates
the eﬀects of methamphetamine on locomotor activity and spatial learning through
DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout
mice. Genes Brain Behav, 5(7):54051, 2006.
130
Bibliography
M.A. Enoch, Z. Zhou, M. Kimura, D.C. Mash, Q. Yuan, and D. Goldman. GABAer-
gic gene expression in postmortem hippocampus from alcoholics and cocaine addicts;
corresponding ﬁndings in alcohol-naïve P and NP rats. PLoS One, 7(1):e29369, 2012.
K.D. Ersche, A.J. Turton, S. Pradhan, E.T. Bullmore, and T.W. Robbins. Drug Ad-
diction Endophenotypes: Impulsive Versus Sensation-Seeking Personality Traits. Biol
Psychiatry, 68(8):770773, 2010.
J.L. Evenden. Varieties of impulsivity. Psychopharmacology (Berl.), 46(4):34861, 1999.
J.L. Evenden and C.N. Ryan. The pharmacology of impulsive behaviour in rats: the eﬀects
of drugs on response choice with varying delays of reinforcement. Psychopharmacology
(Berl.), 128(2):16170, 1996.
B.J. Everitt, J.A. Parkinson, M.C. Olmstead, M. Arroyo, P. Robledo, and T.W. Robbins.
Associative processes in addiction and reward. The role of amygdala-ventral striatal
subsystems. Ann N Y Acad Sci, 877:41238, 1999.
Y.Z. Farnell, G.C. Allen, S.S. Nahm, N. Neuendorﬀ, J.R. West, W.J. Chen, and D.J.
Earnest. Neonatal alcohol exposure diﬀerentially alters clock gene oscillations within
the suprachiasmatic nucleus, cerebellum, and liver of adult rats. Alcohol Clin Exp Res,
32(3):54452, 2008.
S. Fasano and R. Brambilla. Ras-ERK Signaling in Behavior: Old Questions and New
Perspectives. Front Behav Neurosci, 5:79, 2011.
S. Fasano, A. D'Antoni, P.C. Orban, E. Valjent, E. Putignano, H. Vara, T. Pizzorusso,
M. Giustetto, B. Yoon, P. Soloway, R. Maldonado, J. Caboche, and R. Brambilla. Ras-
guanine nucleotide-releasing factor 1 (Ras-GRF1) controls activation of extracellular
signal-regulated kinase (ERK) signaling in the striatum and long-term behavioral re-
sponses to cocaine. Biol Psychiatry, 66(8):75868, 2009.
D.T. Fei, H. Paxton, and A.B. Chen. Diﬃculties in precise quantitation of CD4+ T
lymphocytes for clinical trials: a review. Biologicals, 21(3):22131, 1993.
P.B. Fitzgerald, T.J. Oxley, A.R. Laird, J. Kulkarni, G.F. Egan, and Z.J. Daskalakis. An
analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in
depression. Psychiatry Res, 148(1):3345, 2006.
G. Freund and K.J. Anderson. Glutamate receptors in the frontal cortex of alcoholics.
Alcohol Clin Exp Res, 20(7):116572, 1996.
E. Fries, L. Dettenborn, and C. Kirschbaum. The cortisol awakening response (CAR):
facts and future directions. Int J Psychophysiol, 72(1):6773, 2009.
C. Fukuhara and G. Tosini. Analysis of daily and circadian gene expression in the rat
pineal gland. Neurosci Res, 60(2):192198, 2008.
131
Bibliography
T. Furmark, L. Appel, A. Michelgård, K. Wahlstedt, F. Ahs, S. Zancan, E. Jacobsson,
K. Flyckt, M. Groph, M. Bergström, E.M. Pich, L.G. Nilsson, M. Bani, B. Långström,
and M. Fredrikson. Cerebral blood ﬂow changes after treatment of social phobia with
the neurokinin-1 antagonist GR205171, citalopram, or placebo. Biol Psychiatry, 58(2):
13242, 2005.
M.E. Futschik and H. Herzel. Are we overestimating the number of cell-cycling genes?
The impact of background models on time-series analysis. Bioinformatics, 24(8):10639,
2008.
L. Gautier, L. Cope, B.M. Bolstad, and R.A. Irizarry. aﬀyanalysis of Aﬀymetrix
GeneChip data at the probe level. Bioinformatics, 20(3):307315, 2004.
D.T. George, J. Gilman, J. Hersh, A. Thorsell, D. Herion, C. Geyer, X. Peng, W. Kiel-
basa, R. Rawlings, J.E. Brandt, D.R. Gehlert, J.T. Tauscher, S.P. Hunt, D. Hommer,
and M. Heilig. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
Science, 319(5869):15369, 2008.
M.S. George, R.F. Anton, C. Bloomer, C. Teneback, D.J. Drobes, J.P. Lorberbaum, Z. Na-
has, and D.J. Vincent. Activation of prefrontal cortex and anterior thalamus in alcoholic
subjects on exposure to alcohol-speciﬁc cues. Arch Gen Psychiatry, 58(4):34552, 2001.
J. R. Gerstner and J. C. Yin. Circadian rhythms and memory formation. Nat. Rev.
Neurosci., 11(8):577588, 2010.
J.E. Gibbs, J. Blaikley, S. Beesley, L. Matthews, K.D. Simpson, S.H. Boyce, S.N. Farrow,
K.J. Else, D. Singh, D.W. Ray, and A.S. Loudon. The nuclear receptor REV-ERBα
mediates circadian regulation of innate immunity through selective regulation of inﬂam-
matory cytokines. Proc Natl Acad Sci U S A, 109(2):5827, 2012.
J.M. Gilman, A.R. Smith, V.A. Ramchandani, R. Momenan, and D.W. Hommer. The
eﬀect of intravenous alcohol on the neural correlates of risky decision making in healthy
social drinkers. Addict Biol, 17(2):46578, 2012.
R.Z. Goldstein and N.D. Volkow. Drug Addiction and Its Underlying Neurobiological Basis:
Neuroimaging Evidence for the Involvement of the Frontal Cortex. Am J Psychiatry,
159:16421652, 2002.
H. Gray. Anatomy of the human body. Lea & Febiger, 20th edition, 1918.
A.M. Graybiel. The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol,
15(6):63844, 2005.
A.C. Hall, F.R. Lucas, and P.C. Salinas. Axonal remodeling and synaptic diﬀerentiation
in the cerebellum is regulated by WNT-7a signaling. Cell, 100(5):52535, 2000.
G. Hamilton, J.D. Colbert, A.W. Schuettelkopf, and C. Watts. Cystatin F is a cathepsin
C-directed protease inhibitor regulated by proteolysis. EMBO J, 27(3):499508, 2008.
132
Bibliography
N.K. Hansell, A. Agrawal, J.B. Whitﬁeld, K.I. Morley, S.D. Gordon, P.A. Lind, M.L.
Pergadia, G.W. Montgomery, P.A. Madden, R.D. Todd, A.C. Heath, and N.G. Martin.
Can we identify genes for alcohol consumption in samples ascertained for heterogeneous
purposes? Alcohol Clin Exp Res, 33(4):72939, 2009.
E.S. Hansen, S. Hasselbalch, I. Law, and T.G. Bolwig. The caudate nucleus in obsessive-
compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET
study. Int J Neuropsychopharmacol, 5(1):110, 2002.
Y. Harada, C. Yokota, R. Habas, D.C. Slusarski, and X. He. Retinoic Acid-Inducible G
Protein-Coupled Receptors Bind to Frizzled Receptors and May Activate Non-canonical
Wnt Signaling. Biochem Biophy Res Commun, 358(4):96875, 2007.
B.P. Hasler, L.J. Smith, J.C. Cousins, and R.R. Bootzin. Circadian rhythms, sleep, and
substance abuse. Sleep Med Rev, 16(1):6781, 2012.
M.H. Hastings. Central clocking. Trends Neurosci, 20(10):45964, 1997.
M.L. Hastings, H.A. Ingle, M.A. Lazar, and S.H. Munroe. Post-transcriptional regulation
of thyroid hormone receptor expression by cis-acting sequences and a naturally occurring
antisense RNA. J Biol Chem, 275(15):1150713, 2000.
S.E. Haynes, G. Hollopeter, G. Yang, D. Kurpius, M.E. Dailey, W.B. Gan, and D. Julius.
The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat
Neurosci, 9(12):15129, 2006.
L. Heimer and R.D. Wilson. The subcortical projections of the allocortex: similarities
in the neural associations of the hippocampus, the piriform cortex, and the neocortex.
In M. Santini, editor, Golgi Centennial Symposium, pages 177193. Raven Press, New
York, 1975.
F. Heinrich, A.and Nees, A. Lourdusamy, J. Tzschoppe, S. Meier, S. Vollstädt-Klein,
M. Fauth-Bühler, S. Steiner, C. Bach, L. Poustka, T. Banaschewski, G.J. Barker,
C. Büchel, P.J. Conrod, H. Garavan, J. Gallinat, A. Heinz, B. Ittermann, E. Loth,
K. Mann, E. Artiges, T. Paus, C. Lawrence, Z. Pausova, M.N. Smolka, A. Ströhle,
M. Struve, S.H. Witt, G. Schumann, H. Flor, M. Rietschel, and The IMAGEN consor-
tium. From gene to brain to behavior: schizophrenia-associated variation in AMBRA1
alters impulsivity-related traits. Eur J Neurosci, [Epub ahead of print], 2013.
P. Heiser, M. Heinzel-Gutenbrunner, J. Frey, J. Smidt, J. Grabarkiewicz, S. Friedel,
W. Kühnau, J. Schmidtke, H. Remschmidt, and J. Hebebrand. Twin study on her-
itability of activity, attention, and impulsivity as assessed by objective measures. J
Atten Disord, 9(4):57581, 2006.
A. Herz. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl.),
129(2):99111, 1997.
133
Bibliography
S.P. Hinshaw. Impulsivity, emotion regulation, and developmental psychopathology: speci-
ﬁcity versus generality of linkages. Ann N Y Acad Sci, 1008:14959, 2003.
B. Hoang, M.Jr. Moos, S. Vukicevic, and F.P. Luyten. Primary structure and tissue
distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in
skeletal morphogenesis. J Biol Chem, 271(42):261317, 1996.
A. Holmes, M. Heilig, N.M. Rupniak, T. Steckler, and G. Griebel. Neuropeptide systems
as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci,
24(11):5808, 2003.
M.C. Huang, C.W. Ho, C.H. Chen, S.C. Liu, C.C. Chen, and S.J. Leu. Reduced expression
of circadian clock genes in male alcoholic patients. Alcohol Clin Exp Res, 34(11):1899
904, 2010.
W. Huang da, B.T. Sherman, and R.A. Lempicki. Systematic and integrative analysis of
large gene lists using DAVID bioinformatics resources. Nat Protoc, 4(1):4457, 2009a.
W. Huang da, B.T. Sherman, and R.A. Lempicki. Bioinformatics enrichment tools: paths
toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res, 37
(1):113, 2009b.
B.L. Hungund and B.S. Basavarajappa. Role of endocannabinoids and cannabinoid CB1
receptors in alcohol-related behaviors. Ann N Y Acad Sci, 1025:51527, 2004.
M. Iijima, T. Nikaido, M. Akiyama, T. Moriya, and S. Shibata. Methamphetamine-induced,
suprachiasmatic nucleus-independent circadian rhythms of activity and mPer gene ex-
pression in the striatum of the mouse. Eur J Neurosci, 16(5):9219, 2002.
International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide
screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J
Hum Genet, 69(3):57081, 2001.
R.A. Irizarry, B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and
T.P. Speed. Exploration, normalization, and summaries of high density oligonucleotide
array probe level data. Biostatistics, 4(2):24964, 2003.
S. Itzkovitz and A. van Oudenaarden. Validating transcripts with probes and imaging
technology. Nat Methods, 8(4 Suppl):S129, 2011.
M. Jacobsen, D. Repsilber, A. Gutschmidt, A. Neher, K. Feldmann, H.J. Mollenkopf,
A. Ziegler, and S.H. Kaufmann. Ras-associated small GTPase 33A, a novel T cell factor,
is down-regulated in patients with tuberculosis. J Infect Dis, 192(7):12118, 2005.
B.J. Janssen, C.M. Tyssen, H. Duindam, and W.J. Rietveld. Suprachiasmatic lesions
eliminate 24-h blood pressure variability in rats. Physiol Behav, 55(2):30711, 1994.
R.D. Jindal. Insomnia in patients with depression: some pathophysiological and treatment
considerations. CNS Drugs, 23(4):30929, 2009.
134
Bibliography
K.H. Joe, Y.K. Kim, T.S. Kim, S.W. Roh, S.W. Choi, Y.B. Kim, H.J. Lee, and D.J.
Kim. Decreased plasma brain-derived neurotrophic factor levels in patients with alcohol
dependence. Alcohol Clin Exp Res, 31(11):18338, 2007.
B.A. Johnson. Update on neuropharmacological treatments for alcoholism: scientiﬁc basis
and clinical ﬁndings. Biochem Pharmacol, 75(1):3456, 2008.
B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, K. Beyers, A. McKay,
N. Ait-Daoud, R.F. Anton, D.A. Ciraulo, H.R. Kranzler, K. Mann, S.S. O'Malley, R.M.
Swift, Topiramate for Alcoholism Advisory Board, and Topiramate for Alcoholism Study
Group. Topiramate for treating alcohol dependence: a randomized controlled trial.
JAMA, 298(14):164151, 2007.
E.M. Jones, D. Knutson, and D. Haines. Common problems in patients recovering from
chemical dependency. Am Fam Physician, 68(10):19718, 2003.
P.W. Kalivas. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci, 10
(8):56172, 2009.
P.W. Kalivas and N.D. Volkow. The Neural Basis of Addiction: A Pathology of Motivation
and Choice. Am J Psychiatry, 162:14031413, 2005.
L.S. Kaplow. Cytochemical heterogeneity of human circulating monocytes. Acta Cytol, 19
(4):35865, 1975.
F. Kasanetz, V. Deroche-Gamonet, N. Berson, E. Balado, M. Lafourcade, O. Manzoni,
and P.V. Piazza. Transition to addiction is associated with a persistent impairment in
synaptic plasticity. Science, 328(5986):170912, 2010.
Y. Kawano, C.S. Pontes, H. Abe, S. Takishita, and T. Omae. Eﬀects of alcohol consumption
and restriction on home blood pressure in hypertensive patients: serial changes in the
morning and evening records. Clin Exp Hypertens, 24(1-2):339, 2002.
A. Kawasaki, Y. Shinkai, H. Yagita, and K. Okumura. Expression of perforin in murine
natural killer cells and cytotoxic T lymphocytes in vivo. Eur J Immunol, 22(5):12159,
1992.
F. Kiefer, H. Jahn, T. Tarnaske, H. Helwig, P. Briken, R. Holzbach, P. Kämpf, R. Stracke,
M. Baehr, D. Naber, and K. Wiedemann. Comparing and combining naltrexone and
acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled
study. Arch Gen Psychiatry, 60(1):929, 2003.
H.W. Kim, S.I. Rapoport, and J.S. Rao. Altered expression of apoptotic factors and
synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis, 37
(3):596603, 2010.
135
Bibliography
T. Kishi, T. Kitajima, K. Kawashima, T. Okochi, Y. Yamanouchi, Y. Kinoshita, H. Ujike,
T. Inada, M. Yamada, N. Uchimura, I. Sora, M. Iyo, N. Ozaki, and N. Iwata. As-
sociation Analysis of Nuclear Receptor Rev-erb Alpha Gene (NR1D1) and Japanese
Methamphetamine Dependence. Curr Neuropharmacol, 9(1):12932, 2011.
E.B. Klermann, D.W. Rimmer, D.J. Dijk, R.E. Kronauer, J.F. Rizzo, and C.A. Czeisler.
Nonphotic entrainment of the human circadian pacemaker. Am J Physiol, 274(4 Pt 2):
R9916, 1998.
C.H. Ko and J.S. Takahashi. Molecular components of the mammalian circadian clock.
Hum Mol Genet, 15(2):R2717, 2006.
G.F. Koob. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol
addiction as a reward deﬁcit disorder. Curr Top Behav Neurosci, 13:330, 2013.
G.F. Koob and N.D. Volkow. Neurocircuitry of Addiction. Neuropsychopharmacology, 35:
21738, 2010.
E. Kowalska and S.A. Brown. Peripheral clocks: keeping up with the master clock. Cold
Spring Harb Symp Quant Biol, 72:3015, 2007.
T.P. Laine, A. Ahonen, P. Räsänen, and J. Tiihonen. Dopamine transporter availability
and depressive symptoms during alcohol withdrawal. Psychiatry Res, 90(3):1537, 1999.
H.P. Landolt and J.C. Gillin. Sleep abnormalities during abstinence in alcohol-dependent
patients. Aetiology and management. CNS Drugs, 15(5):41325, 2001.
R. Lape and J.A. Dani. Complex response to aﬀerent excitatory bursts by nucleus accum-
bens medium spiny projection neurons. J Neurophysio, 92(3):127684, 2004.
B. Lemmer, K. Witte, H. Enzminger, S. Schiﬀer, and S. Hauptﬂeisch. Transgenic
TGR(mREN2)27 rats as a model for disturbed circadian organization at the level of
the brain, the heart, and the kidneys. Chronobiol Int, 20(4):71138, 2003.
L. Leyns, T. Bouwmeester, S.H. Kim, S. Piccolo, and E.M. De Robertis. Frzb-1 is a
secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell, 88(6):
74756, 1997.
J.Z. Li, B.G. Bunney, F. Meng, M.H. Hagenauer, D.M. Walsh, M.P. Vawter, S.J. Evans,
P.V. Choudary, P. Cartagena, J.D. Barchas, A.F. Schatzberg, E.G. Jones, R.M. Myers,
S.J.Jr. Watson, H. Akil, and W.E. Bunney. Circadian patterns of gene expression in the
human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A,
110(24):99505, 2013.
S.X. Li, L.J. Liu, W.G. Jiang, and L. Lu. Morphine withdrawal produces circadian rhythm
alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear
cells in rats. J Neurochem, 109(6):166879, 2009.
136
Bibliography
S.X. Li, L.J. Liu, W.G. Jiang, L.L. Sun, S.J. Zhou, B. Le Foll, X.Y. Zhang, T.R. Kosten,
and L. Lu. Circadian alteration in neurobiology during protracted opiate withdrawal in
rats. J Neurochem, 115(2):35362, 2010.
K. Lin, S. Wang, M.A. Julius, J. Kitajewski, M. Jr. Moos, and F.P. Luyten. The cysteine-
rich frizzled domain of Frzb-1 is required and suﬃcient for modulation of Wnt signaling.
Proc Natl Acad Sci U S A, 94(21):11196200, 1997.
G.A. Lincoln, F.J. Ebling, and O.F. Almeida. Generation of melatonin rhythms. Ciba
Found Symp, 117:12948, 1985.
J. Littleton. Acamprosate in alcohol dependence: how does it work? Addiction, 90(9):
117988, 1995.
J. Liu, E. Walter, D. Stenger, and D. Thach. Eﬀects of Globin mRNA Reduction Methods
on Gene Expression Proﬁles from Whole Blood. The Journal of Molecular Diagnostics,
8(5):551558, 2006.
M.K. Lobo and E.J. Nestler. The striatal balancing act in drug addiction: distinct roles of
direct and indirect pathway medium spiny neurons. Front Neuroanat, 5(41):111, 2011.
M. Loos, S. van der Sluis, Z. Bochdanovits, I.J. van Zutphen, T. Pattij, O. Stiedl, Neuro-
BSIK Mouse Phenomics consortium, A.B. Smit, and S. Spijker. Activity and impulsive
action are controlled by diﬀerent genetic and environmental factors. Genes Brain Behav,
8(8):81728, 2009.
P.L. Lowrey and J.S. Takahashi. Genetics of circadian rhythms in Mammalian model
organisms. Adv Genet, 74:175230, 2011.
A. Manasco, S. Chang, J. Larriviere, L.L. Hamm, and M. Glass. Alcohol withdrawal. South
Med J, 105(11):60712, 2012.
H. Manev and T. Uz. Clock genes: inﬂuencing and being inﬂuenced by psychoactive drugs.
Trends Pharmacol Sci, 27(4):1869, 2006.
K. Mann, F. Kiefer, R. Spanagel, and J. Littleton. Acamprosate: recent ﬁndings and future
research directions. Alcohol Clin Exp Res, 32(7):110510, 2008.
K. Mann, A. Bladström, L. Torup, A. Gual, and W. van den Brink. Extending the Treat-
ment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed
Nalmefene. Biol Psychiatry, S0006-3223(12):009420, 2012.
T.A. Manolio. Genomewide association studies and assessment of the risk of disease. N
Engl J Med, 363(2):16676, 2010.
C.G. Marfella, Y. Ohkawa, A.H. Coles, D.S. Garlick, S.N. Jones, and A.N. Imbalzano.
Mutation of the SNF2 family member Chd2 aﬀects mouse development and survival. J
Cell Physiol, 209(1):16271, 2006.
137
Bibliography
B.J. Mason, A.M. Goodman, S. Chabac, and P. Lehert. Eﬀect of oral acamprosate on
abstinence in patients with alcohol dependence in a double-blind, placebo-controlled
trial: the role of patient motivation. J Psychiatr Res, 40(5):38393, 2006.
S. Masubuchi, S. Honma, H. Abe, K. Ishizaki, M. Namihira, M. Ikeda, and K. Honma.
Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor
activity rhythm in rats. Eur J Neurosci, 12(12):420614, 2000.
F. Matthäus, V.A. Smith, A. Fogtman, W.H. Sommer, F. Leonardi-Essmann, A. Lour-
dusamy, M.A. Reimers, R. Spanagel, and P.J. Gebicke-Haerter. Interactive molecu-
lar networks obtained by computer-aided conversion of microarray data from brains of
alcohol-drinking rats. Pharmacopsychiatry, 42 Suppl1:S11828, 2009.
M.M. Maxwell, E.M. Tomkinson, J. Nobles, J.W. Wizeman, A.M. Amore, L. Quinti,
V. Chopra, S.M. Hersch, and A.G. Kazantsev. The Sirtuin 2 microtubule deacetylase is
an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet, 20
(20):398696, 2011.
R.R. McCrae and P.T. Costa. Validation of the ﬁve-factor model of personality across
instruments and observers. J Pers Soc Psychol, 52(1):8190, 1987.
R.E. McCullumsmith and J.H. Meador-Woodruﬀ. Novel approaches to the study of post-
mortem brain in psychiatric illness: old limitations and new challenges. Biol Psychiatry,
69(2):12733, 2011.
J.E. McCutcheon and M Marinelli. Age matters. Eur J Neurosci, 29(5):9971014, 2009.
P.O. McGowan and M. Szyf. The epigenetics of social adversity in early life: implications
for mental health outcomes. Neurobiol Dis, 39(1):6672, 2010.
M.W. Meinhardt, A.C. Hansson, S. Perreau-Lenz, C. Bauder-Wenz, O. Stählin, M. Heilig,
C. Harper, K.U. Drescher, R. Spanagel, and W. H. Sommer. Rescue of infralimbic
mGluR2 deﬁcit restores control over drug-seeking behavior in alcohol dependence. J
Neurosci, 33(7):2794806, 2013.
R.I. Melendez, J.F. McGinty, P.W. Kalivas, and H.C. Becker. Brain region-speciﬁc gene
expression changes after chronic intermittent ethanol exposure and early withdrawal in
C57BL/6J mice. Addict Biol, 17(2):35164, 2012.
W.R. Miller, S.T. Walters, and M.E. Bennett. How eﬀective is alcoholism treatment in the
United States? J Stud Alcohol, 62(2):21120, 2001.
F.G. Moeller, E.S. Barratt, D.M. Dougherty, J.M. Schmitz, and A.C. Swann. Psychiatric
aspects of impulsivity. Am J Psychiatry, 158(11):178393, 2001.
J.A. Mohawk, C.B. Green, and J.S. Takahashi. Central and peripheral circadian clocks in
mammals. Annu Rev Neurosci, 35:44562, 2012.
138
Bibliography
M.P. Moisan, B. Llamas, M.N. Cook, and P. Mormède. Further dissection of a genomic
locus associated with behavioral activity in the Wistar-Kyoto hyperactive rat, an animal
model of hyperkinesis. Mol Psychiatry, 8(3):34852, 2003.
A. Molander, H.H. Lidö, E. Löf, M. Ericson, and B. Söderpalm. The glycine reuptake
inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats. Alcohol
Alcohol, 42(1):118, 2007.
P.E. Molina, K.I. Happel, P. Zhang, J.K. Kolls, and S. Nelson. Focus on: alcohol and the
immune system. Alcohol Res Health, 33(1):97108, 2010.
H.T. Mueller and J.H. Meador-Woodruﬀ. NR3A NMDA receptor subunit mRNA expres-
sion in schizophrenia, depression and bipolar disorder. Schizophr Res, 71(2-3):36170,
2004.
H. Muhle, S. von Spiczak, V. Gaus, S. Kara, I. Helbig, J. Hampe, A. Franke, Y. Weber,
H. Lerche, A.A. Kleefuss-Lie, C.E. Elger, S. Schreiber, U. Stephani, and T. Sander.
Role of GRM4 in idiopathic generalized epilepsies analysed by genetic association and
sequence analysis. Epilepsy Res, 89(2-3):31926, 2010.
M.K. Mulligan, I. Ponomarev, R.J. Hitzemann, J.K. Belknap, B. Tabakoﬀ, R.A. Harris,
J.C. Crabbe, Y.A. Blednov, N.J. Grahame, T.J. Phillips, D.A. Finn, P.L. Hoﬀman,
V.R. Iyer, G.F. Koob, and S.E. Bergeson. Toward understanding the genetics of alcohol
drinking through transcriptome meta-analysis. Proc. Natl. Acad. Sci. U.S.A., 130(16):
636873, 2006.
E.R. Murphy, J.W. Dalley, and T.W. Robbins. Local glutamate receptor antagonism in
the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task.
Psychopharmacology (Berl.), 179(1):99107, 2005.
T. Nagatsu. Tyrosine hydroxylase: human isoforms, structure and regulation in physiology
and pathology. Essays Biochem, 30:1535, 1995.
P. Najt, J. Perez, M. Sanches, M.A. Peluso, D. Glahn, and J.C. Soares. Impulsivity and
bipolar disorder. Eur Neuropsychopharmacol, 17(5):31320, 2007.
K. Nakamura and O. Hikosaka. Role of Dopamine in the Primate Caudate Nucleus in
Reward Modulation of Saccades. J Neurosci, 26(20):53609, 2006.
N. Nakaya, H.S. Lee, Y. Takada, I. Tzchori, and S.I. Tomarev. Zebraﬁsh olfactomedin 1
regulates retinal axon elongation in vivo and is a modulator of Wnt signaling pathway.
J Neurosci, 28(31):790010, 2008.
R.A. Nicholas. Identiﬁcation of the P2Y12 Receptor: A Novel Member of the P2Y Family
of Receptors Activated by Extracellular Nucleotides. Mol Pharmacol, 60(3):41620, 2001.
S.L. Nichols and D.A. Waschbusch. A review of the validity of laboratory cognitive tasks
used to assess symptoms of ADHD. Child Psychiatry Hum Dev, 34(4):2997315, 2004.
139
Bibliography
F.A. Nielsen, D. Balslev, and L.K. Hansen. Mining the posterior cingulate: segregation
between memory and pain components. Neuroimage, 27(3):52032, 2005.
R.D. Oades and G.M. Halliday. Ventral tegmental (A10) system: neurobiology. 1. Anatomy
and connectivity. Brain Res., 434(2):11765, 1987.
K. Oishi, K. Sakamoto, T. Okada, T. Nagase, and N. Ishida. Antiphase circadian expres-
sion between BMAL1 and period homologue mRNA in the suprachiasmatic nucleus and
peripheral tissues of rats. Biochem Biophy Res Commun, 253(2):199203, 1998.
M.F. Olive, H.N. Koenig, M.A. Nannini, and C.W. Hodge. Stimulation of endorphin
neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J
Neurosci, 21(23):RC184, 2001.
J.S. O'Neill and A.B. Reddy. Circadian clocks in human red blood cells. Nature, 469(7331):
498503, 2011.
M. Otsuka and M. Yanagisawa. Pain and neurotransmitters. Cell Mol Neurobiol, 10(3):
293302, 1990.
S. Pachernegg, N. Strutz-Seebohm, and M. Hollmann. GluN3 subunit-containing NMDA
receptors: not just one-trick ponies. Trends Neurosci, 35(4):2409, 2012.
M.G. Packard and B.J. Knowlton. Learning and memory functions of the basal ganglia.
Annu Rev Neurosci, 25:56393, 2002.
T.Y. Pang, T. Renoir, X. Du, A.J. Lawrence, and A.J. Hannan. Depression-related be-
haviours displayed by female C57BL/6J mice during abstinence from chronic ethanol
consumption are rescued by wheel-running. Eur J Neurosci, 37(11):180310, 2013.
M.A. Patestas and L.P. Gartner. A Textbook of Neuroanatomy. Blackwell Publishers, 2006.
J.H. Patton, M.S. Stanford, and E.S. Barratt. Factor structure of the Barratt impulsiveness
scale. J Clin Psychol, 51(6):76874, 1995.
G. Paxinos and C. Watson. The Rat Brain in Stereotaxic Coordinates. Elsevier, 4 edition,
1998.
B. Peng, R.K. Yu, K.L. Dehoﬀ, and C.I. Amos. Normalizing a large number of quantitative
traits using empirical normal quantile transformation. BMC Proc, 1 Suppl 1:S156, 2007.
J.L. Perry and M.E. Carroll. The role of impulsive behavior in drug abuse. Psychophar-
macology (Berl.), 200(1):126, 2008.
C.Y. Pietersen, M.P. Lim, L. Macey, T.U. Woo, and K.C. Sonntag. Neuronal type-speciﬁc
gene expression proﬁling and laser-capture microdissection. Methods Mol Biol, 755:327
43, 2011.
140
Bibliography
H.H. Pothuizen, A.L. Jongen-Rêlo, J. Feldon, and B.K. Yee. Double dissociation of the
eﬀects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour
and salience learning in rats. Eur J Neurosci, 22(10):260516, 2005.
M. Qiang, A.D. Denny, and M.K. Ticku. Chronic intermittent ethanol treatment selectively
alters N-methyl-D-aspertate receptor subunit surface expression in cultured cortical neu-
rons. Mol Pharmacol, 72(1):95102, 2007.
L. Quartara and C.A. Maggi. The tachykinin NK1 receptor. Part I: Ligands and mecha-
nisms of cellular activation. Neuropeptides, 31(6):537563, 1997.
J. Radua and D. Mataix-Cols. Voxel-wise meta-analysis of grey matter changes in obsessive-
compulsive disorder. Br J Psychiatry, 195(5):393402, 2009.
M. Randi¢, H. He¢imovi¢, and P.D. Ryu. Substance P modulates glutamate-induced cur-
rents in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett, 117(1-2):7480,
1990.
R.C. Raymond, M. Warren, R.W. Morris, and J.B. Leikin. Periodicity of presentations of
drugs of abuse and overdose in an emergency department. J Toxicol Clin Toxicol, 30(3):
46778, 1992.
W. Renthal, A. Kumar, G. Xiao, M. Wilkinson, H.E.3rd. Covington, I. Maze, D. Sikder,
A.J. Robison, Q. LaPlant, D.M. Dietz, S.J. Russo, V. Vialou, S. Chakravarty, T.J.
Kodadek, M. Stack, A. Kabbaj, and E.J. Nestler. Genome-wide analysis of chromatin
regulation by cocaine reveals a role for sirtuins. Neuron, 62(3):33548, 2009.
A.F. Ribeiro, D. Correia, A.A. Torres, G.R. Boas, A.V. Rueda, R. Camarini, S. Chiaveg-
atto, R. Boerngen-Lacerda, and A.L. Brunialti-Godard. A transcriptional study in mice
with diﬀerent ethanol-drinking proﬁles: possible involvement of the GABA(B) receptor.
Pharmacol Biochem Behav, 102(2):22432, 2012.
M.J. Robbins, K.J. Charles, D.C. Harrison, and M.N. Pangalos. Localisation of the
GPRC5B receptor in the rat brain and spinal cord. Mol Brain Res, 106(1-2):136144,
2002.
T.W. Robbins. The 5-choice serial reaction time task: behavioural pharmacology and
functional neurochemistry. Psychopharmacology (Berl.), 163(3-4):362380, 2002.
Z.A. Rodd, R.L. Bell, H.J. Sable, J.M. Murphy, and W.J. McBride. Recent advances in
animal models of alcohol craving and relapse. Pharmacol Biochem Behav, 79(3):43950,
2004.
R.S. Ronimus and H.W. Morgan. Cloning and biochemical characterization of a novel
mouse ADP-dependent glucokinase. Biochem Biophy Res Commun, 315(3):6528, 2004.
A.M. Rosenwasser and M.C. Fixaris. Chronobiology of alcohol: Studies in C57BL/6J and
DBA/2J inbred mice. Physiol Behav, 110-111:1407, 2013.
141
Bibliography
A.M. Rosenwasser, M.E. Fecteau, and R.W. Logan. Eﬀects of ethanol intake and ethanol
withdrawal on free-running circadian activity rhythms in rats. Physiol Behav, 84(4):
53742, 2005.
G.J. Royce and E.J. Laine. Eﬀerent connections of the caudate nucleus, including cortical
projections of the striatum and other basal ganglia: An autoradiographic and horseradish
peroxidase investigation in the cat. J Comp Neurol, 226(1):2849, 2004.
K. Rubia, T. Russell, S. Overmeyer, M.J. Brammer, E.T. Bullmore, T. Sharma, A. Sim-
mons, S.C. Williams, V. Giampietro, C.M. Andrew, and E. Taylor. Mapping motor
inhibition: conjunctive brain activations across diﬀerent versions of go/no-go and stop
tasks. Neuroimage, 13(2):25061, 2001.
S. Rösner, A. Hackl-Herrwerth, S. Leucht, P. Lehert, S. Vecchi, and M. Soyka. Acamprosate
for alcohol dependence. Cochrane Database Syst Rev, 8(9):CD004332, 2010.
L. Sachs and J. Hedderich. Angewandte Statistik. Springer, 12 edition, 2006.
A. Sahu. Intracellular leptin-signaling pathways in hypothalamic neurons: the emerging
role of phosphatidylinositol-3 kinase-phosphodiesterase-3B-cAMP pathway. Neuroen-
docrinology, 93(4):20110, 2011.
F. Saint-Preux, L.R. Bores, I. Tulloch, B. Ladenheim, R. Kim, P.K. Thanos, N.D. Volkow,
and J.L. Cadet. Chronic co-administration of nicotine and methamphetamine causes
diﬀerential expression of immediate early genes in the dorsal striatum and nucleus ac-
cumbens of Rats. Neuroscience, 243:8996, 2013.
R. Sandberg and O. Larsson. Improved precision and accuracy for microarrays using
updated probe set deﬁnitions. BMC bioinformatics, 8:48, 2007.
M. Sazdanovi¢, P. Sazdanovi¢, I. Zivanovi¢-Macuzi¢, V. Jakovljevi¢, D. Jeremi¢, A. Peljto,
and J. Tosevski. Neurons of the human nucleus accumbens. Vojnosanit Pregl, 68(8):
65560, 2011.
F.A. Scheer, C. Pirovano, E.J. Van Someren, and R.M. Buijs. Environmental light and
suprachiasmatic nucleus interact in the regulation of body temperature. Neuroscience,
132(2):46577, 2005.
C. Scheiermann, Y. Kunisaki, and P.S. Frenette. Circadian control of the immune system.
Nat Rev Immunol, 13(3):1908, 2013.
M. Schmitz, R. Frey, P. Pichler, H. Röpke, P. Anderer, B. Saletu, and S. Rudas. Sleep
quality during alcohol withdrawal with bright light therapy. Prog Neuropsychopharmacol
Biol Psychiatry, 21(6):96577, 1997.
G. Schumann, L. J. Coin, A. Lourdusamy, P. Charoen, K. H. Berger, D. Stacey, S. Desriv-
ieres, F. A. Aliev, A. A. Khan, N. Amin, Y. S. Aulchenko, G. Bakalkin, S. J. Bakker,
B. Balkau, J. W. Beulens, A. Bilbao, R. A. de Boer, D. Beury, M. L. Bots, E. J. Breetvelt,
142
Bibliography
S. Cauchi, C. Cavalcanti-Proenca, J. C. Chambers, T. K. Clarke, N. Dahmen, E. J.
de Geus, D. Dick, F. Ducci, A. Easton, H. J. Edenberg, T. Esko, T. Esk, A. Fernandez-
Medarde, T. Foroud, N. B. Freimer, J. A. Girault, D. E. Grobbee, S. Guarrera, D. F.
Gudbjartsson, A. L. Hartikainen, A. C. Heath, V. Hesselbrock, A. Hofman, J. J. Hot-
tenga, M. K. Isohanni, J. Kaprio, K. T. Khaw, B. Kuehnel, J. Laitinen, S. Lobbens,
J. Luan, M. Mangino, M. Maroteaux, G. Matullo, M. I. McCarthy, C. Mueller, G. Navis,
M. E. Numans, A. Nunez, D. R. Nyholt, C. N. Onland-Moret, B. A. Oostra, P. F.
O'Reilly, M. Palkovits, B. W. Penninx, S. Polidoro, A. Pouta, I. Prokopenko, F. Ric-
ceri, E. Santos, J. H. Smit, N. Soranzo, K. Song, U. Sovio, M. Stumvoll, I. Surakk,
T. E. Thorgeirsson, U. Thorsteinsdottir, C. Troakes, T. Tyrﬁngsson, A. Tonjes, C. S.
Uiterwaal, A. G. Uitterlinden, P. van der Harst, Y. T. van der Schouw, O. Staehlin,
N. Vogelzangs, P. Vollenweider, G. Waeber, N. J. Wareham, D. M. Waterworth, J. B.
Whitﬁeld, E. H. Wichmann, G. Willemsen, J. C. Witteman, X. Yuan, G. Zhai, J. H.
Zhao, W. Zhang, N. G. Martin, A. Metspalu, A. Doering, J. Scott, T. D. Spector,
R. J. Loos, D. I. Boomsma, V. Mooser, L. Peltonen, K. Stefansson, C. M. van Duijn,
P. Vineis, W. H. Sommer, J. S. Kooner, R. Spanagel, U. A. Heberlein, M. R. Jarvelin,
and P. Elliott. Genome-wide association and genetic functional studies identify autism
susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc.
Natl. Acad. Sci. U.S.A., 108(17):71197124, 2011.
W.J. Schwartz, A. Jr. Carpino, H.O. de la Iglesia, R. Baler, D.C. Klein, Y. Nakabeppu, and
N. Aronin. Diﬀerential regulation of fos family genes in the ventrolateral and dorsomedial
subdivisions of the rat suprachiasmatic nucleus. Neuroscience, 98(3):53547, 2000.
C. Seneviratne, N. Ait-Daoud, J.Z. Ma, G. Chen, B.A. Johnson, and M.D. Li. Susceptibil-
ity locus in neurokinin-1 receptor gene associated with alcohol dependence. Neuropsy-
chopharmacology, 34(11):24429, 2009.
P. Sengupta. A Scientiﬁc Review of Age Determination for a Laboratory Rat: How Old is
it in Comparison with Human Age? Biomedicine International, 2:8189, 2011.
D. Sheedy, T. Garrick, I. Dedova, C. Hunt, R. Miller, N. Sundqvist, and C. Harper. An
Australian Brain Bank: a critical investment with a high return! Cell Tissue Bank, 9
(3):20516, 2008.
H. Shibata, A. Tani, T. Chikuhara, R. Kikuta, M. Sakai, H. Ninomiya, N. Tashiro, N. Iwata,
N. Ozaki, and Y. Fukumaki. Association study of polymorphisms in the group III
metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia. Psychi-
atry Res, 167(1-2):8896, 2009.
Y. Shigeri, R.P. Seal, and K. Shimamoto. Molecular pharmacology of glutamate trans-
porters, EAATs and VGLUTs. Brain Res Brain Res Rev, 45(3):25065, 2004.
J.D. Sinclair. Evidence about the use of naltrexone and for diﬀerent ways of using it in
the treatment of alcoholism. Alcohol Alcohol., 36(1):210, 2001.
143
Bibliography
J.H. Sitz, K. Baumgärtel, B. Hämmerle, C. Papadopoulos, P. Hekerman, F.J. Teje-
dor, W. Becker, and B. Lutz. The Down syndrome candidate dual-speciﬁcity tyro-
sine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related
septin 4. Neuroscience, 157(3):596605, 2008.
J.A. Siuciak, S.A. McCarthy, D.S. Chapin, T.M. Reed, C.V. Vorhees, and D.R.
Repaske. Behavioral and neurochemical characterization of mice deﬁcient in the
phosphodiesterase-1B (PDE1B) enzyme. Neuropharmacology, 53(1):11324, 2007.
Y. Smith and A. Parent. Diﬀerential connections of caudate nucleus and putamen in the
squirrel monkey (Saimiri sciureus). Neuroscience, 18(2):34771, 1986.
R. Spanagel. Alcoholism: a systems approach from molecular physiology to addictive
behavior. Physiol Rev, 89(2):649705, 2009.
R. Spanagel and M. Heilig. Addiction and its brain science. Addiction, 100(12):181322,
2005.
R. Spanagel and S. M. Hölter. Long-term alcohol self-administration with repeated alcohol
deprivation phases: an animal model of alcoholism? Alcohol Alcohol., 34(2):231243,
1999.
R. Spanagel and F. Kiefer. Drugs for relapse prevention of alcoholism: ten years of progress.
Trends Pharmacol Sci, 29(3):10915, 2008.
R. Spanagel and F. Weiss. The dopamine hypothesis of reward: past and current status.
Trends Neurosci, 22(11):5217, 1999.
R. Spanagel, G. Pendyala, C. Abarca, T. Zghoul, C. Sanchis-Segura, M.C. Magnone, J. Las-
corz, M. Depner, D. Holzberg, M. Soyka, S. Schreiber, F. Matsuda, M. Lathrop, G. Schu-
mann, and U. Albrecht. The clock gene Per2 inﬂuences the glutamatergic system and
modulates alcohol consumption. Nat Med, 11(1):3542, 2005.
S.L. Spurgeon, R.C. Jones, and R. Ramakrishnan. High throughput gene expression mea-
surement with real time PCR in a microﬂuidic dynamic array. PLoS One, 3(2):e1662,
2008.
D. Stacey, A. Bilbao, M. Maroteaux, T. Jia, A. C. Easton, S. Longueville, C. Nymberg,
T. Banaschewski, G. J. Barker, C. Buchel, F. Carvalho, P. J. Conrod, S. Desrivieres,
M. Fauth-Buhler, A. Fernandez-Medarde, H. Flor, J. Gallinat, H. Garavan, A. L. Bokde,
A. Heinz, B. Ittermann, M. Lathrop, C. Lawrence, E. Loth, A. Lourdusamy, K. F. Mann,
J. L. Martinot, F. Nees, M. Palkovits, T. Paus, Z. Pausova, M. Rietschel, B. Rug-
geri, E. Santos, M. N. Smolka, O. Staehlin, M. R. Jarvelin, P. Elliott, W. H. Sommer,
M. Mameli, C. P. Muller, R. Spanagel, J. A. Girault, G. Schumann, and the IMAGEN
Consortium. RASGRF2 regulates alcohol-induced reinforcement by inﬂuencing mesolim-
bic dopamine neuron activity and dopamine release. Proc. Natl. Acad. Sci. U.S.A., 18
(51):2112821133, 2012.
144
Bibliography
A.D. Stan, S. Ghose, X.M. Gao, R.C. Roberts, K. Lewis-Amezcua, K.J. Hatanpaa, and
Tamminga C.A. Human Postmortem Tissue: What Quality Markers Matter? Brain
Res., 1123(1):111, 2006.
P.F. Sullivan, C. Fan, and C.M. Perou. Evaluating the comparability of gene expression
in blood and brain. Am J Med Genet B Neuropsychiatr Genet, 141B(3):2618, 2006.
R. Sultana, C.E. Yu, J. Yu, J. Munson, D. Chen, W. Hua, A. Estes, F. Cortes, F. de la
Barra, D. Yu, S.T. Haider, B.J. Trask, E.D. Green, W.H. Raskind, C.M. Disteche, E. Wi-
jsman, G. Dawson, D.R. Storm, G.D. Schellenberg, and E.C. Villacres. Identiﬁcation of
a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair
of autistic twins. Genomics, 80(2):12934, 2002.
R.M. Swift. Naltrexone and nalmefene: any meaningful diﬀerence? Biol Psychiatry, 73
(8):7001, 2013.
C. Taccioli, J. Tegnér, V. Maselli, D. Gomez-Cabrero, G. Altobelli, W. Emmett, F. Lescai,
S. Gustincich, and E. Stupka. ParkDB: a Parkinson's disease gene expression database.
Database (Oxford), 2011:bar007, 2011.
Y. Takeda, K.B. Chou, J. Takeda, B.S. Sachais, and J.E. Krause. Molecular cloning,
structural characterization and functional expression of the human substance P receptor.
Biochem Biophy Res Commun, 179(3):123240, 1991.
R. Taylor. Interpretation of the Correlation Coeﬃcient: A Basic Review. JDMS, 1:3539,
1990.
M. Teboul, M.A. Barrat-Petit, X.M. Li, B. Claustrat, J.L. Formento, F. Delaunay, F. Lévi,
and G. Milano. Atypical patterns of circadian clock gene expression in human peripheral
blood mononuclear cells. J Mol Med (Berl), 83(9):6939, 2005.
SW Thompson. "Daimon Drink": Ancient Greek and Roman Explanations for Drunken-
ness. Christian Spirituality and Science, 8(1):119, 2010.
H. Tomita, M.P. Vawter, D.M. Walsh, S.J. Evans, P.V. Choudary, J. Li, K.M. Overman,
M.E. Atz, R.M. Myers, E.G. Jones, S.J. Watson, H. Akil, and W.E.Jr. Bunney. Eﬀect of
agonal and postmortem factors on gene expression proﬁle: quality control in microarray
analyses of postmortem human brain. Biol Psychiatry, 55(4):34652, 2004.
J.A. Trapani. Target cell apoptosis induced by cytotoxic T cells and natural killer cells
involves synergy between the pore-forming protein, perforin, and the serine protease,
granzyme B. Aust N Z J Med, 25(6):7939, 1995.
M. Trepel. Neuroanatomie: Struktur und Funktion. Urban & Fischer Verlag/Elsevier
GmbH, 4th edition, 2008.
P. Triﬁlieﬀ and D. Martinez. Imaging addiction: D2 receptors and dopamine signaling in
the striatum as biomarkers for impulsivity. Neuropharmacology, [Epub ahead of print]pii:
S0028-3908(13):003006, 2013.
145
Bibliography
I. Ubeda-Bañon, A. Novejarque, A. Mohedano-Moriano, P. Pro-Sistiaga, C. de la Rosa-
Prieto, R. Insausti, F. Martinez-Garcia, E. Lanuza, and A. Martinez-Marcos. Projections
from the posterolateral olfactory amygdala to the ventral striatum: neural basis for
reinforcing properties of chemical stimuli. BMC Neurosci, 8:103, 2007.
N.A. Uranova, V.M. Vostrikov, D.D. Orlovskaya, and V.I. Rachmanova. Oligodendroglial
density in the prefrontal cortex in schizophrenia and mood disorders: a study from the
Stanley Neuropathology Consortium. Schizophr Res, 67(2-3):26975, 2004.
T. Uz, M. Akhisaroglu, R. Ahmed, and H. Manev. The pineal gland is critical for circa-
dian Period1 expression in the striatum and for circadian cocaine sensitization in mice.
Neuropsychopharmacology, 28(12):211723, 2003.
H.H. van Rossum, F.P. Romijn, K.J. Sellar, N.P. Smit, P.J. van der Boog, J.W. de Fijter,
and J. van Pelt. Variation in leukocyte subset concentrations aﬀects calcineurin activity
measurement: implications for pharmacodynamic monitoring strategies. Clin Chem, 54
(3):51724, 2008.
J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, A. De Paepe, and
F. Speleman. Accurate normalization of real-time quantitative RT-PCR data by geo-
metric averaging of multiple internal control genes. Genome Biol, 3(7):RESEARCH0034,
2002.
G. Varga, A. Szekely, P. Antal, P. Sarkozy, Z. Nemoda, Z. Demetrovics, and M. Sasvari-
Szekely. Additive eﬀects of serotonergic and dopaminergic polymorphisms on trait im-
pulsivity. Am J Med Genet B Neuropsychiatr Genet, 159B(3):2818, 2012.
L.F. Vendruscolo, E. Terenina-Rigaldie, F. Raba, A. Ramos, R.N. Takahashi, and P. Mor-
mède. A QTL on rat chromosome 7 modulates prepulse inhibition, a neuro-behavioral
trait of ADHD, in a Lewis x SHR intercross. Behav Brain Funct, 12:221, 2006.
V. Vengeliene, F. Leonardi-Essmann, W.H. Sommer, H.M. Marston, and R. Spanagel.
Glycine transporter-1 blockade leads to persistently reduced relapse-like alcohol drinking
in rats. Biol Psychiatry, 68(8):70411, 2010.
B.A. Vogt and D.N. Pandya. Cingulate cortex of the rhesus monkey: II. Cortical aﬀerents.
J Comp Neurol, 262(2):27189, 1987.
B.A. Vogt and G. Paxinos. Cytoarchitecture of mouse and rat cingulate cortex with human
homologies. Brain Struct Funct, [Epub ahead of print]:18, 2012.
B.A. Vogt, D.N. Pandya, and D.L. Rosene. Cingulate cortex of the rhesus monkey: I.
Cytoarchitecture and thalamic aﬀerents. J Comp Neurol, 262(2):25670, 1987.
B.A. Vogt, E.A. Nimchinsky, L.J. Vogt, and P.R. Hof. Human cingulate cortex: Surface
features, ﬂat maps, and cytoarchitecture. J Comp Neurol, 359(3):490506, 2004.
U.S. von Euler and J.H. Gaddum. An unidentiﬁed depressor substance in certain tissue
extracts. J Physiol, 72:7487, 1931.
146
Bibliography
M.Wan, K. Hejjas, Z. Ronai, Z. Elek, M. Sasvari-Szekely, F.A. Champagne, A. Miklósi, and
E. Kubinyi. DRD4 and TH gene polymorphisms are associated with activity, impulsivity
and inattention in Siberian Husky dogs. Anim Genet, [Epub ahead of print], 2013.
J.A. Wasielewski and F.A. Holloway. Alcohol's interactions with circadian rhythms. A
focus on body temperature. Alcohol Res Health, 25(2):94100, 2001.
M. Watanabe, A. Hida, S. Kitamura, M. Enomoto, Y. Ohsawa, Y. Katayose, K. Nozaki,
Y. Moriguchi, S. Aritake, S. Higuchi, M. Tamura, M. Kato, and K. Mishima. Rhythmic
expression of circadian clock genes in human leukocytes and beard hair follicle cells.
Biochem Biophys Res Commun, 425(4):9027, 2012.
D.R. Weaver. The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms, 13
(2):10012, 1998.
H. Weiner, R.D. Myers, C.W. Simpson, and M.S. Thurman. The Eﬀect of Alcohol on
Dopamine Metabolism in the Caudate Nucleus of an Unanesthetized Monkey. Alcohol
Clin Exp Res, 4(4):42730, 1980.
H. Wijnen. Circadian rhythms. A circadian loop asSIRTs itself. Science, 324(5927):5989,
2009.
C.A. Winstanley, D.M. Eagle, and T.W. Robbins. Behavioral models of impulsivity in
relation to ADHD: translation between clinical and preclinical studies. Clin Psychol
Rev, 26(4):37995, 2006.
R.A. Wise and M.A. Bozarth. Brain reward circuitry: four circuit elements "wired" in
apparent series. Brain Res Bull, 12(2):2038, 1984.
J.T. Wolstenholme, J.A. Warner, M.I. Capparuccini, K.J. Archer, K.L. Shelton, and M.F.
Miles. Genomic analysis of individual diﬀerences in ethanol drinking: evidence for non-
genetic factors in C57BL/6 mice. PLoS One, 6(6):e21100, 2011.
A.H. Wong, B.K. Lipska, O. Likhodi, E. Boﬀa, D.R. Weinberger, J.L. Kennedy, and H.H.
Van Tol. Cortical gene expression in the neonatal ventral-hippocampal lesion rat model.
Schizophr Res, 77(2-3):26170, 2005.
H. Yan, L. Tian, W. Yan, J. Sun, Q. Liu, Y.B. Zhang, X.M. Li, Y.F. Zhang, and D. Zhang.
Functional and anatomical connectivity abnormalities in cognitive division of anterior
cingulate cortex in schizophrenia. PLoS One, 7(9):e45659, 2012.
Q.S. Yan, M.J. Feng, and S.E. Yan. Diﬀerent expression of brain-derived neurotrophic
factor in the nucleus accumbens of alcohol-preferring (P) and -nonpreferring (NP) rats.
Brain Res, 1035(2):2158, 2005.
J. Zalewska-Kaszubska, B. Bajer, D. Gorska, D. Andrzejczak, W. Dyr, and P. Bie«kowski.
Eﬀect of repeated treatment with topiramate on voluntary alcohol intake and beta-
endorphin plasma level in Warsaw alcohol high-preferring rats. Psychopharmacology
(Berl.), 225(2):27581, 2013.
147
Bibliography
A. Zavada, M.C. Gordijn, D.G. Beersma, S. Daan, and T. Roenneberg. Comparison of the
Munich Chronotype Questionnaire with the Horne-Ostberg's Morningness-Eveningness
Score. Chronobiol Int, 22(2):26778, 2005.
M.L. Zeise, S.G. Madamba, G.R. Siggins, J. Putzke, and W. Ziegelgansberger. The anti-
craving substance Acamprosate reduces glutamatergic synaptic transmission and a high
threshold calcium current in neocortical and hippocampal pyramidal neurons. Alcohol
Clin Exp Res, 18(2):36A, 1994.
H. Zhang, H.R. Kranzler, B.Z. Yang, X. Luo, and J. Gelernter. The OPRD1 and OPRK1
loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence
risk. Mol Psychiatry, 13(5):53143, 2008.
J. Zhang, X. Dong, Y. Fujimoto, and H. Okamura. Molecular signals of Mammalian
circadian clock. Kobe J Med Sci, 50(3-4):1019, 2004.
J. Zhang, J. Baran, A. Cros, J.M. Guberman, S. Haider, J. Hsu, Y. Liang, E. Rivkin,
J. Wang, B. Whitty, M. Wong-Erasmus, L. Yao, and A. Kasprzyk. International Cancer
Genome Consortium Data Portala one-stop shop for cancer genomics data. Database
(Oxford), 2011:bar026, 2011.
B. Zheng, D.W. Larkin, U. Albrecht, Z.S. Sun, M. Sage, G. Eichele, C.C. Lee, and
A. Bradley. The mPer2 gene encodes a functional component of the mammalian cir-
cadian clock. Nature, 400(6740):16973, 1999.
148
Publications with content from this thesis
Pitzoi S, Petretto E, Mar AC, Theobald DE, Yolanda Pena O, Jordan ER, Atanur S,
Srivastava P, Saar K, Huebner N, Sommer WH, Staehlin O, Spanagel R, Robinson ES,
Schuhmann G, Everitt BJ, Robbins T, Schumann G, Aitman TJ, Dalley JW ( - ) Inte-
grated transcriptional proﬁling and linkage analysis of high impulsive behaviour in rats.
Status: in preparation.
Stacey D, Bilbao A, Maroteaux M, Jia T, Easton AC, Longueville S, Nymberg C, Ba-
naschewski T, Barker GJ, Büchel C, Carvalho F, Conrod P, Desrivières S, Fauth-Buehler
M, Fernandez-Medarde A, Flor H, Gallinat J, Garavan H, Bokde A, Heinz A, Ittermann B,
Lathrop M, Lawrence C, Loth E, Lourdusamy A, Mann K, Martinot J-L, Nees F, Palkovits
M, Paus T, Pausova Z, Rietschel M, Ruggeri B, Santos E, Smolka MN, Staehlin O, Jarvelin
MJ, Elliott P, Sommer WH, Mameli M, Müller CP, Spanagel R, Girault JA, Schumann
G, and the IMAGEN consortium (www.imagen-europe.com)(2012) RASGRF2 regulates
alcohol-induced reinforcement by inﬂuencing mesolimbic dopamine neuron activity and
dopamine release. Proc Natl Acad Sci U.S.A. 109(51):21128-33.
doi: 10.1073/pnas.1211844110
G. Schumann, L. J. Coin, A. Lourdusamy, P. Charoen, K. H. Berger, D. Stacey, S.
Desriv- ieres, F. A. Aliev, A. A. Khan, N. Amin, Y. S. Aulchenko, G. Bakalkin, S. J.
Bakker, B. Balkau, J. W. Beulens, A. Bilbao, R. A. de Boer, D. Beury, M. L. Bots, E. J.
Breetvelt, S. Cauchi, C. Cavalcanti-Proenca, J. C. Chambers, T. K. Clarke, N. Dahmen, E.
J. de Geus, D. Dick, F. Ducci, A. Easton, H. J. Edenberg, T. Esko, T. Esk, A. Fernandez-
Medarde, T. Foroud, N. B. Freimer, J. A. Girault, D. E. Grobbee, S. Guarrera, D. F. Gud-
bjartsson, A. L. Hartikainen, A. C. Heath, V. Hesselbrock, A. Hofman, J. J. Hot- tenga,
M. K. Isohanni, J. Kaprio, K. T. Khaw, B. Kuehnel, J. Laitinen, S. Lobbens, J. Luan,
M. Mangino, M. Maroteaux, G. Matullo, M. I. McCarthy, C. Mueller, G. Navis, M. E.
Numans, A. Nunez, D. R. Nyholt, C. N. Onland-Moret, B. A. Oostra, P. F. O'Reilly, M.
Palkovits, B. W. Penninx, S. Polidoro, A. Pouta, I. Prokopenko, F. Ric- ceri, E. Santos,
J. H. Smit, N. Soranzo, K. Song, U. Sovio, M. Stumvoll, I. Surakk, T. E. Thorgeirsson, U.
Thorsteinsdottir, C. Troakes, T. Tyrﬁngsson, A. Tonjes, C. S. Uiterwaal, A. G. Uitterlin-
den, P. van der Harst, Y. T. van der Schouw, O. Staehlin, N. Vogelzangs, P. Vollenweider,
G. Waeber, N. J. Wareham, D. M. Waterworth, J. B. Whitﬁeld, E. H. Wichmann, G.
Willemsen, J. C. Witteman, X. Yuan, G. Zhai, J. H. Zhao, W. Zhang, N. G. Martin, A.
Metspalu, A. Doering, J. Scott, T. D. Spector, R. J. Loos, D. I. Boomsma, V. Mooser,
L. Peltonen, K. Stefansson, C. M. van Duijn, P. Vineis, W. H. Sommer, J. S. Kooner, R.
Spanagel, U. A. Heberlein, M. R. Jarvelin, and P. Elliott (2011) Genome-wide association
149
Publications with content from this thesis
and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in
the regulation of alcohol consumption. Proc Natl Acad Sci U.S.A. 108(17):7119-24.
doi: 10.1073/pnas.1017288108
150
Acknowledgments
My sincere gratitude goes to Professor Spanagel for accepting me at the Institute of Psy-
chopharmacology and for giving me the opportunity to pursue a PhD in the ﬁeld of addic-
tion biology. I wish to thank Dr. Wolfgang Sommer for the overall guidance throughout
my PhD studies and the abundance of scientiﬁc input he has given me. I'm also very
thankful to Prof. Gebicke-Härter for sharing his ideas with me and letting me participate
in the study on circadian rhythms in human blood.
I'm particularly grateful to Elisabeth, our technical assistant, for all her support and
advise. I owe a debt of gratitude to Stéphanie Perreau-Lenz who introduced me so enthu-
siastically to circadian rhythm research.
My deepest thanks go to all the people who shared the oﬃce with me: Marcus Meinhardt,
Laura Broccoli, Natalie Hirth, Stefanie Uhrig and all the others students and guests who
shared their ideas so wonderfully and helped me stay upbeat. I'm also indebted to Fernando
Leonardi-Essmann who introduced me to the statistical software R and who has been a
great partner in many fruitful discussions about my projects and addiction research in
general.
I also wish to thank all the other people of my research group. Valentina Vengeliene,
Anita Hansson, Rick Bernardi, Ainhoa Bilbao Leis, Miriam Schneider, Chris Friemel, Peggy
Schneider, Hamid Noori and Briac Halbout helped me in so many ways and I'm deeply
thankful for that.
Special thanks go to Josef Frank, whose readiness to share his statistical and R program-
ming skills was of inestimable value to me. My sincere gratitude goes also to Franziska
Matthäus and Lily Villarín Pildaín from the Interdisciplinary Center for Scientiﬁc Com-
puting in Heidelberg who provided vital input to the circadian rhythm studies, shared
their technical expertise and taught me how to set up a proper LaTeX document. The
numerous consultations with Dr. Jennen-Steinmetz from the department of Biostatistics
at the Central Institute of Mental Health have always been very helpful. I'm very thankful
for this excellent support.
I also wish to express my thanks to the staﬀ of the microarray core facility of the
DKFZ and the respective unit of the university medical centre in Mannheim. Sabine
Henze, Oliver Heil, Melanie Bewerunge-Hudler and Maria Sailer were all very helpful in
overcoming technical hurdles so that we could obtain the diﬀerent gene expression data
sets.
There surely would be many more names which I should mention here. I hope their
missing will not be regarded as a sign of ingratitude and that you will indulgently overlook
the shortcomings of my memory.
Last but not least I wish to thank my family and friends for their ongoing support.
151
